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ABSTRACT
The mortality rate due to behavioral causes among veterans diagnosed with chronic posttraumatic stress disorder (PTSD) is much higher than the rate found among the normal
population. In particular, veterans diagnosed with chronic PTSD die more frequently
from conditions related to substance abuse, such as Hepatitis C, blood diseases, violence,
aggression, and suicide. In addition, rates of behaviorally-related diseases such as
obesity, diabetes, and heart disease are high among veterans diagnosed with chronic
PTSD. These findings highlight a need to promote healthy behavioral practices among
veterans diagnosed with PTSD. A manualized health promotion group treatment for
veterans with PTSD was developed to target health risk behaviors prevalent among this
population. The manual incorporates psychoeducation, motivational interviewing and the
transtheoretical model to increase veterans’ awareness of their engagement in health risk
behaviors and increase motivation for change. The meta-intention of the treatment
protocol is to promote positive health practices and increase longevity and quality of life
among this veteran population. This project focuses specifically on the development of
the assessment strategy component of the group intervention. The assessment measures
are interwoven into the group treatment and offer a comprehensive strategy for evaluating
the efficacy of the treatment protocol.

1
Introduction
Recent research has found that Vietnam veterans diagnosed with chronic combatrelated post-traumatic stress disorder (PTSD) die from high-risk behavioral causes,
particularly those behaviors related to substance use, at a rate significantly greater than
that of the normal population (Drescher, Rosen, Burling, & Foy, 2003). A follow-up
study by Schafer (2008) found that 45% of PTSD veteran deaths were due to behavioral
causes. This is striking when compared with the mortality rate of 8% due to behavioral
causes in the normal population. Of particular note were those deaths from Hepatitis C
(21.5% vs. 0.2%), blood diseases (1.5% vs. 0.5%), and alcohol and drug use (24% vs.
1%). An examination of these causes of death, as well as that which influences their
acquisition and maintenance, suggests that the high rate of death due to behavioral causes
seen in this population could be decreased with appropriate intervention.
The prevalence rates of Hepatitis C (HCV) and Human Immunodeficiency Virus
(HIV) infection in the veteran population are significantly greater than that of the general
population (Brau et al., 2002; Desai, Rosenheck, & Agnello, 2003). Estimates of HCV
infection among veterans range from 7% - 44% (Cheung, 2000; Cheung, Hanson,
Maganti, Keeffe, & Matsui, 2002; Desai et al.; Roselle, Danko, Kralovic, Simbarti, &
Kizer, 2002). Estimates of HIV infection are also wide-ranging, with findings of positive
HIV infection from 1.8% among treatment seeking homeless veterans (Cheung et al.) to
as high as 37% among a random sample of veterans from the National Survey of
Veterans (Hoff, Beam-Goulet, & Rosenheck, 1997). Despite the wide range of HCV and
HIV prevalence rates, the rate of HCV and HIV infection among veterans is considerably
higher than that of the normal population. In comparison, prevalence rates of HCV in the
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normal population are estimated to be 1.8% (Centers for Disease Control and Prevention,
2006) and 0.6% for HIV (Unicef, n.d.). In addition, co-morbidity of the two diseases is
common (Backus, Boothroyd, & Deyton, 2005; Cheung et al.). When examining veterans
with PTSD, rates of HIV and HCV infection are even higher (Backus et al.; Hoff et al.;
Lim, Cronkite, Goldstein, & Cheung, 2006; Nguyen et al., 2002).
The rates of comorbidity of substance use disorders (SUDs) and PTSD among
veterans is also alarmingly high, with prevalence rates for comorbid SUDs ranging from
37-92% in veterans with PTSD (Boudewyns, Albrecht, Talbert, & Hyer, 1991; Eisen et
al., 2004; Roszell, McFall, & Malas, 1991) and comorbid PTSD rates of 46% among
veterans with SUDs (McFall, Mackay, & Donovan, 1991). In fact, research has
demonstrated that SUDs are the most frequently co-occurring disorders among veterans
with PTSD (Faustman & White, 1989; Hryvniak, 1989). Although higher rates of alcohol
abuse or dependence are found among veterans with PTSD, rates of drug abuse or
dependence also remain very high (Hryvniak). Lifetime alcohol dependence rates range
from 31-85% and lifetime drug dependence rates range from 4-60% (Eisen et al.; McFall,
Mackay, & Donovan, 1992; Rozell et al.; Sutker, Uddo, Brailey, Vasterling, & Errera,
1994).
Significant interrelationships can be found between HCV and HIV infection and
substance use disorders. Those veterans who have a history of intravenous drug use or
alcohol abuse and/or dependence are at risk for acquiring HCV and HIV (Backus et al.,
2005; Brau et al., 2002). Substance use may also serve to worsen HIV disease
progression in veterans. Drinking is associated with poor virologic control, hepatic comorbidity, anemia (Conigliaro, Gordon, McGinnis, Rabeneck, & Justice, 2003), and
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decreased medication compliance in HIV positive veterans (Braithwaite et al., 2005).
Those HCV positive veterans with substance use disorders or active psychiatric disorders
are less likely to be eligible for treatment and experience more adverse effects resulting in
premature discontinuation of treatment (Bini et al., 2005; Ho et al. 2001; Huckans,
Blackwell, Harms, & Hauser, 2006).
Substance use has also been linked to other health risks, such as violence,
suicidality, and chronic health problems in populations of veterans with PTSD (McFall et
al., 1991; McFall, Fontana, Raskin, & Rosenheck, 1999; Prince, Risk, Haden, Lewis, &
Spitaznagel, 2004; Tate, Norman, McQuaid, & Brown, 2007). Violence, suicide, and
health problems are common causes of mortality among veterans diagnosed with PTSD
with veterans with PTSD dying at higher rates from violence and suicide than the general
population (suicide, 5% vs. 1%; homicide, 3% vs. 0.5%) and dying from heart disease at
a rate of 20% (Schafer, 2008).
In addition to direct causes of mortality in the PTSD veteran population, there are
indirect behavioral influences on mortality that also affect veteran quality of life. Sleep
disturbances are cardinal features of PTSD. Sleep disturbances manifest as recurrent
distressing dreams of the trauma and difficulty falling or staying asleep (Diagnostic and
Statistical Manual of Mental Disorders-Fourth Edition Text Revision, 2000). Nightmares
are the most common sleep disturbances among veterans with PTSD and occur at a rate
of 65-94% (Jukic, Sumic, Brecic, & Muzinic-Masle, 1999; Leskin, Woodward, Young, &
Sheikh, 2002). Other common sleep disturbances reported by veterans with PTSD with
more frequency than by veterans without PTSD are insomnia, startle awakenings,
nonrestorative sleep, and body movement during sleep (Husain, Miller, & Carwile, 2001;

4
Leskin et al.; Mellman, Kulick-Bell, Ashlock & Nolan, 1995). Sleep laboratory studies
have also identified significantly decreased sleep efficiency and more microawakenings
during sleep among veterans with PTSD when compared with normal controls (Husain et
al.; Mellman et al.; Mellman, Nolan, Hebding, Kulick-Bell, & Dominguez, 1997).
Sleep disturbances are linked to strong emotional and physiological responses in
veterans with PTSD. Trauma-related nightmares are accompanied by strong emotions
that would have been appropriate during the traumatic event itself, such as rage, intense
fear, or grief and may result in terror upon awakening (Ross, Ball, Sullivan, & Caroff,
1989). Insomnia in veterans with PTSD is also characterized by high levels of anxiety,
psychomotor activity, and fear (Inman, Silver, & Doghramji, 1990).
Although there has been little research about the effect of sleep on high-risk
health behaviors in veterans with PTSD, substance abuse/dependence literature suggests
a link between sleep disturbance and substance use as well as substance use and PTSD. It
is hypothesized that veterans with PTSD self-medicate with drugs and alcohol to decrease
ideational reexperiencing and physiological arousal (McFall, et al. 1992; Roszell, et al.,
1991). The sleep disturbances found with high frequency among veterans with PTSD are
associated with both reexperiencing and arousal symptoms and, thus, may be tied to
increased distress and substance use in this population.
The research demonstrates the substantial prevalence of sexually transmitted
diseases, substance use, and sleep disturbances among veterans with PTSD and the
extensive toll they take on the health and longevity of veterans. An intervention targeting
these health risk behaviors and promoting behavioral change could lead to a decrease in
the premature mortality rate found in this population as well as an increase in the positive
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health practices and quality of life among veterans diagnosed with PTSD. In addition, a
health promotion intervention could be used as a preventative measure to prevent the
acquisition of health risk behaviors among those recently diagnosed with PTSD.
The primary motivation of this project was to develop a manualized health
promotion group treatment promoting behavioral change of health risk behaviors
commonly identified among veterans with PTSD. Research has shown that motivational
interviewing is effective at reducing alcohol use, drug use, cigarette smoking, and risky
sexual practices among adult populations (Ball et al., 2006; Bellack, Bennett, Gearson,
Brown, & Yang, 2006; Butler et al., 1999; Carroll et al., 2005). Although the research is
limited among veteran populations, studies examining the efficacy of motivational
interviewing in various behavioral domains suggest its efficacy extends to the veteran
population (Davis, Baer, Saxon, & Kivlahan, 2003; Project MATCH Research Group,
1997). In light of the success of motivational interviewing in promoting behavioral
change, this intervention incorporates motivational interviewing strategies to increase
veterans’ awareness of their engagement in health risk behaviors and increase their
motivation to change. To the developer’s knowledge, there is currently no standardized,
motivational interviewing treatment protocol that focuses on addressing health risk
behaviors in veterans diagnosed with PTSD.
This dissertation focuses specifically on the development of the assessment
strategy which was designed to be an integral component of the motivational
interviewing group intervention. The assessment strategy provides objective measures
that allow the veterans to increase their awareness of their engagement in health risk
behaviors and examine their current motivation to change. In addition, the integrated
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assessments provide useful information to the group facilitators about the needs of the
group members as well as the efficacy of the intervention. Furthermore, the assessment
strategy provides a blueprint for empirical validation of the group treatment.
Methods
Purpose of the Resource
Current research has demonstrated that mortality rates due to preventable
behavioral causes are significantly higher in veterans with PTSD than in the general
population. As such, a well-designed strategy to decrease health risk behaviors and
promote positive health practices among veterans diagnosed with PTSD is needed. The
purpose of this project was to develop a systematic approach to targeting those health risk
behaviors that occur with increased frequency among veterans diagnosed with PTSD and
lead to higher rates of mortality with the intention of promoting positive health practices
and increasing longevity and quality of life among these veterans.
This project proposed to create a group treatment comprised of a three-piece
manual set that serves multiple functions. The manual set is intended to offer a systematic
approach for the integration of health promotion practices in trauma treatment. It offers a
well-designed approach for practitioners who wish to incorporate health promotion
interventions into programs that provide services to veterans diagnosed with PTSD.
Additionally, it integrates assessment measures into the treatment protocol that enhance
the motivational interviewing treatment and allow for empirical investigation and
validation of the efficacy of the group treatment.
This project was founded on the Live Long and Prosper group, a group that was
previously run at the Menlo Park Veterans Administration Medical Center’s (Menlo Park
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VAMC) residential PTSD treatment program. The Live Long and Prosper group was
conceived by Kent Drescher, Ph.D. and Josef Ruzek, Ph.D. The development of the
group was undertaken by Josef Ruzek, Ph.D. and, once outlined, was merged into an
ongoing group designed and facilitated by Judith Faris, R.N.P. The materials developed
by Ruzek and Faris served as the foundation for the development of this manual set. The
three-component manual set is comprised of a facilitator’s manual, member workbook,
and an assessment strategy and was collaboratively developed by three Pepperdine
University doctoral candidates over a four-year period.
Live Long and Prosper Group Development History
The inspiration for the original Live Long and Prosper group was rooted in the
trauma literature and the research of providers working with combat veterans in a
residential PTSD treatment program at the Menlo Park VAMC. This 60-day inpatient
program offers group-based treatment with adjunctive individual psychotherapy as
needed. Through research led by Kent Drescher, Ph.D. and David Foy, Ph.D. as well as
reviews of the trauma literature, it became clear to clinicians and researchers at the Menlo
Park VAMC that veterans in residential PTSD treatment were at increased risk of death
from high-risk behaviors, including preventable diseases such as diabetes, cardiovascular
disease, and Hepatitis C and from substance-related deaths such as accidents, suicides,
and homicides. This realization led Kent Drescher, Ph.D. and Josef Ruzek, Ph.D. to
create a high-risk behavior questionnaire and to develop a group designed to reduce
mortality risk due to high-risk behaviors in this population. The issues of most concern
for Drescher and Ruzek were aggression, gun ownership, aggressive driving, anger, poor
nutrition, lack of exercise due to isolated and sedentary lifestyles, substance use, and
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smoking. Dr. Ruzek outlined the content for the group and ultimately merged the
conceived high-risk behavior group with an on-going psychoeducational group run by
Judith Faris, R.N.P. The intention of the new Live Long and Prosper group was to offer
information and motivational strategies to aid veterans in making informed choices about
their life, health, and futures.
The original Live Long and Prosper group ran for five years from 2002-2007. It
was a 90-minute, once weekly group for between 20 and 40 group members. The group
followed a rolling admissions model, which is the primary model employed at the Menlo
Park VAMC residential PTSD treatment program. Due to the high levels of avoidance
found among veterans with chronic PTSD, attendance at the group was mandatory.
Assessment measures that evaluated engagement in high-risk behaviors were given at
intake. Although the group was originally designed to have additional assessment
measures completed at discharge and at four months post-treatment, these questionnaires
were never created. In addition to the High-Risk Behaviors Questionnaire given at intake,
veterans completed a gun ownership and a gun ownership stages of change questionnaire.
The idea to create the current proposed manualized health promotion group
treatment came from inconsistencies that were identified in the content and facilitation of
the original Live Long and Prosper group at the Menlo Park VAMC. The content, style,
and format of the group varied widely depending on the individual facilitator. It was
determined that content derived from thorough knowledge of the literature and use of
validated motivational techniques could increase the group’s efficacy and relevance to
the population served.
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Target Audience
The project developers used existing group materials from the Live Long and
Prosper group as the foundation for the development of the new health promotion group
that incorporates the transtheoretical model and health risk behavioral frequency
measurement into a formulized assessment strategy. The purpose of this dissertation was
to develop the assessment strategy component of the group treatment. The target
audience for the assessment strategy is the group facilitator who is implementing the
health promotion group intervention.
Development of the Resource
The development of this manualized group protocol arose out of two preestablished models of group treatment for veterans diagnosed with PTSD-Trauma Focus
Group Therapy (Foy, Ruzek, Glynn, Riney, & Gusman, 2002) and the Trauma and
Spirituality Group (Leoni, 2005; Romesser, 2005; Sornborger, 2005). Trauma Focus
Group Therapy is a group treatment designed to enhance the ability of veterans with
combat-related PTSD to manage their traumatic stress symptoms. The Trauma and
Spirituality Group is designed to promote healthy spiritual practices among veterans with
PTSD in order to improve coping abilities and enhance quality of life in this population.
The decision to create a facilitator’s guide, member workbook, and assessment strategy
for this health promotion group treatment for veterans diagnosed with PTSD was based
on the structure of these pre-established group treatments.
The concept and content of the health promotion resource was built upon the
original Live Long and Prosper group that was conducted at the Menlo Park VAMC. This
group provided patient education on relevant health-related topics and emphasized the
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use of psychoeducation as a means of promoting change in health risk behaviors. To
build upon the intent of the original Live Long and Prosper group to motivate behavioral
change, the developers of the current manual set decided to incorporate motivational
interviewing into the treatment protocol. Current research has shown that motivational
interviewing can be an effective method for promoting behavioral change across a widevariety of behavioral domains. This large body of research provides strong support for the
efficacy of a health risk behavior intervention for veterans with PTSD constructed using
the motivational interviewing treatment model.
Division of the Literature
Current research has identified numerous health risk behaviors and health
conditions that are prevalent among the veteran population. McFall and Cook (2000), in
their review of the literature, found that smoking, alcohol use, obesity, and physical
inactivity all presented significant health risk for veterans with PTSD. Experts in the
field of PTSD in veteran populations have further identified areas of needed health risk
behavioral intervention through their clinical and research experiences. Based on the
literature and the research and clinical expertise of expert practitioners, the developers of
the current resource selected the health topics to be included in the current health
promotion group. It was determined that the group would address aggression, diabetes,
diet, gun safety, exercise, heart disease, obesity, sexually transmitted diseases, sleep,
tobacco use, and substance abuse. In order to comprehensively explore the available
research on the selected health topics, relevant empirical literature on diabetes, exercise,
heart disease, sexually transmitted diseases, sleep, and substance abuse as well as
motivational interviewing and the transtheoretical model were strategically divided and

11
reviewed by three doctoral candidates based on their thematic content. Relevant empirical
literature reviews on aggression, diet, guns, obesity, and smoking previously completed
by Pepperdine University doctoral students in a PTSD research lab were additionally
included. For a comprehensive review of all health topics, refer to the other two
components of this health promotion group, the Live Long and Prosper Facilitator’s
Manual and Live Long and Prosper Member Workbook, as well as Pepperdine University
dissertations by Carol Rotko, James M. Keener, Katherine Jakel, Lea Didion, Sarah Metz,
and Edrick H. Dorian.
Purpose and Content of the Assessment Strategy
The assessment strategy was designed to accompany the facilitator’s manual and
the member workbook. The assessment strategy comprehensively and systematically
assesses veteran engagement in health risk behaviors and veteran motivation for change
and is an integral component of the motivational interviewing protocol. Motivational
interviewing seeks to “enhance intrinsic motivation for change by exploring and
resolving ambivalence” (Miller & Rollnick, 2002, p. 25). Motivational interviewing
exercises facilitate exploration of values and goals and the dissonance between these
values and goals and current behavior. Assessment instruments strategically placed
within the group protocol allow veterans to objectively assess their frequency of
engagement in health risk behaviors and their current stage of change. They are
encouraged to reflect upon the results of the behavioral frequency measures and explore
how their current behavior correlates with personal values, interests, and goals. The
objective results of these measures are thus integral to the process of developing
discrepancy. In addition, the stages of change measures assist the veterans in identifying
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their current level of desire to change, how their current stage of change may impact their
goals and values, and assist veterans in monitoring any changes in their level of
motivation throughout the intervention.
The assessment strategy also offers a way to systematically assess facilitator
fidelity to the treatment protocol. Collins et al. (2009) believe that facilitator adherence
to the treatment protocol is key to establishing significant treatment effects to an
intervention. In addition, facilitator adherence measures enable group facilitators to
monitor their fidelity to the protocol and identify any obstacles to such adherence
quickly. In the Live Long and Prosper group, the facilitators will complete Facilitator’s
Adherence Checklists following each session which may be used for empirical evaluation
of the treatment protocol and self-monitoring by the group facilitators.
The assessment strategy provides a comprehensive blueprint for empirical
validation of the treatment protocol. Pre- and post-intervention measures are included
which allow for comparison of behavioral engagement and motivation for change preand post- intervention. In addition, pre- and post- session measures of motivation for
change are included, which allow for validation of the efficacy of the intervention for
each health risk behavior. In addition, adherence to the treatment protocol is measured
following each session to ensure fidelity to the intervention. Included within the
assessment strategy are schedules for test administration to facilitate ease of evaluation
and promote consistency among empirical studies. Alternative assessment schedules are
offered for those sites unable to administer all measures.
The assessment strategy includes assessments in five domains: a) frequency of
veteran engagement in health risk behaviors pre- and post- intervention, b) veteran
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readiness to change pre- and post- intervention, c) veteran engagement in session specific
health risk behaviors, d) veteran readiness to change heath risk behaviors pre- and postsession, and e) facilitator adherence to the treatment protocol. During the initial group
session, all group participants are administered a comprehensive self-report measure
assessing the frequency of their engagement in all relevant health risk behaviors and a
readiness to change measure assessing their current stage of change for health related
behaviors, attitudes, and practices. These measures will be re-administered at completion
of the treatment to monitor changes in these domains. Each session, veterans will
complete pre- and post-session readiness to change measures specifically related to the
session content and session specific measures of behavioral frequency. Facilitators will
complete assessments following each session that are designed to enhance facilitator
adherence to the group treatment.
Development Process
The assessment strategy was developed in conjunction with the facilitator’s
manual and member’s workbook by three Pepperdine doctoral students over a four year
period. The development of the assessment strategy and the manual set occurred in
several distinct phases. First, the developers reviewed existing motivational interviewing
group treatment protocols. The two most influential resources to the development of this
manual set were Group Treatment for Substance Abuse: A Stages-of-Change Therapy
Manual (Velasquez, Maurer, Crouch, & DiClemente, 2001) and Curriculum-Based
Motivation Group: A Five Session Motivational Interviewing Group Intervention (Fields,
2004). In addition to these two manuals, group developers also consulted Motivational
Enhancement Therapy with Drug Abusers (Miller, 1995), Motivational Enhancement
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Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with
Alcohol Abuse and Dependence (Miller, Zweben, DiClimente, & Rychtarik, 1995), and
Motivational Groups in Community Substance Abuse Programs (Ingersoll et al., 2002).
These group treatment protocols were reviewed in order to generate ideas regarding the
format and content of the manual set as well as offer insights into the use of motivational
interviewing techniques into a group protocol.
The developers also received training in motivational interviewing though the
Motivational Interviewing: Professional Training Series (Miller, Rollnick, & Moyers,
1998) as well as the seminal work Motivational Interviewing: Preparing People for
Change, 2nd Edition (Miller & Rollnick, 2002), Motivational Interviewing in Healthcare:
Helping Patients Change Behavior (Rollnick, Miller & Butler, 2008), and Motivational
Interviewing in the Treatment of Psychological Problems (Arkowitz, Westra, Miller, &
Rollnick, 2007). These sources informed the selection and application of motivational
interviewing techniques into the group treatment protocol.
Following review of the group treatment protocols and training in the
motivational interviewing technique, the three developers began the co-creation of the
facilitator’s manual. The facilitator’s manual was developed in ongoing collaboration
between the three developers to ensure continuity of format, language, and content across
the three components of the group treatment. During the construction of the facilitator’s
manual, the tenor of the intervention, structure of the psychoeducational and motivational
interviewing components, and requirements of the member workbook and assessment
strategy were defined. The content of the original Live Long and Prosper group informed
both the choice of session topic as well as the tenor of the group, in which group
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participation is fostered through the use of open-ended questions regarding the health risk
behaviors and subsequent provision of psychoeducation.
As progress was made with the facilitator’s manual, feedback was gathered from
Pepperdine graduate students in a PTSD research lab and experts in the field of veterans
and trauma regarding the clarity, structure, content, and usability of the intervention.
Their feedback was integrated into the manual set on an ongoing basis throughout its
development.
As the development of the facilitator’s manual approached completion, the
developers were able to begin the creation of the assessment strategy and the member
workbook. The exercises included in the member workbook stemmed directly from the
interventions outlined in the facilitator’s manual and sought to maintain consistency of
usage and ease of usability. Workbook exercises designed to be used across sessions as
well as session specific exercises were created. The developers also included
psychoeducation on each health risk behavior to help group members gain familiarity
with each session topic as well as help them identify ways in which each health risk
behavior may be impacting their lives. Finally, an introductory chapter introducing the
group members to the motivational interviewing approach and the stages of change
model and a concluding chapter of additional resources and positive behavioral
substitutes were generated.
In the development of the assessment strategy, assessment measures utilized in
the existing group treatments previously mentioned were reviewed. In addition,
behavioral frequency and stages of change measures available on the internet for diet,
exercise, and sleep difficulties were reviewed. The content and assessment measures
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from numerous websites, specifically the National Institute of Health, Centers for Disease
Control and Prevention, United States Department of Health and Human Services,
American College of Sports Medicine, National Institute on Aging, United States
Department of Agriculture, and the Cancer Prevention Research Center informed the
assessment measures created by the developers. In addition, components of the High Risk
Behavior Questionnaire developed by Kent Drescher, Ph.D. and Josef Ruzek, Ph.D.,
which was used as an assessment instrument used in the original Live Long and Prosper
group, were adapted to inform session specific measures of behavioral frequency and
motivation to change. Research was also undertaken to determine the most common
measures of behavioral frequency used to assess substance use and smoking in research
done within the veteran population. Those measures that appeared with the most
frequency in the literature were identified, their ease of usability was ensured, and they
were integrated into the assessment strategy. In addition, the Facilitator’s Adherence
Checklist was adapted from the Trauma and Spirituality Group (Romesser, 2005) to meet
the needs of the current intervention.
Measures of Behavioral Frequency
Pre-existing measures of the frequency of engagement in health risk behaviors as
well as developer-created measures of behavioral engagement are included in the
assessment strategy. Behavioral frequency measures are administered at the
commencement of the group intervention, at completion of the group intervention, and
during each session.
Health Behavior Frequency Measure. The Health Behavior Frequency Measure
(HBFM) is a developer-created self-report instrument that examines the frequency of
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engagement in health risk behaviors. This measure is administered to the group
participants at the beginning of the first session of the health promotion group
intervention and at the completion of the intervention. The HBFM assesses each domain
of health risk behaviors that are a part of the group protocol; specifically, diet, exercise,
sleep difficulties, risky sex behavior, aggressive acts, gun safety, substance use, and
tobacco use. The measure incorporates questions regarding aggressive acts, gun
ownership, and risky sex behavior from the High Risk Behavior Questionnaire (Ruzek et
al., 2000), an unpublished measure used in the original Live Long and Prosper group. In
addition, questions regarding substance use were informed by the structure of questions
from the High Risk Behavior Questionnaire, Alcohol Use Disorders Identification Test
(Babor, de la Fuente, Saunders, and Grant, 1992) and the Drug Use Questionnaire
(Skinner, 1982), pre-existing measures incorporated into the substance use session.
Assessment questions pertaining to diet, exercise, and sleep difficulties were informed by
review of research in these areas.
The HBFM is a 21-question scale, with answers provided in a Yes-No format or
on a Likert scale. The measure allows for the qualitative analysis of veteran engagement
in a variety of health risk behaviors that are found with great frequency among veterans
diagnosed with PTSD and lead to increased mortality in this population. This measure is
designed to provide information to the group facilitator about the frequency of veteran
engagement in each behavioral domain at the onset of the group, which allows the
facilitator to address the needs of individual veterans, as well as illuminate changes in
frequency of engagement in risky behaviors when administered post-intervention. As the
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measure is administered pre- and post-intervention, it allows for empirical validation of
the intervention based on changes noted in veteran engagement in health risk behaviors.
Developer-created session specific measures of behavioral frequency. Sessionspecific measures of behavioral frequency are administered during each session. These
self-report instruments provide veterans with objective information about their level of
engagement in health risk behaviors. These measures promote veteran awareness of their
current level of behavioral engagement and provide information integral to the
motivational interviewing exercises included in the group protocol.
Following an extensive review of measures assessing diet, heart disease, exercise,
sleep, and safe sex behavior, the developers determined that the intervention would be
best served by the creation of new measures specifically designed for the group
intervention. The developer’s created five behavioral frequency measures designed to
assess eating habits, risk for heart disease, exercise, sleep, and safe sex behavior. Each
assessment measure was informed by the research and follows the recommendations of
relevant groups dedicated to prevention of disease/health risk in these areas; specifically,
the National Institute of Health, Centers for Disease Control and Prevention, United
States Department of Agriculture, United States Department of Health and Human
Services, American College of Sports Medicine, and the National Institute on Aging.
The self-report measures of behavioral frequency are presented in a variety of
formats. Veterans are asked to respond using a Yes-No format, Likert scale, or by
checking off individual boxes. Scoring is included for each measure and is designed to be
user friendly. The scoring provides pertinent information that can be easily disseminated
to the veterans orally by the group facilitators. The information provided in the scoring
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component is designed to elicit consideration by the veterans of their current level of
engagement in health risk behaviors and offers suggestions for behavioral change.
Aggressive Behavior Questionnaire and Firearm Safety Questionnaire. The
Aggressive Behavior Questionnaire and the Firearm Safety Questionnaire were created
from the High-Risk Behavior Questionnaire (Ruzek et al., 2000). The High-Risk
Behavior Questionnaire (HRBQ) is an unpublished instrument that assesses multiple
domains of health-risk behaviors among the veteran population. It was originally
designed to be administered to veterans as part of a comprehensive assessment package
upon intake at the Menlo Park VAMC residential PTSD treatment program. The
developers extracted and combined the questions measuring veteran engagement in
aggressive behaviors and firearm safety from the HRBQ to create comprehensive
measures.
The Aggressive Behavior Questionnaire is an 8-item self-report measure of
aggressive behavior. Specifically, the measure assesses engagement in verbal threats,
assault, property damage, and aggressive driving within the last year. Veterans are also
asked to rate their frequency of engagement in any aggressive behavior in the last year on
a Likert scale. The Firearm Safety Questionnaire is a 7-item self-report measure. It
assesses whether firearms are kept according to National Rifle Association safety
guidelines and personal risks factors for unsafe gun use, such as previous suicide attempt
with a firearm or previous discharge of a weapon outside of military or law enforcement
service. Veterans are asked to answer questions about firearm safety in a Yes-No format.
The developers decided to extend the time-frame of measurement from four months in
the HRBQ to one year in the Aggressive Behavior Questionnaire and six months in the
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Firearm Safety Questionnaire in order to gain a more comprehensive picture of veteran
engagement in aggressive acts and account for possible time spent in treatment. The
measures are administered concurrently during Session 7: Aggressive Behavior/Gun
Safety.
Alcohol Use Disorders Identification Test. The Alcohol Use Disorders
Identification Test (AUDIT; Babor, de la Fuente, Saunders, & Grant, 1992) is a 10question measure of alcohol use scored on a 5-point Likert scale. It was developed by the
World Health Organization as a brief screening tool for excessive drinking. It is
frequently used in the assessment of drinking behavior in research pertaining to veterans.
The AUDIT provides an accurate risk assessment for hazardous or harmful alcohol use or
alcohol dependence across cultures, gender, and age (Babor, Higgins-Biddle, Saunders,
& Monteiro, 2001). Research has shown the AUDIT to have favorable sensitivity (.90)
and lower but still acceptable specificity (.80) for current ICD-9 alcohol use disorders
when using the cut-off score of 8 (Babor et al.), the cutoff score used in this assessment
strategy. Research has also shown the AUDIT to have high internal consistency and high
reliability (r=.86; Babor et al.).
The AUDIT was created for primary care workers to identify those who would
benefit from reducing their level of alcohol consumption and to provide a framework for
intervention among this population. These intentions are in line with the rationale for the
current manual set targeting health risk behaviors and promoting motivation to change
substance use habits. In the current group protocol, the AUDIT is administered during the
Substance Use session to increase veteran’s awareness of their current drinking habits.
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Drug Use Questionnaire, Short Form. The Drug Use Questionnaire, Short Form
(DAST-10; Skinner, 1982) is a 10-item self-report instrument designed for brief clinical
screening and treatment evaluation research to determine psychoactive drug abuse
(Gavin, Ross & Skinner, 1989). Veterans are asked to note “yes” or “no” to questions
regarding their engagement in drug use over the past 12 months. Research studies have
found that the DAST, the original 28-item version, has high levels of internal consistency
reliability (0.92), a largely unidimensional scale, and concurrent validity with frequency
of drug use in the last 12 months (Skinner, 1982). At a cut-off point between 5/6 and
9/10, the DAST shows sensitivity between 96% to 78% and specificity between 79% and
89% with overall accuracy of 85% (Gavin et al.). The DAST is also highly correlated
with current (r=0.75) and lifetime (r=0.74) DSM-III drug diagnosis (Gavin et al.).
The DAST-10 is administered during the Substance Use session of the group
intervention along with the AUDIT. The developers chose to administer the DAST-10,
the short form of the DAST, rather than the DAST, a 28-item measure, to avoid fatiguing
the group participants as multiple measures of behavioral frequency are administered
during this session. In the current group protocol, the DAST-10 is administered with the
intention of increasing veteran awareness of their level of drug use.
Fagerström Test for Nicotine Dependence. The Fagerström Test for Nicotine
Dependence (FTND; Heatherton, Kozlowski, Frecker, & Fagerström, 1991) is a 6-item
self-report instrument designed to assess for level of nicotine dependence. Specifically, it
assesses smoking frequency and habits. The FTND has been tested for reliability and
validity among a psychiatric population and a population of veterans with PTSD
(Buckley et al., 2005). Among these populations, the FTND was found to be stable based
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on test-retest reliability (0.82) and was correlated at statistically significant levels with
biological and psychological measures of dependence (0.40; Buckley et al.).
The FTND is administered to the group participants during the Tobacco Use
session. It is designed to assist veterans in acknowledging their level of nicotine
dependence and to promote critical thinking about their tobacco use.
Stages of Change Measures
Developer-created stages of change measures are included in the assessment
strategy. Stage of change is measured pre- and post- intervention as well as pre- and postsession. The developers performed a comprehensive review of existing stages of change
measures including the University of Rhode Island Change Assessment Scale
(DiClemente & Hughes, 1990), stages of change measures utilized in research studies,
stages of change measures included in other group protocols, and stages of change
measures for health risk behaviors from the Cancer Prevention Research Center. As the
stages of change measures found did not meet the exact needs of the current group
protocol, the developers created new measures informed by their research and containing
the most salient aspects of measurement of stages of change found across measures.
Health Risk Stages of Change measure. The pre- and post- intervention Health
Risk Stages of Change measure was designed to assess the group participants’ current
stage of change related to any behaviors in which they currently engage that may have a
negative impact on their health. Although the group participants are encouraged to reflect
upon those behaviors included in the group protocol, specific measures of stage of change
for individual health risk behaviors are not included.
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The measure assesses the group participants current stage of change by having the
group participants first select one of six statements pertaining to their health related
behaviors and then circle the stage of change the corresponds to the original statement
selected. By separating the statement which best reflects their current health related
behavior and the related stage of change, the developers hope to decrease judgment and
promote honest disclosure of health risk behavior engagement.
The pre- and post- intervention Health Risk Stages of Change measure is designed
to fulfill several functions. The pre- and post- intervention design offers a format for
collecting empirical data about the efficacy of the group protocol to increase group
participants’ motivation to change health risk behaviors over the course of the
intervention. It also offers the group participants objective data on changes in their own
motivation for change before and following the intervention. In addition, the preintervention measure is placed within the first session of the group protocol and is used to
educate the group participants about the transtheoretical model and to familiarize them
with the type of measure they will be asked to complete each week.
Session specific stages of change measures. The group protocol includes seven
session specific stages of change measures which are administered pre- and post- session.
The group participant is asked to first select one of six statements pertaining to their
session specific health related behaviors and then circle the stage of change that
corresponds to the original statement selected. As with the pre- and post- intervention
Health Risk Stages of Change measure, the session specific measures separate the
statement which best reflects the group participant’s current health related behavior and
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the related stage of change to decrease judgment and promote honest disclosure of health
risk behavior engagement.
The session specific stages of change measures are intended to perform multiple
functions. First, they are designed to increase the group participants’ awareness of their
current level of motivation for change, promote critical thinking about their own
motivations, and illuminate any changes in motivation following the group session. In
addition, the pre- and post- session design allows for empirical evaluation of the efficacy
of the individual group sessions to motivate change in health risk behaviors.
Faciltator’s Adherence Checklist
Following each session, the facilitator will complete a session-specific Faclitator’s
Adherence Checklist. The Facilitator’s Adherence Checklist was adapted from the
Adherence Checklist (Romesser, 2005) found in the Trauma and Spirituality Group
protocol (Leoni, 2005; Romesser, 2005; Sornborger, 2005). In the Facilitator’s
Adherence Checklist, the major components of each session are identified and the
facilitator is asked to check off the completed components. Additional space is provided
so the facilitator may note areas of difficulty, obstacles to completion, or issues of
relevance for each session component. The Facilitator’s Adherence Checklist allows for
assessment of fidelity to the protocol. It also serves as a means of identifying problem
areas, obstacles to successful session protocol completion, and areas for review when
pilot testing the group intervention.
Discussion
Current Applications
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Veterans diagnosed with chronic PTSD are more likely to die, and to die at an
earlier age, from behavioral causes than the general population. Many of the common
sequelae of PTSD, such as substance abuse, aggression, and related behaviors such as
risky sexual practices, contribute to these increased mortality rates. In addition, new
research demonstrates that veterans with PTSD also suffer from increased rates of
behaviorally-related chronic diseases such as diabetes, heart disease, and obesity. The
Live Long and Prosper group treatment is designed to meet the needs of this population
by decreasing veteran engagement in behaviors that have negative health impacts and to
promote positive health practices among veterans diagnosed with chronic PTSD. The
developers hope that this may reduce the risk of early mortality due to behavioral causes
among this population.
The majority of the research on which this group intervention is formulated is
based on samples of older veterans, generally those who served during the Vietnam era.
Among this group of veterans, health risk behaviors have often become chronic. For this
older veteran population, the Live Long and Prosper group intervention offers the
opportunity for older veterans to examine their level of their engagement in health risk
behaviors, explore the reasoning behind their engagement in these behaviors, and begin
to explore options for behavioral change. The intention of the intervention is to decrease
veteran engagement in health risk behaviors and improve veteran quality of life.
This group can also be used for those groups of veterans among whom health risk
behaviors have yet to become chronic. Statistics demonstrate that 10 to 18% of military
personnel are returning from the current military engagements in Afghanistan and Iraq
with probable diagnoses of PTSD (Litz & Schlenger, 2009). Among these new veterans,
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the Live Long and Prosper group may be used preventatively. The group can be used to
educate new veterans diagnosed with PTSD about the health risk behaviors associated
with their mental disorder and mitigate their engagement in health risk behaviors prior to
or at the early stages of their engagement in such behaviors. Early intervention may assist
new veterans in maintaining positive health practices and increase their motivation to
abstain from behaviors which may negatively impact their health and longevity.
The current manual set is based on the Live Long and Prosper group which
originated at the Menlo Park VAMC residential PTSD treatment program. As the
Veterans Administration is now servicing larger numbers of veterans through outpatient
services, the current group is designed to be implemented in an outpatient setting. To
foster greater flexibility in an outpatient treatment setting, the group protocol can be
implemented using either a cohort or a rolling enrollment model, with the understanding
that each veteran should participate in an initial orientation session prior to joining the
ongoing group sessions. Despite being designed for an outpatient setting, the group can
easily be implemented in a residential PTSD treatment program.
Clinical Implications
The Live Long and Prosper group treatment is designed as an intervention for
male veterans diagnosed with PTSD; however, it may be an effective intervention for
both male and female veterans. The number of women who are exposed to military or
combat-related trauma is increasing and, as such, the rates of PTSD in the female veteran
population will also increase. It is likely that female veterans diagnosed with PTSD will
engage in behaviors that risk their health and would benefit from a health promotion
group treatment. Further research into the specific health risk behaviors prevalent among
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female veterans or female trauma survivors would be necessitated to ensure that health
risk behaviors specific to women are adequately addressed in the group intervention and
to determine the level of health risk to women of the behaviors already included in the
Live Long and Prosper group.
Although this group intervention is specifically targeted at a veteran population,
there may be other populations who have been exposed to high levels of trauma for
which a manualized health promotion group intervention may be beneficial. Research
among police officers in the United Kingdom found that prevalence rates of PTSD were
six to seven times that of individuals in the community (Green, 2004). Also, a study of
firefighters in Germany found high rates of PTSD among this population, with 18% of
firefighters exhibiting PTSD symptoms (Wagner, Heinrichs, & Ehlert, 1998). Due to the
high rates of PTSD found in these populations, it may be that a revised version of the
Live Long and Prosper group treatment specifically focused on police officers or fire
fighters would benefit these populations.
Limitations
Although this intervention has sought to be comprehensive, several limitations
exist which may affect its implementation or the efficacy of the intervention. Due to the
high levels of avoidance found among veterans with chronic PTSD, the developers
decided to maintain the expectation of the original inpatient Live Long and Prosper group
of mandatory attendance. In an outpatient setting, mandatory attendance at the group may
be difficult to sustain or enforce, particularly for those sessions in which group
participants do not believe they are at risk. It becomes the responsibility of the group
facilitator to reinforce the importance of group attendance in building group cohesion and
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reinforce that the insights and experiences of each veteran, no matter what their stage of
change for a particular health risk behavior, are useful for the group as a whole. The
intervention also requires two facilitators who have received training in the motivation
interviewing model, eight ninety-minute sessions, and the use of many workbook
exercises and assessment measures. Limited resources in any of these areas may make it
difficult to effectively implement the group intervention.
The Live Long and Prosper group is designed to increase motivation for change
and promote engagement in positive health practices among veterans diagnosed with
PTSD. Although strategies for implementing behavioral change are discussed in each
session and examples of ways to change behaviors are provided in the member
workbook, the intervention does not include follow-up behavior modification for those
veterans who would like to change their behaviors. It is recommended that the group
facilitators assess the motivation for change of each veteran and refer them to appropriate
groups, short-term psychotherapy, or other appropriate avenues following the group
intervention that will assist the veterans in following through on their desires for
behavioral change.
The assessment strategy for the Live Long and Prosper group treatment is
comprised of pre-existing as well as developer-created assessment instruments. The lack
of validation for the developer created instruments is a limitation of the current group
treatment and may create difficulties when attempting to study the efficacy of the current
protocol with the intended population. In addition, there is currently no scoring system in
place for the HBFM, an integral component of any research into the validity of the
intervention itself. Currently, only qualitative data can be gleaned from this instrument.
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In addition, as of the publication of this dissertation, the intervention has not been
validated with the population intended. Further validation of the instruments and pilot
testing of the protocol itself are necessary to ensure its usability, user friendliness, and
efficacy with the intended population.
Future Research
Psychological assessments are an integral component of this motivational
interviewing group treatment. They foster awareness and promote further evaluation of
health risk behavior engagement and motivation for change among the group participants,
provide information necessary to develop discrepancy and identify commitment to
change, assist the group facilitators in monitoring the efficacy of the intervention, and
offer a comprehensive method of empirically evaluating the protocol. As such, an
important area for future research is the validation of the developer-created assessment
instruments. In addition, a comprehensive scoring system for the HBFM needs to be
developed which would provide quantitative results of veteran engagement in health risk
behaviors.
To determine the ease of usability of the intervention, identify problem areas for
improvement, and evaluate the efficacy of the group treatment, pilot testing of the Live
Long and Prosper group intervention with outpatient veterans diagnosed with PTSD
needs to be undertaken. The results of such testing would assist the developers in further
refining the group treatment and improving its usability with the veteran population. In
addition, due to the increase in female veterans diagnosed with PTSD who receive
treatment within the VA system, it is important that health risks relevant to female
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veterans diagnosed with PTSD be researched and the manual set be adapted for use with
female as well as male veterans.
The Live Long and Prosper Health Promotion group treatment provides a
systematic means to promote positive health practices among veterans and integrate
health promotion into the treatment of veterans diagnosed with PTSD. It is a unique
manual set that uses motivational interviewing and the transtheoretical model, already
common treatment paradigms among substance abuse treatment programs for veterans, to
fill a very relevant need in the VA system. The developers hope this protocol will initiate
change among veterans diagnosed with PTSD who have poor health practices and
prevent the acquisition of new negative health practices. This may, in the long run,
increase veteran health, decrease treatment utilization, and increase longevity and quality
of life among veterans diagnosed with PTSD.
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Narrative of the Empirical Literature
A review of the literature was undertaken to establish a need-base for specific
health risk behaviors to be included in the proposed “Live Long and Prosper” manualized
group treatment for male combat veterans with PTSD. This review focused on sexually
transmitted diseases, specifically Hepatitis C and Human Immunodeficiency Virus,
substance use disorders, and sleep disturbances. Several computer databases were used to
locate relevant literature (PsychINFO, ProQuest databases, PubMed, and Dissertation
Abstracts) using specific search terms (Hepatitis C, HIV, combat veterans, PTSD, STDs,
substance abuse, sleep disorders, high-risk behaviors) as well as their different variations
(e.g. PTSD, posttraumatic stress disorder, alcohol abuse, SUD, sleep problems). Twentysix empirical studies comprise the literature review for STDs, 20 for SUDs, and 16 for
sleep disturbances. The selection criteria limited the articles to quantitative studies
comprised of 30 or more male veterans with PTSD. However, the number of participants
required for sleep laboratory and psychopharmacological studies was reduced to 15 as the
nature of the research methodologies limits the number of potential participants. In
addition, due to the paucity of research in the area of HCV in veterans with PTSD, the
STD literature review was expanded to include all veterans. The literature supports the
assertion that STDs, SUDs, and sleep disturbances pose substantial health-related risks
for veterans.
Hepatitis C and Human Immunodeficiency Virus
The literature demonstrates significantly higher rates of sexually transmitted
diseases among the veteran population than the normal population. Prevalence rates for
HCV vary from 7% - 35% among outpatient veterans (Brau et al., 2005; Cheung, 2000;
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Huckans, Blackwell, Harms, & Hauser, 2006; Roselle, Danko, Dralovic, Simbarti &
Kizer, 2002) to 42% - 44% among homeless veterans (Cheung, Hanson, Maganti, Keeffe,
& Matsui, 2002; Desai, Rosenheck, & Agnello, 2003). In a study of 168 Department of
Veterans Affairs sites from 1991-1994, the rates of HCV-positivity increased 285% while
the sites only experienced a 5% increase in patients during the same time period (Roselle,
Mendenhall, & Danko, 1997). HCV prevalence rates among veterans are particularly
striking when compared to rates of HCV in active duty military personnel, which are less
than or equal to the prevalence rates for HCV found in the normal population (Hyams et
al., 2001). Prevalence rates of HIV infection are also high with estimates of up to 37%
among a national survey of veterans (Hoff, Beam-Goulet, & Rosenheck, 1997). These
prevalence rates suggest that HCV and HIV are overrepresented in the veteran
population.
A relationship between HCV and HIV was also demonstrated in the literature.
When HCV/HIV co-morbidity was examined, 2% of HCV-positive veterans were also
HIV-positive (Cheung et al., 2002) and 37% of HIV-positive veterans were also HCVpositive (Backus, Boothroyd, & Deyton, 2005). A study of homeless veterans (Cheung et
al.) found that among those veterans who had multiple disease infections including HIV,
Hepatitis B, and tuberculosis, HCV was found in each case.
Although the rates of HCV and HIV are high for the entire veteran population,
they present with greater frequency in those veterans with mental illness (Backus et al.,
2005; Nguyen et al., 2002; Yovtcheva, Rifai, Moles, & Van der Linden, 2001). In
particular, veterans with PTSD are more likely to be HCV and HIV positive (Hoff et al.,
1997; Lim, Cronkite, Goldstein, & Cheung, 2006). Studies have found rates of PTSD
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ranging from 20 - 43% among HCV-positive veterans (El-Serag, Kunkik, Richardson, &
Rabeneck, 2002; Lehman, & Cheung, 2002; Nguyen et al.). These findings correspond to
the significant relationship found between service during the Vietnam era and HCV and
HIV infection (Backus et al.; Bini et al., 2005; Desai et al., 2003; Nguyen et al.; Roselle
et al., 2002; Seal et al., 2007), suggesting that Vietnam-era combat veterans are at
particular risk of acquiring both HCV and HIV.
An examination of the risk factors for HCV and HIV acquisition in veterans
suggests relationships between these STDs and specific health risk behaviors including
intravenous drug use (IVDU) and alcohol abuse. Significant associations were found
between HCV and HIV positivity and IVDU (Brau et al., 2002; Cheung, 2000; Cheung et
al., 2002; Conigliaro, Gordon, McGinnis, Rabeneck, & Justice, 2003; Desai et al., 2003).
Those veterans who were HCV-positive were more likely to report IVDU (Backus et al.,
2005; Brau et al.; Cheung; Cheung et al.) and those with a lifetime history of drug use
were 5-7 times more likely to be HCV-positive than those without such history (Desai et
al.; El Serag et al., 2002). HCV-positive veterans were also more likely to report alcohol
abuse (Backus et al.; Brau et al.) and current hazardous drinking was common among
HIV-positive veterans (Conigliaro et al.). Rates of alcohol abuse and dependence range
between 27% - 86% among HCV-positive veterans (Brau et al.; El-Serag et al.; Lehman
et al., 2002; Lim et al., 2006; Nguyen et al., 2002; Yovtcheva et al., 2001) and up to 36%
among HIV-positive veterans (Conigliaro et al.). Those veterans with substance use
disorders were significantly more likely to test positive for HCV, HIV, and HCV/HIV
(Backus et al.; Hoff et al., 1997; Huckans et al., 2006) and where PTSD and co-morbid
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substance use disorders were found, veterans were 11.5 times more likely to be HIV
positive (Hoff, 1997).
High-risk sexual behavior is also a risk factor for HCV and HIV infection (Cook
et al., 2006; Seal et al., 2007). Alcohol and drug use were related to risky sex behavior in
HIV-positive veterans, with intoxication before intercourse positively related to
inconsistent condom use (Cook et al., 2006). Ganguly, Lenox, Quiroz, and Sinnott (2002)
also found that a majority of veterans did not use condoms despite having sexual
relationships with multiple partners. HIV transmission knowledge was also a concern as
veterans with PTSD demonstrated inaccurate HIV transmission knowledge (Strauss,
Bosworth, Stechuchak, Meador, & Butterfield, 2006).
Substance abuse is not only a risk factor for HCV and HIV disease acquisition,
but it impacts HIV disease progression, medication compliance, HCV treatment
candidacy and treatment completion, and mortality in veteran populations (Bini et al.,
2005; Braithwaite et al., 2005; Conigliaro et al., 2003; Huckans et al., 2006; Johnson,
Finney & Moss, 2005; Seal et al., 2007). Conigliaro et al. found that drinking may be
associated with poor virologic control, hepatic co-morbidity, and anemia among HIV
positive veterans. Decreased virologic control may be related to the temporal and dose
response relationship of drinking behavior to poor medication adherence found among
HIV positive veterans. Braithwaite et al. found that consumption of alcohol was related to
decreased medication adherence for two days following drinking and was particularly
poor when quantities of alcohol that met criteria for hazardous drinking were consumed.
Treatment candidacy and completion is also impacted by substance use among
HCV and HIV positive veterans. Those veterans with substance use disorders were less
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likely to be eligible for HCV treatment (Bini et al., 2005; Huckans et al., 2006) and
experienced more adverse events resulting in discontinuation of therapy (Ho et al., 2001).
Seal et al. (2007) found no association between IVDU and treatment candidacy, however
their findings did support the inverse relationship between alcohol consumption and
treatment candidacy and treatment completion found in other studies. Finally, HIV/AIDS
status has been found to predict mortality in substance abusing veterans (Johnson et al.,
2005).
In addition to those with substance use disorders, those with active psychiatric
disorders were less likely to be eligible for HCV treatment (Bini et al., 2005; Huckans et
al., 2006). The rates of active psychiatric disorders and/or recent substance use were
between 33% - 73% among HCV positive veterans (Backus et al., 2005; El-Serag et al.,
2002; Lehman et al., 2002), suggesting that a large portion of the infected veteran
population, including those with chronic PTSD, may not be eligible for treatment for
HCV infection.
The literature has shown alarmingly high rates of HCV and HIV infection among
veterans, with veterans with PTSD at particular risk for infection. Substance abuse or
dependence is the number one risk factor for HCV and HIV infection and also negatively
impacts disease progression, treatment, and mortality among HCV and HIV positive
veterans. HCV and HIV infection, as well as comorbid substance use, poses a substantial
health risk for veterans with PTSD. These findings suggest that a treatment that focuses
on HCV and HIV disease acquisition, as well as comorbid substance use, could impact
the quality of life and longevity of veterans with PTSD.
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Substance Use Disorders
Substance use disorders are the most frequent co-occurring diagnoses among
veterans with PTSD (Faustman & White, 1989; Hryvniak, 1989; Sutker, Uddo, Brailey,
Vasterling, & Errera, 1994). SUDs were found at a rate of 91% among inpatient veterans
with PTSD (Boudewyns, Albrecht, Talbert, & Hyer, 1991; Boudewyns, Woods, Hyer, &
Albrecht, 1991) and at a rate of 47-68% among treatment-seeking veterans with PTSD
(Davidson, Kudler, Saunders, & Smith, 1990). In a representative national sample of
veterans with PTSD, 75% had comorbid SUDs (Kulka, Schlenger, & Fairbank, 1990).
When substance abusing or dependent veteran populations were examined, 46% of
veterans with SUDs had a co-occurring diagnosis of PTSD (McFall, Mackay, &
Donovan, 1991). In addition, substance-abusing veterans with PTSD had more severe
drug and alcohol problems than substance abusing veterans without PTSD (McFall,
Mackay, & Donovan, 1992).
When alcohol and drug use are examined separately, higher rates of alcohol abuse
or dependence were found among veterans with PTSD than drug abuse or dependence
(Hryvniak, 1989). Lifetime alcohol dependence rates among veterans with PTSD range
from 31-85% (Eisen et al., 2004; Kulka et al., 1990; Rozell, McFall, & Malas, 1991;
Sutker et al., 1994), which far exceeds lifetime prevalence rates for alcohol dependence
in the general male population. Rates of current alcohol abuse or dependence among
veterans with PTSD range from 4-68% (Eisen et al.; Kulka et al.; Rozell et al.; Sutker et
al.). Although occurring with less frequency, rates of drug abuse or dependence among
PTSD veterans remained high. Lifetime drug dependence rates among veterans with
PTSD range from 4-60% (Eisen et al.; Kulka et al.; McFall et al., 1992; Rozell et al.;
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Sutker et al.) and rates of current drug abuse or dependence range between 1-10% (Eisen
et al.; McFall et al.; Rozell et al.; Sutker et al.). These studies demonstrate that both
alcohol and drug abuse and dependence are found with distressing frequency among
veterans with PTSD.
The high comorbidity rate of PTSD and SUDs among veterans led researchers to
hypothesize about the etiological relationship between the two disorders in this
population. The literature supports a functional relationship between substance use and
PTSD. It suggests that veterans abuse alcohol and drugs to self-medicate against PTSD
symptoms (Vaidya & Garfield, 2003). One study found that 37% of veterans with PTSD
reported using alcohol or drugs to avoid dealing with trauma memories or feelings
associated with the trauma (Roszell et al., 1991). Similarly, McFall et al. (1992) found a
positive relationship between alcohol and drug abuse and the occurrence of ideational
reexperiencing, physiological arousal, and avoidance/numbing among PTSD veterans.
Veterans with PTSD have also reported that alcohol, heroin, benzodiazepines, and
marijuana served as effective mediators of PTSD symptoms (Bremner, Southwick,
Darnell, & Charney, 1996). Post-treatment studies also support the self-medication
hypothesis. Steindl, Yound, Creamer, and Crompton (2003) found that drinking status
was significantly associated with PTSD symptoms at follow-up, with unchanged
hazardous drinkers experiencing more severe avoidance, numbing and arousal symptoms
when compared to new low-risk drinkers. Increased psychiatric symptoms were also
significantly greater prior to relapse among those with trauma histories (Norman, Tate,
Anderson & Brown, 2007).
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Substance abuse in veterans with PTSD has been linked to several health risk
behaviors including violence, suicidality, and chronic health problems. In addition,
substance use is linked to the acquisition of STDs in veterans and has negative
implications for treatment and disease progression in HIV and HCV positive veterans
(see Hepatitis C and Human Immunodeficiency Virus for review of the literature).
Substance abuse was found to contribute significantly to the variance in violence levels
among treatment seeking PTSD veterans (McFall, Fontana, Raskind, & Rosenheck,
1999). PTSD also contributed to the prediction of difficulty controlling violent tendencies
in veterans seeking substance use treatment (McFall et al., 1991). Among substance using
veterans, PTSD was found to contribute significantly to suicidal thoughts (McFall et al.,
1991) and remission from suicidality occurred more slowly in veterans with comorbid
PTSD and drug dependence (Prince, Risk, Haden, Lewis, & Spitznagel, 2004). Veterans
with comorbid substance use disorders and PTSD were also found to have increased rates
of chronic health problems, such as musculoskeletal problems (e.g. joint problems),
gastrointestinal problems, and cardiovascular problems than those with substance use
disorders only (Tate, Norman, McQuaid, & Brown, 2007).
The extraordinary prevalence rates of SUDs among veterans with PTSD and the
health risk behaviors that are associated with this comorbid pattern support the need for a
program to target substance use and its relationship to health risk behaviors in veterans
with PTSD. Additional literature suggests that it may be important to offer treatment to
non-combat veterans with PTSD as well. Mixed findings regarding the relationship
between substance use disorders and combat experience suggest that both combat and
noncombat veterans with PTSD may be susceptible to the development of SUDs. In a
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study of non-combat Persian Gulf veterans exposed to trauma, Sutker et al. (1994) found
that the first incidence of alcohol or drug dependence among recent war-zone returnees
was 11%, compared with 0% in those who remained stateside. Also, postmilitary factors
have been found to contribute significantly to the variance in alcohol and drug abuse
disorders over and above premilitary and military factors in a population of male veterans
with PTSD (Green, Grace, Lindy, Gleser, & Leonard, 1990). These findings suggest that
a health promotion group that targets substance use may be useful for veterans with both
combat-related and non-combat-related PTSD.
Sleep Disturbances
Sleep disturbances are found with high frequency among veterans with PTSD
(Roszell, McFall, & Malas, 1991). Commonly experienced sleep problems include
combat and non-combat related nightmares, insomnia, nonrestorative sleep, decreased
sleep quantity, and startle or panic-like awakenings. Nightmares are the most prominent
sleep disturbance found in veterans with PTSD and are reported with great frequency by
this population (Neylan et al.,1998). Frequency rates of nightmares among combat
veterans with PTSD range between 65-94% (Jukic, 1999; Leskin, Woodward, Yound, &
Sheikh, 2002). Forty percent of veterans with PTSD report avoiding sleep because of the
anticipation of troubling thoughts or dreams (Roszell et al.).
The prevalence rates of other sleep disorders in the PTSD veteran population are
also high, with 80-100% of a national sample of PTSD veterans reporting insomnia and
61-88% reporting an exaggerated startle response, which may lead to startle or panic-like
awakenings (Leskin et al., 2002). In addition, 59-73% of veterans with PTSD report
nonrestorative sleep (Mellman, Kulick-bell, Ashlock, & Nolan, 1995). There is also a
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higher frequency of body movement and periodic limb movement during sleep among
veterans with PTSD when compared to veterans without PTSD (Husain, Miller, &
Carwile, 2001; Mellman et al.).
Sleep laboratory studies have been able to provide objective information about
sleep disturbances in veterans with PTSD. Sleep efficiency, or the proportion of actual
sleep to potential sleep, has been shown to be significantly decreased in veterans with
PTSD (Husain et al., 2001; Mellman et al., 1995; Mellman, 1997), confirming veteran
self-report data. Veterans with PTSD appear to spend significantly more time awake
during sleep and experience more microawakenings than healthy male controls (Mellman
et al.). REM sleep is also affected in PTSD veterans, although the direction of the
findings is mixed. Engdahl, Eberly, Hurwitz, Mahowald, and Blake (2001) found that
PTSD veterans spent more time in REM sleep and had fewer arousals from nonREM
sleep than veterans without PTSD. However, laboratory studies by Mellman (1995, 1997)
found that PTSD veterans experienced decreased time in REM sleep and increased wakeduring-sleep when compared with other clinical or non-clinical samples.
A large proportion of the research on sleep disorders relies on self-report findings.
The nightmares reported by PTSD veterans are distinguished from those of veterans
without PTSD by their fright content (Husain et al., 2001) and are highly associated with
combat experience (Neylan et al., 1998). Veterans with PTSD often recall more dreams
and have difficulty returning to sleep after having a nightmare (Inman, 1990). In addition
to nightmares, insomnia in veterans with PTSD is characterized by high levels of anxiety,
high levels of psychomotor activity, and fear (Inman). PTSD veterans report fear of going
to sleep, returning to sleep, fear of the dark, and fear of thoughts of Vietnam (Inman).
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Middle of the night awakening and subsequent decrease in hours of sleep are associated
with combat nightmares, movement during sleep, and startle or panic-like awakenings
(Mellman et al., 1995; Woodward, Arsenault, Murray, & Bliwise, 2000).
The nightmares, insomnia, and nonrestorative sleep that are associated with PTSD
in veterans represent a risk to their global clinical status. This is demonstrated by the
profusion of psychopharmacological studies aimed at reducing overall PTSD symptom
presentation by decreasing the frequency of trauma-related nightmares and sleep latency,
and increasing sleep efficiency (Aukst-Margetic, Margetic, Tosic, & Bilic-Prcic, 2004;
David, De Faria, & Mellman, 2006; Raskind, Peskind, Hoff, & Hart, 2007; Stein, Kline,
& Matloff, 2002). The pharmaceuticals Prazosin, Levomepraomazine, and Risperidone
are reported to significantly decrease distressing dreams, increase sleep duration, and
decrease nighttime awakenings in veterans with PTSD (Aukst-Margetic et al.; David et
al.; Raskind et al.), while Olanzapine was not found to be superior to treatment with a
placebo when clinical status was considered (Stein et al.).
Sleep disturbances are common among veterans with PTSD. Trauma-related
nightmares are the most prominent sleep disturbance, however high rates of insomnia,
nighttime awakenings, and nonrestorative sleep are also found. Sleep efficiency is
significantly decreased in this population and is characterized by increased sleep latency
and increased microawakenings. Many of these sleep disturbances are characterized by
fear related to high levels of anxiety. Current research is focused on
psychopharmacological interventions to decrease sleep disturbances in this population.
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Conclusion
A comprehensive review of the literature focusing on sexually transmitted
diseases, substance abuse disorders, and sleep disturbances among veterans and veterans
with PTSD has shown that these problems represent significant health risks for veterans
with PTSD. Not only do they occur with high frequency, but they impact multiple areas
of life including disease progression, treatment, health, aggression, and sucidality. A
treatment protocol designed to decrease incidence of these health risk behaviors in
veterans with PTSD may serve to increase longevity and quality of life in this veteran
population.

54
REFERENCES
Aukst-Margetic, B., Margetic, B., Tosic, G., & Bilic-Prcic, A. (2004). Levomepromazine
helps to reduce sleep problems in patients with PTSD. European Psychiatry, 19,
235-236.
Backus, L. I. , Boothroyd, D., & Deyton, L. R. (2005). HIV, hepatitis C and
HIV/hepatitis C virus co-infection in vulnerable populations. AIDS, 19(suppl. 3),
513-519.
Bini, E. J., Brau, N., Currie, S., Shen, H., Anand, B. S., Hu, K., et al. (2005). Prospective
multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans
with chronic hepatitis C infection. American Journal of Gastroenterology, 100,
1772-1779.
Boman, B. (1986). Combat stress, post-traumatic stress disorder, and associated
psychiatric disturbance. Psychosomatics, 27(8), 567-573.
Boudewyns, P. A., Albrecht, J. W., Talbert, F. S., & Hyer, L. A. (1991). Comorbidity and
treatment outcome of inpatients with chronic combat-related PTSD. Hospital and
Community Psychiatry, 42(8), 847-84.
Boudewyns, P. A., Woods, M. G., Hyer, L., & Albrecht, J. W. (1991). Chronic combatrelated PTSD and concurrent substance abuse: Implications for treatment of this
frequent “dual diagnosis”. Journal of Traumatic Stress, 4(4), 549-560.
Braithwaite, R. S., McGinnis, K. A., Conigliaro, J., Maisto, S. A., Crystal, S., Day, N. et
al. (2005). A temporal and dose-response association between alcohol
consumption and medication adherence among veterans in care. Alcoholism:
Clinical and Experimental Research, 29(7), 1190-1197.

55
Bremner, J. D., Southwick. S. M., Darnell, A., & Charney, D. S. (1996). Chronic PTSD
in Vietnam combat veterans: Course of illness and substance abuse. The American
Journal of Psychiatry, 153(3), 369-375.
Brau, N., Bini, E. J., Shabidi, A., Aytaman, A., Xiao, P., Stancic, S., et al. (2002).
Prevalence of hepatitis C and coinfection with HIV among United States veterans
in the New York City metropolitan area. The American Journal of
Gastroenterology, 97(8), 2071-2078.
Bremner, J. D., Southwick. S. M., Darnell, A., & Charney, D. S. (1996). Chronic PTSD
in Vietnam combat veterans: Course of illness and substance abuse. The American
Journal of Psychiatry, 153(3), 369-375.
Cheung, R. C. (2000). Epidemiology of hepatitis C virus infection in American veterans.
The American Journal of Gastroenterology, 95(3), 740-747.
Cheung, R. C., Hanson, A. K., Maganti, K., Keeffe, E. B., & Matsui, S. M. (2002). Viral
hepatitis and other infections diseases in a homeless population. Journal of
Clinical Gastroenterology, 34(4), 476-480.
Conigliaro, J., Gordon, A. J., McGinnis, K. A., Rabeneck, L., & Justice, A. (2003). How
harmful is hazardous alcohol use and abuse in HIV infection: Do health care
providers know who is at risk. Journal of Acquired Immune Deficiency
Syndromes, 33, 512-525.
Cook, R. L., McGinnis, K., Kraemer, K. L., Gordon, A. J., Conigliaro, J., Maisto, S. A.,
et al. (2006). Intoxication before intercourse and risky sexual behavior in male
veterans with and without human immunodeficiency virus infection. Medical
Care, 44(8), S31-S36.

56
David, D., De Faria, L., Mellman, T. A. (2006). Adjunctive risperidone treatment and
sleep symptoms in combat veterans with chronic PTSD. Depression and Anxiety,
23, 489-491.
Davidson, J., Kudler, H. S., Saunders, W. B., & Smith, R. D. (1990). Symptom and
comorbidity patterns in World War II and Vietnam veterans with posttraumatic
stress disorder. Comprehensive Psychiatry, 31(2), 162-170.
Desai, R. A., Rosenheck, R. A, & Agnello, V. (2003). Prevalence of hepatitis C infection
in a sample of homeless veterans. Social Psychiatry and Psychiatric
Epidemiology, 38, 396-401.
Eisen, S. A., Griffith, K. H., Xian, H., Scherrer, J. F., Fischer, I. D., &
Chantarujikaponhg, S. (2004). Lifetime and 12-month prevalence of psychiatric
disorders in 8,169 male Vietnam war era veterans. Military Medicine, 169, 896902.
El-Serag, H. B., Kunik, M., Richarson, P. & Rabeneck, L. (2002). Psychiatric disorders
among veterans with hepatitis C infection. Gastroenterology, 123, 476-482.
Engdahl, B. E., Eberly, R. E., Hurwitz, T. D., Mahowald, M. W., & Blake, J. (2000).
Sleep in a community sample of elderly war veterans with and without
posttraumatic stress disorder. Biological Psychiatry, 47, 520-525.
Faustman, W. O., & White, P. A. (1989). Diagnostic and psychopharmacological
treatment characteristics of 536 inpatients with posttraumatic stress disorder. The
Journal of Nervous and Mental Disease, 177(3), 154-159.
Ganguly, R., Lenox, B., Quiroz, E., & Sinnott, J. (2002). HIV infection, risk factors, and
testing in a veteran population. American Clinical Laboratory, 21(2), 32-39.

57
Green, B. L., Grace, M. C., Lindy, J. D., Gleser, G. C., & Leonard, A. (1990). Risk
factors for PTSD and other diagnoses in a general sample of Vietnam veterans.
American Journal of Psychiatry, 147(6), 729-733.
Ho, S. B., Nguyen, H., Tetrick. L. I., Opitz, G. A., Basara, M. L., & Dieperink, E. (2001).
Influence of psychiatric diagnoses on interferon-alpha treatment for chronic
hepatitis C in a veteran population. The American Journal of Gastroenterology,
96(1), 157-164.
Hoff, R. A., Beam-Goulet, J., Roenheck, R. A. (1997). Mental disorder as a risk factor for
human immunodeficiency virus infection in a sample of veterans. The Journal of
Nervous and Mental Disease, 185(9), 556-560.
Hryvniak, M. R. (1989). Concurrent psychiatric illness in inpatients with post-traumatic
stress disorder. Military Medicine, 154(8), 399-401.
Huckans, M. S., Blackwell, A. D., Harms, T. A., & Hauser, P. (2006). Management of
hepatitis C disease among VA patients with schizophrenia and substance use
disorders. Psychiatric Services, 57(3), 403-406.
Hyams, K. C, Riddle, J., Rubertone, M., Trump, D., Alter, M. J., Cruess, D. F. et al.
(2001). Prevalence and incidence of hepatitis C virus infection in the US military;
A seroepidemiologic survey of 21,000 troops. American Journal of Epidemiology,
153(8), 764-770.
Husain, A. M., Miller, P. P., & Carwile, S. T. (2001). REM sleep behavior disorder:
Potential relationship to post-traumatic stress disorder. Journal of Clinical
Neurophysiology, 18(2), 148-157.

58
Inman, D. J., Silver, S. M., & Doghramji, K. (1990). Sleep disturbance in post-traumatic
stress disorder: A comparison with non-PTSD insomnia. Journal of Traumatic
Stress, 3(3), 429-437.
Johnson, D. R., Fontana, A., Lubin, H., Corn, B., & Rosenheck, R. (2004). Long-term
course of treatment-seeking Vietnam veterans with posttraumatic stress disorder:
Mortality, clinical condition, and life satisfaction. The Journal of Nervous and
Mental Disease, 192(1), 35-41.
Johnson, J. E., Finney, J.W., & Moos, R.H. (2005). Predictors of 5-year mortality
following inpatient/residential group treatment for substance use disorders.
Addictive Behaviors, 30, 1300-1316.
Jukic, V., Sumic, J. C., Brecic, P., & Muzinic-Masle, L. (1999). Sleep disturbances and
nightmares as symptoms of posttraumatic stress disorder. Psychiatia Danubina,
11(1-2), 13-17.
Justice, A. C., McGinnis, K. A., Atkinson, J. H., Heaton, R. K., Young, C., Sadek, J., et
al. (2004). Psychiatric and neuro-cognitive disorders among HIV-positive and
negative veterans in care: Veterans aging cohort five-site study. AIDS, 18(suppl
1), S49-S59.
Kulka, R. A., Schlenger, W. E., Fairbank, J. A., Hough, R. L., Jordan, B. K., Marmar, C.
R., et al. (1990). Trauma and the Vietnam War Generation. Levittown,
Pennsylvania: Brunner/Mazel.
Lehman, C. L., & Cheung, R. C. (2002). Depression, anxiety, post-traumatic stress, and
alcohol-related problems among veterans with chronic hepatitis C. The American
Journal of Gastroenterology, 97(10), 2640-2646.

59
Leskin, G. A., Woodward, S. H., Yound, H. E., & Sheikh, J. I. (2002). Effects of
comorbid diagnoses on sleep disturbance in PTSD. Journal of Psychiatric
Research, 36, 449-452.
Lim, J. K., Cronkite, R., Goldstein, M. K., & Cheung, R. C. (2006). The impact of
chronic hepatitis C and comorbid psychiatric illnesses on health-related quality of
life. Journal of Clinical Gastroenterology, 40(6), 528-534.
McFall, M., Mackay, P. W., & Donovan, D. M. (1991). Combat-related PTSD and
psychosocial adjustment problems among substance abusing veterans. Journal of
Nervous and Mental Disease, 179(1), 33-38.
McFall, M. E., Mackay, P. W., & Donovan, D. M. (1992). Combat-related posttraumatic
stress disorder and severity of substance abuse in Vietnam veterans. Journal of
Studies on Alcohol, 53(4), 357-363.
McFall, M., Fontana, A., Rasking, M., & Rosenheck, R. (1999). Analysis of violent
behavior in Vietnam combat veteran psychiatric inpatients with posttraumatic
stress disorder. Journal of Traumatic Stress, 12(3), 501-517.
Mellman, T. A., Kulick-Bell, R., Schlock, L. E., & Nolan, B. (1995). Sleep events among
veterans with combat-related posttraumatic stress disorder. The American Journal
of Psychiatry, 152(1), 110-115.
Mellman, T. A., Nolan, B., Hebding, J., Kulick-Bell, R,. & Dominguez, R. (1997). A
polysomnographic comparison of veterans with combat-related PTSD, depressed
men, and non-ill controls. Sleep, 20(1), 46-51.
Neylan, T. C., Marmar, C., Metzler, T. J., Weiss, D. S., Zatzick, D. F., Delucchi, K. L.,
et al. (1998). Sleep disturbances in the Vietnam generation: Findings for a

60
nationally representative sample of male Vietnam veterans. The American Journal
of Psychiatry, 155(7), 929-933.
Norman, S. B., Tate, S. R., Anderson, K. G., & Brown, S. A. (2007). Do trauma history
and PTSD symptoms influence addiction relapse context? Drug and Alcohol
Dependence, 90, 89-96.
Nguyen, H. A., Miller, A .I., Dieperink, E., Willenbring. M., Tetrick, L. L., Durfee, J. M.
et al. (2002). Spectrum of disease in U.S. veteran patients with hepatitis C. The
American Journal of Gastroenterology, 97(7), 1813-1820.
Price, R. K., Risk, N. K., Haden, A. H., Lewis, C. E., & Spitznagel, E. I. (2004). Posttraumatic stress disorder, drug dependence, and suicidality among male Vietnam
veterans with a history of heavy drug use. Drug and Alcohol Dependence: Special
Issue Drug Abuse and Suicidality, 76(Suppl 7), S31-S43.
Raskind, M. A., Peskind, E. R., Hoff, D. J., Hart, K. L., Holmes, H. A., Warren, D., et al.
(2007). A parallel group placebo controlled study of prazosin for trauma
nightmares and sleep disturbance in combat veterans with post-traumatic stress
disorder. Biological Psychiatry, 61, 928-934.
Roselle, G. A., Mendenhall, C. L., & Danko, L. H. (1997). A four-year review of patients
with hepatitis C antibody in department of veterans affairs facilities. Military
Medicine, 162(11), 711-714.
Roselle, G. A., Danko, L. H., Kralovic, S. M., Simbarti. L. A., & Kizer, K. W. (2002).
National hepatitis C surveillance day in the veterans health administration of the
department of veterans affairs. Military Medicine, 167(9), 756-759.

61
Roszell, D. K., McFall, M. E., & Malas, K. L. (1991). Frequency of symptoms and
concurrent psychiatric disorder in Vietnam veterans with chronic PTSD. Hospital
and Community Psychiatry, 42(3), 293-296.
Seal, K. H., Currie, S. L., Shen, H., Anand, B. S., Bini, E. J., Brau, N. et al. (2007).
Hepatitis C treatment candidacy and outcomes among 4318 US veterans with
chronic hepatitis C virus infection. Journal of Clinical Gastroenterology, 41(2),
199-205.
Stein, M. B., Kline, N. A., & Matloff, J. L. (2002). Adjunctive olanzapine for SSRIresistant combat-related PTSD: A double-blind, placebo-controlled study.
American Journal of Psychiatry, 159(10), 1777-1779.
Steindl, S. R., Yound, R. M., Creamer, M., & Crompton, D. (2003). Hazardous alcohol
use and treatment outcome in male combat veterans with posttraumatic stress
disorder. Journal of Traumatic Stress, 16(1), 27-34.
Strauss, J., Bosworth, H. B., Stechuchak, K. M., Meador, K. M., & Butterfield, M.I.
(2006). Knowledge and risks of human immunodeficiency virus transmission
among veterans with severe mental illness. Military Medicine, 171, 325-330.
Sutker, P. B., Uddo, M., Brailey, K., Vasterling, J. J., & Errera, P. (1994).
Psychopathology in war-zone deployed and nondeployed operation desert storm
troops assigned graves registration duties. Journal of Abnormal Psychology,
103(2), 383-390.
Szerlip, M. A., DeSalvo, K. B., & Szerlip, H. M. (2005). Predictors of HIV-infection in
older adults. Journal of Aging and Health, 17(3), 293-298.

62
Tate, S. R., Norman, S. B., McQuaid, J. R., & Brown, S. A. (2007). Health problems of
substance-dependent veterans with and those without trauma history. Journal of
Substance Abuse Treatment, 33, 25-32.
Vaidya, N. A., & Garfield, D. A. S. (2003). A comparison of personality characteristics
of patients with posttraumatic stress disorders and substance dependence:
Preliminary findings. The Journal of Nervous and Mental Disease, 191(9), 616618.
Woodward, S. H., Arsenault, N. J., Murray, C., & Bliwise, D. L. (2000). Laboratory sleep
correlates of nightmare complaint in PTSD inpatients. Biological Psychiatry, 48,
1081-1087.
Yovtcheva, S. P., Rifai, M. A., Moles, J. K., & Van der Linden, B. J. (2001). Psychiatric
comorbidity among hepatitis C-positive patients. Psychosomatics, 42(5), 411-415.

63

APPENDIX B
Tables of the Empirical Literature

Table A1
Summary of Articles in Literature
Review (N = 62 )
Sample Characteristics

Sexually Transmitted Diseases n=26

Substance Abuse n=20

Sleep Disorders n=16

Size:

Type of Study:

Type of Study:

Type of Study:

(10) 0-50

(13) Retrospective Chart Review

(2) Retrospective Chart Review

(4) Pharmacological

Rates of HCV and HIV

(11) 51-100

(6) Prevalence

(2) Prevalence

(4) Sleep Laboratory

infection are significantly

(2) Longitudinal

(2) Retrospective Chart Review

higher among veterans than

(5) Review of the Literature

(2) Prevalence

the normal population and

(1) Cross-sectional

occur with greater

(19) 101-500

General Outcomes

(7) 501-1000

Variables:

(6) 1001-5000

(3) HIV and HCV

(2) 5001-10,000

(6) HIV and Alcohol Use

Variables:

(4) 10,001-30,000

(3) HIV and Psychiatric Comorbidity

(10) PTSD and Psychiatric Comorbidity

Variables:

PTSD.

(2) 30,000+

(5) HIV and Risk Factors

(9) PTSD and Substance Use

(1) 168 sites

(2) HCV and IVDU

(1) PTSD and Risk Factors

(10) PTSD and Sleep Disruption
(5) PTSD and Nightmares

SUDs are a risk factor for

(8) HCV and Psychiatric Comorbidity

(2) PTSD, SUD, and Psychiatric Comorbidity

(2) PTSD and REM

HCV and HIV acquisition and

(8) HCV and Risk Factors

(2) PTSD, SUD, and Suicidality

(1) PTSD and Insomnia

effect disease course.

(1) PTSD, SUD, Violence

(1) PTSD and Major Depression
(1) PTSD and RSD

Participants:
(9) Vietnam Vets

frequency among veterans with

(1) Non-Tx Seeking Vets

Analyses:

(1) PTSD, SUD, Personality

(13) Tx Seeking Vets

(16) Regression Analyses

(1) PTSD, SUD, Health

(2) Homeless Tx Seeking Vets

(9) Nonparametric

(9) Tx Seeking Vets w/HCV
(3) Tx Seeking Vets Tested for
HCV

(6) Descriptive

Analyses:

(4) T-tests

(3) T-tests

(10) Nonparametric

(3) Nonparametric

Substance abuse in veterans

(4) Tx Seeking Vets w/SUD

(2) Correlation

(9) Regression Analyses

(3) ANOVA/MANOVA

is linked with violence,

(6) ANOVA/MANOVA

(3) Correlation

suicidality, and chronic
health problems.

(20) Tx Seeking Vets w/PTSD

SUDs are the most
frequently occurring disorders

Analyses:

among veterans with PTSD.

(1) Vets with SUD

Other Variables:

(6) Descriptive

(2) Regression Analyses

(1) Vets with Substance Use

(19) Demographics

(3) Correlation

(1) ANCOVA

(1) Vets with PTSD

(8) Treatment Considerations

(1) Odds Ratio

(1) Descriptive Statistics

(1) Vets w/Severe Mental Illness

(6) Age

(5) Vets Aging Cohorts Study

(5) Virologic Response

Other Variables:

Other Variables:

(1) National Survey of Vets

(3) War Era

(7) Combat Status

(3) Level of Trauma

(1) Former POWs

(2) HIV Knowledge

(7) Demographics

(2) Demographics

Common forms of sleep

(1) Refugees with PTSD

(1) Mortality

(5) Treatment

(2) Drug Efficacy

disturbances are nightmares,

(2) Civilian Control

(1) QOL

(1) Mortality

(2) Treatment

decreased sleep efficiency,

(1) Social Support

(1) Relapse

(1) Age

insomnia, and increased

(1) War Era

(1) Substance Abuse

sleep latency.

Sleep disturbances are found at
high frequencies among
veterans with PTSD.
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Sexually Transmitted Diseases Literature Table n=26
AUTHORS

Backus, L. I.,
Boothroyd, D., &
Deyton, L. R.
2005

Bini, E. J., Brau,
N., Currie, S.,
Shen, H., Anand,
B. S., Hu, K. , et
al. 2005

TITLE

HIV, Hepatitis C, and
HIV/Hepatitis C Virus
Co-infection in
Vulnerable Populations

Prospective Multicenter
Study of Eligibility for
Antiviral Therapy
Among 4,804 US
Veterans with Chronic
Hepatitis C Virus
Infection

PARTICIPANTS

n=18,349 veterans in the
VA Immunology Case
Registry who received
care in the VA in 2002
who had an interpretable
HCV result

n=4,084 treatmentseeking veterans who had
a positive HCV antibody
test at 24 VA Medical
Centers

INSTRUMENTS

Enzyme immunoassay
antibody test results

COBAS Amplicor HCV
Monitor Test version 2.0
or the COBAS Amplicor
HCV Test version 2.0 to
test HCV RNA

METHODS

Retrospective review. ICD-9
codes used to determine
psychiatric diagnoses.
Medical diagnoses also
discerned by prescribed
medication.

RESULTS





Analyses: Pearson chi-square
test, Wilcoxon rank-sum test



Interviewed to obtain
demographic, clinical and
risk factor information.
Evaluated for HCV therapy
using standardized criteria.
Eligible veterans were
treated with Rebetron for up
to 24 or 48 weeks.



Analyses: t-tests or
Wilcoxon, chi-square test,
regression models, odds
ratios






Braithwaite, R. S.,
McGinnis, K. A.,
Conigliaro, J.,
Maisto, S. A.,
Crystal, S., Day,
N., et al. 2005

A Temporal and DoseResponse Association
Between Alcohol
Consumption and
Medication Adherence
Among Veterans in Care

n=2,352 HIV+ and
matched HIV- veterans
participating in the
Veterans Aging Cohort
Study; n=99 veterans who
reported widely varying
levels of alcohol
consumption during the
30-day period for doseresponse analyses selected
out from larger sample for
analyses

Alcohol Timeline Follow
Back; Timeline Follow
Back Modified for
Adherence; PHQ-9 for
depression

Cross-sectional study.
Telephone surveyed for
demographics, drug use, and
homelessness.




Analyses: regression
analyses

37% HCV seropositive
HCV seropositive veterans were more
likely to report IVDU, alcohol abuse,
substance abuse, and to have been
diagnosed with mental illness.
Rate of mental health illness was very
high in both groups (63.1% HIV,
76.1% HIV/HCV).
Those with HIV/HCV were less likely
to develop AIDS but more likely to
die.

32.2% of candidates were eligible for
HCV treatment. The most common
reasons for exclusion were on-going or
recent substance abuse, active
psychiatric disease, and comorbid
medical disease.
Of those eligible for treatment, 76.2%
agreed to receive treatment.
Factors associated with increased odds
of declining therapy: 50 years of age or
older, having more than 50 lifetime
sexual partners.

A strong temporal and dose-response
association was found between alcohol
consumption and poor adherence and
dose-response.
Consumption on a particular day was
associated with decreased adherence to
medication on that day and for two
days immediately following that day.
A relationship between poor adherence
and quantity of alcohol consumed was
found, with particularly poor adherence
when quantities of alcohol were
consumed that met the criteria for
hazardous drinking.
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AUTHORS

Brau, N., Bini, E.
J., Shahidi, A.,
Aytaman, A. l.,
Xiao, P., Stancic,
S., et al. 2002

Cheung, R. C.
2000

Cheung, R. C.,
Hanson, A. K.,
Maganti, K.,
Keeffe, E. B., &
Matsui, S. M.
2002

TITLE

Prevalence of Hepatitis C
and Coinfection With
HIV Among United
States Veterans in the
New York/New Jersey
Veterans Integrated
Service Network

Epidemiology of
Hepatitis C Virus
Infection in American
Veterans

Viral Hepatitis and Other
Infectious Diseases in a
Homeless Population

PARTICIPANTS

n=1,098 patients
undergoing phlebotomy at
six Veterans Affairs
Medical Centers in the
NYC metropolitan area

n=8,558 veterans who
were tested for anti-HCV
serology

n=597 homeless veterans
admitted to inpatient
treatment

INSTRUMENTS

Third generation enzyme
immunoassay; HCV
RNA and HCV
recombinant immunoblat
assay antibody testing;
HCV viral load, HCV
genotype, HIV
antibodies testing; Studygenerated questionnaire
for demographics and
HCV risk factors

Anti-HCV serology second generation
ELISA; Commercial
immunoassays for
Hepatitis B surface
antigen; Beckman or
Hitachi automated
chemistry analyzers;
Author-generated selfreport questionnaire
completed by primary or
referring physician

Author-generated selfreport questionnaire;
Tuberculin skin test and
chest radiograph if
determined necessary;
Enzyme-linked
immunosorbent assay
using commercial kits for
antibody to HCV;
Hepatitis B surface
antigen for chronic HBV
infection; Hepatitis B
surface antigen for past
HBV infection; Antibody
to HIV 1/2.

METHODS

1-day cross-sectional survey.
All veterans having blood
drawn on a particular day
were asked to complete the
questionnaire and have blood
additionally analyzed for
HCV.
Analyses: Student’s t test,
chi-square, regression
analyses

Risk factors for HCV were
reported by primary or
referring physician.
Analyses: descriptive
statistics

RESULTS

















Interview conducted by
experienced interviewers and
adapted from an established
instrument to confirm selfreport measures.
Analyses: regression
analyses






10.6% HCV positivity
Independent risk factors for HCV
infection: injection drug use, blood
exposure during combat, alcohol
abuse, and service during Vietnam.
53.4% reported alcohol abuse.
24.8% HCV/HIV co-infection
Independent risk factor for HIV
coinfection: age (<50 years).
Rates of anti-HCV positive were
significantly higher than that of the
general population.
56% of HCV-positive patients were
unaware of their diagnosis.

35% HCV prevalence
Authors estimate a true prevalence rate
of 7-35% .
More than 80% of those HCV positive
were between the ages of 41 and 60
with only 0.2% between the ages of 21
and 3.
IVDU was the most common risk
factor (81%).

Prevalence rates: HCV (41.7%), PPD
(20.6%), HIV (1.8%), HBsAg (1.2%)
52.6% tested positive for one of four
diseases with majority presenting with
only one disease.
In cases with multiple disease
presentations, HCV was found in each
case.
IVDU was significantly associated
with HCV infection, past HBV
infection and positive PPD.
HCV was an independent risk factor
for HBV infection.
Anti-HBV positivity and IVDU were
independent risk factors for anti-HCV
positivity.

66

AUTHORS

Conigliaro, J.,
Gordon, A. J.,
McGinnis, K. A.,
Rabeneck, L., &
Justice, A., 2003

TITLE

How Harmful Is
Hazardous Alcohol Use
and Abuse in HIV
Infection: Do Health Care
Providers Know Who Is
at Risk

PARTICIPANTS

n=881 treatment-seeking
veterans with HIV
infection from the
Veterans Aging Cohort 3Site Study

INSTRUMENTS

AUDIT

METHODS
Retrospective chart review
and longitudinal study. ICD9 codes for diagnoses of
alcohol abuse of dependence
and laboratory variables
collected from VA electronic
medical records. Surveyed
clients at baseline and 12month follow up. Health care
providers were surveyed for
their perception of veteran
alcohol use.

RESULTS







Analyses: chi-square, t-tests,
regression analyses


Cook, R. L.,
McGinnis, K. A.,
Kraemer, K. L.,
Gordon, A. J.,
Conigliaro, J.
Maisto, S. A., et
al. 2006

Intoxication Before
Intercourse and Risky
Sexual Behavior in Male
Veterans With and
Without Human
Immunodeficiency Virus
Infection

n=1,719 veterans enrolled
in the Veterans Aging
Cohort 5-Site Feasibility
Study (n=1009 HIV+,
n=710 HIV-)

Study-generated survey
for demographics,
current depression,
sexual behaviors, drug
and alcohol use; AUDIT;
DAST

Cross-sectional study. Openended questions assessing
sexual behaviors and
condom use.



Analyses: chi square,
regression analyses



Desai, R. A.,
Rosenheck, R. A.,
& Agnello, V.
2003

Prevalence of Hepatitis C
Virus Infection in a
Sample of Homeless
Veterans

n=418 treatment-seeking
homeless veterans

Abbott HCV EIA 2.0 test
for HCV antibodies;
PCR assay test for HCV
infection in sera; Selfreport data forms
collected on admission

Compared profile to that of
patients enrolled in other
DCHV programs throughout
the country.
Analyses: regression
analyses






36% of HIV+ veterans reported current
hazardous drinking (AUDIT score of
>= 8 or binge drinking in the past 12
months) .
Hazardous drinking was associated
with younger age and current drug use.
27% had at least 1 ICD-9 alcoholrelated diagnosis in the last 5 years.
ICD-9 alcohol-related diagnosis was
associated with higher transaminase
levels, anemia and elevated mean
corpuscular volume.
Health care providers’ report of current
drinking and current hazardous
drinking were poor.

1 in 10 veterans regardless of HIV
status reported 2 or more sexual
partners with inconsistent condom use
in the past year.
Intoxication before intercourse was
significantly associated with
inconsistent condom use, 2 or more
sexual partners and inconsistent
condom use, and having 5 or more
sexual partners in the last year among
HIV+ veterans.

44.02% HCV positive prevalence rate
with significant association to age (4050) and to service era (51.35 Vietnam
era, 42.21 post-Vietnam era).
Homeless population was 10 times
more likely to have HCV positivity
than the US population of same age
group.
Those veterans who served during the
Vietnam era were 4.66 times more
likely to be HCV positive.
Those veterans with a lifetime history
of drug abuse were 6.86 times more
likely to be HCV positive.
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AUTHORS

TITLE

PARTICIPANTS

INSTRUMENTS

METHODS

RESULTS


El-Serag, H. B.,
Kunik, M.,
Richardson, P., &
Rabeneck, L.
2002

Psychiatric Disorders
Among Veterans with
Hepatitis C Infection

n=33, 824 hospitalized
HCV-infected veterans;
n=22,342 HCV-infected
Vietnam veterans
compared with n=43, 267
non-HCV-infected
Vietnam veterans

Retrospective chart review.
Data collection from
chart including ICD-9
codes and demographics

Analyses: univariate
analyses, chi square, t tests,
regression analyses






Ganguly, R.,
Lenox, B., Quiroz,
E., & Sinnott, J.
2002

Ho, S. B.,
Nguyen, H.,
Tetrick, L. L.,
Opitz, G. A.,
Basara, M. L, &
Dieperink, E.
2001

HIV Infection, Risk
Factors, and Testing in a
Veteran Population

Influence of Psychiatric
Diagnoses on InterferonTreatment for Chronic
Hepatitis C in a Veteran
Population

n=152 treatment-seeking
veterans

n=35 veterans with
chronic HCV who were
eligible for IFN treatment

34-item survey
questionnaire instrument
generated for the study

Complete medical and
psychiatric history at
beginning of protocol;
HCV RNA testing
throughout treatment
protocol

Cross-sectional survey study.
Self-report measures
administered onsite with a
45% return rate.
Analyses: frequency
analysis, cross-tabulations
and chi square analysis,
correlational analyses,
regression analyses

Retrospective review of
medical records for
psychiatric diagnoses.
Participants were enrolled in
a high dose IFN- treatment
protocol. All those on antidepressant or anti-psychotic
medications during therapy
were followed by psychiatric
service during treatment.
Analyses: contingency table
and chi square analysis










85% of HCV+ veterans had at least
one past or present psychiatric, druguse, or alcohol-use disorder
diagnosis.1/3 of HCV+ veterans had
active psychiatric or drug-use
disorders. Only 6.5% had a psychiatric
disorder without a drug or an alcohol
use disorder.
42.8 % prevalence of PTSD among
HCV+ veterans.
Among Vietnam-era veterans, there
was a 4 fold increase in alcohol use, 5
fold increase in drug use, and 2 fold
increase in suicide attempts when
comparing HCV+ and HCV- veterans.
53.3% of veterans sampled had highrisk factors. More younger veterans
(age<50) had risk factors than older
veterans.
Most of veterans believed that condom
use prevented HIV transmission, but
65.8% of veterans did not use
condoms.
Resistance to condom use was related
to age, with those <50 years old more
willing to use condoms.
None of the veterans reporting multiple
sexual partners in the last six months
used a condom consistently.

HCV+ veterans with an established
diagnoses of psychiatric conditions
prior to treatment experienced a >2
fold frequency of major adverse events
resulting in discontinuation of therapy
or interventions when compared with
patients without these diagnoses.
Four of the five HCV+ veterans
diagnosed with PTSD experienced a
major adverse event; however, the n is
too small to make definitive
conclusion.
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AUTHORS

TITLE

PARTICIPANTS

INSTRUMENTS

METHODS

RESULTS



Hoff, R. A.,
Beam-Goulet, J.,
& Rosenheck, R.
A. 1997

Mental Disorder as a
Risk Factor for Human
Immunodeficiency Virus
Infection in a Sample of
Veterans

n=11,645 veterans from
the National Survey of
Veterans

Study-generated
telephone interview

Random digit dialing of US
and Puerto Rican numbers to
a random sample of veterans
from the VA Compensation
and Pension Files, VA
patient treatment files, and
outpatient VA clinic files.
Analyses: regression
analyses

Huckans, M. S.,
Blackwell, A. D.,
Harms, T. A., &
Hauser, P. 2006

Hyams, K. C.,
Riddle, J.,
Rubertone, M.,
Trump, D., Alter,
M. J., Cruess, D.
F., et al. 2001.

Management of Hepatitis
C Disease Among VA
Patients With
Schizophrenia and
Substance Use Disorders

n=293,445 treatmentseeking veterans

Prevalence and Incidence
of Hepatitis C Virus
Infection in the US
Military: A
Seroepidemiologic
Survey of 21,000 troops.

n=21,000 military
personnel (n=10, 000
active duty, n=2,000
active duty inducted in
2007, n=2000 reservists,
n=1000 active duty who
served in Vietnam, n=
2000 active duty who
retired in 1997 after 20+
years of service, n=2000
women on active duty,
n=1000 non-white/nonAfrican American active
duty, n=1000 active duty
personnel with health care
job classification)

Used database to collect
demographic data,
psychiatric diagnoses,
HCV laboratory results,
and prescriptions.

Retrospective data base
study.
Analyses: descriptive
statistics, odds ratios














Second generation
enzyme immunoassay
and recombinant
immunobloat assay
(RIBA) to determine
HCV-positivity; HCV
RNA testing

Proportion of each group was
chosen in proportion to
number of individuals from
each branch of the military.
Serum samples from the
Department of Defense
Serum Repository were used
for HCV analyses.




Analyses: chi square, t-tests,
regression analyses

37% of sample were HIV+
1.44% of those with a diagnosis of
drug or alcohol abuse were HIV+.
1.03% of those with PTSD were HIV+
26% of those with PTSD had comorbid drug or alcohol abuse.
40.52% of those with PTSD had a comorbid mental disorder other than
substance abuse.
Those with substance use were 4.9
times more likely to be HIV+ and those
with PTSD were 3.17 times more
likely to be HIV+.
Those with PTSD alone were not at
increased risk but those with substance
abuse were 2.43 times more likely to
be HIV+ and those with both were
11.50 times more likely to be HIV+.
11.4% veterans tested HCV+
High risk groups were significantly
more likely to test HCV antibody
positive.
Veterans in high-risk groups were less
likely to receive IFN therapy if they
were in the substance disorders or cooccurring disorders groups.

HCV prevalence rates were
substantially lower than those of the
civilian population less than 40 years
of age (0.1% among those >35 years;
1.1% among those 35-39 years).
Prevalence rates of older personnel
were comparable to the civilian
population (3.0% among those 40+
years).
Potentially high risk groups such as
health care personnel and Vietnam era
veterans did not have an increased risk
of infection.
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AUTHORS

Johnson, J. E.,
Finney, J. W., &
Moss, R. H. 2005

TITLE

Predictors of 5-year
Mortality Following
Inpatient/Residential
Group Treatment for
Substance Use Disorders

PARTICIPANTS

n=3,698 male SUD
treatment inpatient
veterans

INSTRUMENTS

METHODS

Intake Information Form
(n=3698); Discharge
Information Form
(n=3331); Follow-up
Information Form
(n=3018)

Administered questionnaires
at intake, discharge, and 12months post-discharge. Used
VA Beneficiary
Identification and Record
Locator System database to
verify and ascertain death
status for those who could
not be reached for follow-up.

RESULTS




Analyses: regression
analyses

Justice, A. C.,
McGinnis, K. A.,
Atkinson, J. H.,
Heaton, R. K.,
Young, C., Sadek,
J., et al. 2004

Psychiatric
Neurocognitive Disorders
Among HIV-positive and
Negative Veterans in
Care: Veterans Aging
Cohort Five-Site Study

n=50 veterans
(convenience sample) who
were part of the Veterans
Aging Cohort 5-site Study
who consented to
participate in formal NCP
testing; (n=28 HIV+,
n=22 HIV-)

Composite International
Diagnostic Interview;
WRAT-3; WAIS III
(Digit Symbol, Symbol
Search, Letter-Number
Sequencing); Trail
Making Test Part A & B;
Paced Auditory Serial
Addition Task;
Controlled Oral Word
Association; Hopkins
Verbal Learning Test Revised (Total Trials 1-3
& Delayed Recall); Brief
Visuospatial Memory
Test- Revised (Total
Trials 1-3 & Delayed
Recall); Wisconsin Card
Sorting Test; Grooved
Pegboard (Dominant and
Non-Dominant Hand);
Patient Health
Questionnaire; AUDIT,
DAST

Alcohol and drug use
confounds were determined
by interviewer based on
interview, ICD-9 diagnoses,
and self-report screening
measures. Blind clinical
rating to characterize the
presence of global NCP
impairments.



HIV/AIDS status was the strongest
predictor of mortality in the sample.
Those who were HIV-, who consumed
less than 3oz of ethanol on nondrinking days, who were employed,
and who were partnered 1 year after
discharge had a dramatically decreased
risk of death within the next 5 years
(5%) than those who were not (56%).

Older HIV+ veterans demonstrate
higher rates of depressive symptoms,
alcohol abuse or dependence, and drug
abuse or dependence than age-stratified
HIV- veterans.

Analyses: kappa statistics,
chi square tests, regression
analyses
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AUTHORS

Lehman, C. L., &
Cheung, R. C.
2002

TITLE

Depression, Anxiety,
Post-Traumatic Stress,
and Alcohol-Related
Problems Among
Veterans With Chronic
Hepatitis C

PARTICIPANTS

n=120 veterans with HCV
referred for evaluation and
treatment

INSTRUMENTS

Beck Depression
Inventory; Anxiety
Sensitivity Index; PostTraumatic Stress
Disorder Checklist;
AUDIT

METHODS

Veterans underwent a
physical exam, psychiatric
interview, and self-report
medical history was
collected. Retrospective
medical chart review for
preexisting psychiatric
diagnosis. The PostTraumatic Stress Disorder
Check List was only
administered to those who
reported history of
significant trauma. The
AUDIT was only
administered to those who
admitted alcohol use in the
last 12 months.

RESULTS







49.4% of HCV+ veterans had a history
of non-substance abuse psychiatric
disorders and 81% had a history of an
alcohol use disorder.
Clinically significant levels of PTSD
(20.8%) and alcohol-related problems
(26.7%) were observed.
Positive correlations were found
between PTSD symptoms and alcohol
use problems.
Coexisting unstable psychiatric
disorders and/or recent substance use
was found in 73.4% of the veterans.

Analyses: independent t
tests, Pearson R correlations



Lim, J. K.,
Cronkite, R.,
Goldstein, M. K.,
& Cheung, R. C.
2006

The Impact of Chronic
Hepatitis C and
Comorbid Psychiatric
Illness on Health-related
Quality of Life

n=864 veterans who
participated in the 1999
Large Health Survey and
had been tested for antiHCV

SF-36V ( a selfadministered HRQoL
questionnaire)

ICD-9CM psychiatric
diagnoses were determined
from VHA administrative
databases.




Analyses: chi square tests, t
tests, regression analyses

Anti-HCV+ veterans were more likely
to be younger, male, nonwhite, and
unmarried.
Anti-HCV+ veterans were more likely
to have at least 1 of 6 psychiatric
diagnoses, including PTSD (27.9%), or
alcohol dependence (43.8%).
Health related quality of life was
significantly lower for anti-HCV+
veterans on role emotional, mental
health, general health, and social
functioning. Those with PTSD
experienced additional impairments.
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AUTHORS

Nguyen, H. A.,
Miller, A. I.,
Dieperink, E.,
Willenbring, M.
L., Tetrick, L. L.,
et al. 2002

TITLE

Spectrum of Disease in
U.S. Veteran Patients
with Hepatitis C

PARTICIPANTS

n=206 veterans with HCV
who met eligibility criteria
for interferon a -2b
therapy

INSTRUMENTS

Qualitative polymerase
chain reaction assays
(PCR) for HCV; Liver
biopsies;

METHODS

Review of medical records
for ICD-9 codes and
treatment for alcohol use
history and psychiatric
diagnoses. Treatment
included Interferon a-2b
monotherapy or a
combination therapy of
interferon and ribavirin. PCR
performed before treatment
initiation, at 3-6 months, at
the end of 6-12 months, and
6 months after the end of
treatment.

RESULTS







Analyses: contingency
tables, chi square analyses

Roselle, G. A.,
Danko, L. H.,
Kralovic, S. M.,
Simbarti, L. A., &
Kizer, K. W. 2002

National Hepatitis C
Surveillance Day in the
Veterans Health
Administration of the
Department of Veterans
Affairs

n=26,102 treatment
seeking veterans from 138
of 142 reporting sites

Diversity of serologic
methods for HCVantibodies

VHA patients having lab
studies performed were
asked to undergo HCVAb
testing at 142 VHA sites.
Data were collected at each
site and extracted from VHA
electronic surveillance
systems and sent to the
Austin Automation Center.




Psychiatric illnesses were present in
60% of patients, with the most
common diagnosis being depression or
PTSD.
A history of alcohol use or dependence
was found in 80% and a history of
IVDU or cocaine use in 78% of
veterans sampled.
A majority of HCV+ veterans sampled
(77%) served during the Vietnam era
and 66% had a history of IVDU.
Significant liver fibrosis is common in
the patients with psychiatric diagnoses
when they are initially evaluated for
treatment. . The rates of liver fibrosis
seen are higher than those in the
general population.

HCVAb prevalence rates of 6.6% were
found.
Those who were HCVAb seropositive
were likely to be Vietnam era veterans.

Analyses: t-tests, odds ratios,
regression analyses

Roselle, G. A.,
Mendenhall, C. L.,
& Danko, L. H.
1997

A Four-Year Review of
Patients with Hepatitis C
Antibody in Department
of Veterans Affairs
Facilities

n=168 Department of
Veterans Affairs sites

Census instrument asking
for the number of
patients who tested
positive in the designated
fiscal year (from 19911994), also included
common causes of
infectious hepatitis as
well as emerging
pathogens

Data reviewed and analyzed
using Quatro Pro for
Windows.
Analyses: correlational
statistics



Increase of 285% in positive tests for
HCV antibody from 1991-1994 among
client population that only increased
4.87% over the four years.
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AUTHORS

Seal, K. H.,
Currie, S. L.,
Shen, H., Anand,
B. S., Bini, E. J.,
Brau, N., et al.
2007

TITLE

Hepatitis C Treatment
Candidacy and Outcomes
Among 4318 US
Veterans with Chronic
Hepatitis C Virus
Infection

PARTICIPANTS

n=4,462 treatmentseeking veterans from 24
VA medical centers

INSTRUMENTS

Study-generated
questionnaire including
sociodemographics and
drug and sexual risk
behavior

METHODS
Clinical assessments
including detailed medical
and mental health history and
laboratory tests were done to
determine treatment
candidacy using VA HCV
Treatment
Recommendations.
Treatment with Rebetron for
up to 24-28 weeks. Veterans
returned for follow-up at
week 1, 2 and months 1, 3, 6,
9, and 12 to monitor
treatment compliance,
physical and psychiatric side
effects, and viral response.

RESULTS





61% of those evaluated for HCV
treatment reported a history of IVDU
and were significantly more likely to
be Vietnam-era veterans who drink
more than 3 alcoholic drinks a day in
the last year, engage in high risk sexual
behavior, and are HIV seropositive.
IVDU was not significantly associated
with HCV treatment candidacy,
treatment acceptance, early
discontinuation of therapy, or treatment
response.

Analyses: regression
analyses

Srauss, J. L.,
Bosworth, H. B.,
Stechuchak, K.
M., Meador, K.
M., & Butterfield,
M. I. 2006

Knowledge and Risks of
Human
Immunodeficiency Virus
Transmission among
Veterans with Severe
Mental Illness

n=353 psychiatric
inpatient veterans (45%
Schizophrenia, 16%
Bipolar I, 39% PTSD)

Standardized semistructured assessment
interview; select items
from AIDS Risk
Inventory; Dartmouth
Assessment of Lifestyle
Instrument

Interview conducted by
experienced interviewers and
adapted from an established
instrument. Review of
medical records and
psychiatric records and
current admission records for
diagnoses.
Analyses: regression
analyses

Szerlip, M. A.,
Desalvo, K. B., &
Szerlip, H. M.
2005

Predictors of HIVInfection in Older Adults

n=53 HIV+ veterans and
n=106 HIV- matched
controls

Retrospective chart
review

Retrospective chart review
for potential HIV predictors
HIV risk behaviors, history
of diseases associated with
HIV risk or infection and
routine laboratory values,
non-HIV related comorbid
diseases requiring chronic
care, and substance abuse
history.
Analyses: chi-square
analyses









More than 40% of participants
answered at least one AIDS related
knowledge question incorrectly.
Most common incorrect answers were:
"Most people become sick quickly
after getting the AIDS virus" (31.4%)
and "People who can give you the
AIDS virus always look sick" (15.9%).
Inaccurate HIV knowledge was not
associated with clinical diagnosis.

HIV+ veterans exhibited significantly
more alcohol abuse than HIVveterans.
HIV+ veterans were more likely to
have a history of sexually transmitted
diseases such as syphilis, gonorrhea,
Chlamydia or herpes and were more
likely to test VDRL positive, have
previous HBV exposure, and have a
history of alcohol abuse.

73

AUTHORS

Yovtcheva, S. P.,
Rifai, M. A.,
Moles, J. K., &
Van der Linden,
B. J. 2001

TITLE

Psychiatric Comorbidity
Among Hepatitis CPositive Patients

PARTICIPANTS

n=306 HCV+ veterans

INSTRUMENTS

Retrospective chart
review

METHODS
Retrospective chart review
for demographics and
psychiatric disorders.
Symptoms in medical
records compared with
DSM-IV criteria to confirm
diagnoses.
Analyses: descriptive
statistics

RESULTS




Prevalence rates of a variety of
psychiatric disorders were higher in
HCV+ veterans than the general
population.
Alcohol use disorders were the most
common (86%) followed by
polysubstance use (60%) and IVDU
(28%). PTSD was found in 19% of the
sample.
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Substance Use Disorders Literature Table n=20
AUTHORS

STUDY

PARTICIPANTS

INSTRUMENTS

Boudewyns, P .A.,
Albrecht, J. W.,
Talbert, F. S., &
Hyer, L. A. 1991

Comorbidity and
Treatment Outcome of
Inpatients with Chronic
Combat-related PTSD

n=102 inpatient male
Vietnam combat veterans
with PTSD

Diagnostic Interview
Schedule (computerized
version)

METHODS
Psychiatric rehospitalization
data collected from record
review.

RESULTS



Analyses: chi square analyses


Boudewyns, P. A.,
Woods, M. G.,
Hyer, L., &
Albrecht, J. W.
1991

Bremner, J. D.,
Southwick, S. M.,
Darnell, A., &
Charney, D. S.
1996

Davidson, J,
Kudler, H.,
Saunders, W., &
Smith, R. 1990

Chronic Combat-related
PTSD and Concurrent
Substance Abuse:
Implications for
Treatment of this
Frequent 'Dual
Diagnosis'

Chronic PTSD in
Vietnam Combat
Veterans: Course of
Illness and Substance
Abuse

Symptom and
Comorbidity Patterns in
World War II and
Vietnam Veterans with
Posttraumatic Stress
Disorder

n=102 inpatient male
Vietnam combat veterans
with PTSD

n=61 treatment-seeking
combat veterans with
combat-related PTSD

n=44 treatment-seeking
male veterans with PTSD
(19 WWII, 25 Vietnam)

Diagnostic Interview
Schedule (computerized
version)

Mississippi Scale for
Combat-Related
Posttraumatic Stress
Disorder; Combat
Exposure Scale;
Longitudinal History for
Vietnam Veterans
Interview; Structured
Clinical Interview for
PTSD from DSM-III-R;
Addiction Severity Index
Interview; Authorgenerated assessment for
stressful life events
Hamilton Depression and
Anxiety Scale; Newcastle
Index; Clinical Global
Impression of Severity of
Illness; Impact of Events
Scale; Symptom
Checklist-90; SI-PTSD;
Schedule for Affective
Disorders and
Schizophrenia

PTSD was determined by a
Diagnostic Interview
Schedule and independent
diagnosis by the unit staff.



Analyses: chi square analyses







Record review for history of
PTSD treatment and
hospitalizations.
Analyses: ANOVA,
correlations, t tests






Patients were assessed at
baseline by a physician.
Baseline ratings were taken
after the patients had been
free of medication for at least
10 days.
Analyses: chi-square tests




All participants exhibited the presence
or history of one co-morbid Axis I
disorder.
91% exhibited lifetime history of
alcohol, drug, or mixed alcohol and
drug abuse or dependence.
91.2% of veterans had at least a
lifetime diagnosis of some form of
substance abuse/dependence.
32% admitted to drug/alcohol use in
the last 6 months.
A strong connection between
substance abuse/use and stress was
noted.
Those veterans with a diagnosis of
alcohol abuse/dependence in last year
were less likely to complete the PTSD
treatment program.
PTSD symptoms were noted to
plateau, become chronic, and
gradually increase within a few years
of the war.
The course of alcohol and substance
abuse followed a pattern similar to
that of PTSD in the period during and
immediately following the war.
Veterans reported that alcohol, heroin,
marijuana, opiates, and
benzodiazepines were beneficial in
mitigating their symptoms of PTSD.

Vietnam veterans appeared more
symptomatic and more severely
affected with respect to observed
depression and PTSD
symptomatology.
Assessment showed a high frequency
of alcoholism (47% WWII, 68% VN).
Alcoholism preceded or occurred at
the same time as PTSD in Vietnam
veterans but followed PTSD
symptoms in WWII veterans.
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AUTHORS

STUDY

Eisen, S. A.,
Griffith, K. H.,
Xian, H., Scherrer,
J. F., Fischer, I. D.,
Chantarujikapong,
S. et al. 2004

Lifetime and 12-month
Prevalence of
Psychiatric Disorders in
8169 Male Vietnam War
Era Veterans

Faustman, W. O.,
& White, P. A.
1989

Diagnostic and
Psychopharmacological
Treatment
Characteristics of 536
Inpatients with
Posttraumatic Stress
Disorder

PARTICIPANTS

n=8,169 male Vietnam
era veterans

INSTRUMENTS

National Institute of
Mental Health Diagnostic
Interview Schedule

METHODS
Instrument administered by
telephone using a
computerized version of the
DIS-III-R.

RESULTS




Analyses: odds ratios,
descriptive statistics

n=536 male veterans
with PTSD or
provisional diagnosis of
PTSD (n=139 from
Psychiatric Ward [PW]
and n=397 Stress
Disorder Program [SDP])

Discharge Summaries

Retrospective chart review;
8000 records from inpatient
psychiatric services were
reviewed and 536 veterans
with PTSD or provisional
PTSD were identified. The
536 PTSD veterans were
rated based on demographics,
discharge diagnosis, alcohol
and/or substance abuse, and
psychotropic medications.







Analyses: Descriptive
statistics; separate data
analyses were performed for
the PW and SDP groups.

Green, B. L.,
Grace, M. C.,
Lindy, J. D.,
Gleser, G. C., &
Leonard, A. L.
1990

Risk factors for PTSD
and Other Diagnoses in a
General Sample of
Vietnam Veterans

n=200 male veterans (1/3
from clinical sources and
2/3 non-treatment
seeking)

Schedule of Affective
Disorders and
Schizophrenia Lifetime
Version; 6-point scale of
Psychosocial Adjustment
in Adolescence; SADS:L;
Wilson and Krauss
Combat Experience and
Specific Stressor
Questionnaires
(modified); 6-item
questionnaire assessing
help-seeking behavior;
Author-generated PTSD
Scale



3 1/2 hour interviews



Analyses: regression analyses



55% exhibited a lifetime prevalence
and 17% had a 12-month history of
alcohol abuse and /or depression.
10.2% exhibited a lifetime history and
1.3% had a 12-month history of illicit
drug abuse and/or dependence.

Alcohol abuse (23.3%) and alcohol
dependence (13.1%) were the most
frequent concomitant diagnoses found
with PTSD.
18% of the veterans were found to
have an alcohol abuse history that was
not represented by an Axis I diagnosis
in their charts.
56% of the SDP and 36% of the PW
chart summaries noted current and/or
remote history of maladaptive alcohol
use or drug use.

Premilitary factors contributed 9% to
the prediction of PTSD; however
military factors played a larger role,
accounting for 19% of the variance
over and above premilitary factors.
Post-military factors accounted for an
additional 12% of the variance over
and above both premilitary and
military factors and explained
significant variance in the diagnosis of
alcohol and drug abuse.
The strongest predictor of PTSD was
exposure to grotesque death.
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AUTHORS

Hryvniak, M. R.
1989

STUDY

Concurrent Psychiatric
Illness in Inpatients with
Post-traumatic Stress
Disorder

PARTICIPANTS

n=374 inpatient veterans
in general psychiatry
ward

INSTRUMENTS

Diagnostic Interview

METHODS
Diagnoses made using DSMIII and DSM-III-R criteria, by
ongoing observation, and
appropriate review of hospital
records, collaboration from
family members, consultation
with previous treating
physicians, and assessment
with psychological testing.

RESULTS






Analyses: chi-square

Johnson, D. R.,
Fontana, A., Lubin,
H., Corn, B., &
Rosenheck, R. 2004

Long-term Course of
Treatment Seeking
Vietnam Veterans with
Posttraumatic Stress
Disorder: Mortality,
Clinical Condition, and
Life Satisfaction

n=51 inpatient treatmentseeking male veterans
with PTSD

Mississippi PTSD Scale;
War Stress Interview
Follow-up Version;
Clinician Administered
PTSD Scale; Combat
Exposure Scale;

6-year longitudinal study with
assessment at admission, 18
months, and 6 years. Combat
experience was confirmed by
review of military files.
Veterans were questioned
about experience with and
frequency of 11 categories of
stressful life events at 6 year
follow-up, were asked to rate
10 dimensions of functioning
at 3 time periods, and were
asked to rate the degree of
impact of treatment program
on same 10 dimensions.







Mean number of diagnoses for the
PTSD group was 2.9, compared with
1.4 in non-PTSD group.
Concurrent diagnoses most often
associated with PTSD were alcohol
abuse (42.9%), substance use and
depression (36.5%).
Alcohol abuse occurred significantly
more frequently among the PTSD
group.

There was a 17% mortality rate over 6
years. This rate is 5 times higher than
the expected rate among American
men in this age range.
More convictions, more medical
problems, greater need for help with
drug abuse, and fewer employers
since military discharge were
significantly associated with veteran
death.
Most of causes of death appear to be
associated with either self-destructive
or high-risk behavior.

Analyses: ANOVA,
regression analyses, t-tests



Kulka, R. A.,
Schlenger, W. E.,
& Fairbank, J. A.
1990

Trauma and the Vietnam
War Generation: Report
of Findings from the
National Vietnam
Veterans Readjustment
Study

n=1200 male Vietnam
theatre veterans, n=412
male Vietnam era
veterans, n=450 male
civilian comparison
subjects from the
NVVRS

Mississippi CombatRelated PTSD Scale;
MMPI; Structured
Clinical Interview for the
DSM-III

Connected to veterans via
telephone.
Analyses: unable to
determine.




Male Vietnam theatre veterans had
high levels of lifetime alcohol
dependence or abuse (40%) when
compared with civilian males (25%).
6% lifetime drug abuse rates for male
Vietnam theatre veterans.
Almost three-fourths of veterans with
PTSD had a lifetime alcohol abuse or
dependence disorder, and 22% had
those disorders currently.
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McFall, M. E.,
Mackay, P. A., &
Donovan, D. M.
1992

Combat-related PTSD
and Severity of
Substance Abuse in
Vietnam Veterans

n=108 treatment-seeking
Vietnam-theatre veterans
and n=151 treatmentseeking Vietnam-era
veterans

Revised Combat
Exposure Scale;
Mississippi Scale for
Combat-Related PTSD;
Michigan Alcohol
Screening Test; DAST

3-hour orientation at intake to
Addictions Treatment Center
during which time the battery
of assessments was
administered. Demographic
data, including military
history variables, were
obtained from the self-report
version of the Addiction
Severity Index.
Analyses: t-tests, chi-square,
correlations, regression
analyses









McFall, M. E.,
Mackay, P. W., &
Donovan, D. M.
1991

Combat-related PTSD
and Psychosocial
Adjustment Problems
Among Substance
Abusing Veterans

n=489 treatment-seeking
male veterans with
substance abuse disorders

Modified Addiction
Severity Index; Revised
Combat Scale;
Mississippi Scale for
Combat-related PTSD

3 hour orientation session
with a clinical interview and
administration of the
psychometric instruments.



Analyses: t-tests, regression
analyses, chi-square


McFall, M.,
Fontana, A.,
Raskind, M., &
Rosenheck, R. 1999

Analysis of Violent
Behavior in Vietnam
Combat Veteran
Psychiatric Inpatients
with Posttraumatic
Stress Disorder

n=228 treatment-seeking
male Vietnam combat
veterans , n=64 male
veteran psychiatric
inpatients with no history
of combat exposure or
PTSD, n= 273 male
Vietnam veterans with
PTSD who had never
been hospitalized on a
VA inpatient psychiatry
unit from NVVRS data
set

Revised Combat
Exposure Scale (to
n=58); Mississippi Scale
for Combat-Related
PTSD (brief version);
National Comorbidity
Survey (comparison
group); PTSD Screening
Form; War Stress
Interview - Admissions
Supplement; 10-item
RCES; War Stress Intake
Questionnaire; PTSD
Discharge Process Form

Standard clinical interview to
determine PTSD diagnosis
(DSM-III-R); Self-report of
violent acts for inpatient
groups similar to items on the
NVVRS, also derived by
direct interview and review of
medical records; Violent acts
by community residents
assessed by adaptation of the
Conflict Tactics Scale






Analyses: odds ratios, chisquare tests, regression
analyses

92% of total veterans presented with
alcohol-abuse disorder, 60% with a
drug-abuse disorder, and 53% with
both alcohol and drug abuse disorders.
Combat-exposed veterans with PTSD
have more severe alcohol and drugabuse problems than theatre veterans
without PTSD.
PTSD veterans were at greater risk for
concurrent dependence on both
alcohol and drugs than non -PTSD
theatre veterans.
Overall severity of PTSD was more
strongly associated with drug abuse
than alcohol abuse.
Physiological arousal and ideational
reexperiencing were significantly
correlated with MAST scores while
the DAST was positively related to
avoidance/numbing.
46% of Vietnam theatre veterans
presented with clinically significant
PTSD symptoms.
PTSD contributed to the prediction of
history of psychiatric hospitalizations,
lifetime trouble with thoughts of
suicide, and lifetime trouble
controlling violent
tendencies/behavior.
Among the inpatient PTSD group,
54% had alcohol abuse-dependence
and 32% had drug abuse-dependence
PTSD inpatients were significantly
more likely than psychiatric inpatients
without PTSD to have engaged in one
or more violent acts during the 4
months prior to hospitalization and
were significantly more violent than
the NVVRS sample.
PTSD, atrocities, and substance use
contribute to the variation in violence.
A significant proportion of PTSD
inpatients were classified as highly
violent when compared with the nonPTSD inpatients and community
PTSD groups.
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Norman, S. B.,
Tate, S. R.,
Anderson, K. G., &
Brown, S. A. 2007

Do Trauma History and
PTSD Symptoms
Influence Addiction
Relapse Context?

n=134 treatment-seeking
male veterans (n= 68
SUD-only, n=34 SUDTrauma, and n=32 SUDPTSD)

Semi-Structured
Assessment for the
Genetics of Alcoholism,
Lifetime Version; Brief
Symptom Inventory;
Timeline FollowBack for
Substance Use; Tox
screen (20% of
participants); Contextual
Cue Assessment

Diagnostic interviews
conducted to assess lifetime
and current PTSD; Charts
screened for potential
participants; Structured
interviews 2 weeks after
abstinence; Telephone
contacts at 4 post-treatment
time periods and in-person
interviews at 4 post-treatment
time periods; Interview of
collateral contact person
quarterly






Analyses: regression analyses

Price, R. K., Risk,
N. K., Haden, A.
H., Lewis, C. E., &
Spitznagel, E. L.
2004

Post-traumatic Stress
Disorder, Drug
Dependence, and
Suicidality among Male
Vietnam Veterans with a
History of Heavy Drug
Use

n=641 Vietnam veterans
who were in the original
VES cohort

VES Survey

Death certificates were used
to identify those who
committed suicide with
external causes of death
qualifying for suicide coded
by an expert cause-of-death
coder. Non-fatal suicidality
was determined by answers to
questions about frequent
thoughts of suicide, making a
suicide plan or attempted
suicide.





SUD-PTSD and SUD-Trauma groups
did not have worse post-treatment
outcomes than SUD-only group
Those with trauma histories reported
significantly higher psychiatric
symptom scores than the SUD-only
group prior to relapse.
SUD-PTSD patients had significantly
more anxiety and total symptoms than
SUD-Trauma.
Higher levels of anxiety and PTSD
symptoms predicted an increased
likelihood of relapse in negative
interpersonal contexts and negative
physiological contexts, but a reduced
likelihood of drinking in the context
of social pressure

Remission from suicidality occurred
more slowly for veterans with
concurrent PTSD or with concurrent
drug dependence.
Drug dependence had the second
largest effect, following depression,
on suicidal timing.

Analyses: descriptive
statistics, t-tests, ANOVAs


Roszell, D. K.,
McFall, M. E., &
Malas, K. L. 1991

Frequency of Symptoms
and Concurrent
Psychiatric Disorder in
Vietnam Veterans with
Chronic PTSD

n=116 male Vietnam
veterans referred for
PTSD evaluation

SCID-P

n=48 had 4-6 hours of
clinical interviewing to assess
for military history and DSMIIIR Axis I mental disorders
using SCID-P; n=68 only
administered the PTSD
portion of the SCID-P
Analyses: correlations






36.8% of veterans reported alcohol or
nonprescription substance use to avoid
dealing with memories or feelings
associated with the trauma.
Alcohol abuse diagnosed in 4.2%,
alcohol dependence 33.3%, drug
abuse 4.2%, drug dependence 10.4%.
Symptoms of reexperiencing were
significantly related to symptoms of
avoidance or numbing and
physiological arousal.
Avoidance or numbing symptoms
were significantly correlated with
physiological arousal.
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Steindl, S. R.,
Yound, R. M.,
Creamer, M.
Crompton, D. 2003

Sutker, P. B., Uddo,
M., Brailey, K.,
Vasterling, J. J., &
Errera, P. 1994

Hazardous Alcohol Use
and Treatment Outcome
in Male Combat
Veterans with
Posttraumatic Stress
Disorder

Psychopathology in
War-zone Deployed and
Nondeployed Operation
Desert Storm Troops
Assigned Graves
Registration Duties

n=608 Australian war
veterans

n=60 US Army
Reservists (n=40
deployed to the Persian
Gulf and n=20 stateside)

Clinician Administered
PTSD Scale;
Posttraumatic Stress
Disorder Checklist;
AUDIT; The Combat
Exposure Scale;
Demographic
Information

Demographic
Questionnaire; Shipley
Institute of Living Scale;
Graves Registration Duty
Scale; SCID-P for Axis I
Disorders; State-Trait
Anxiety Inventory; StateTrait Anger Scale: Beck
Depression Inventory;
20-Item Physical
Symptom Checklist

CAPS used to confirm
diagnosis. AUDIT, PCL and
demographic information
collected at intake. Measures
were given at intake and 9month follow-up.
Analyses: MANOVA, t-tests,
ANOVA, regression analyses

Assessment and debriefing
conducted approximately 12months after termination of
duties. Self-report instruments
were administered as well as
individually-administered
structured clinical interviews,
and small-group debriefing
sessions. War-zone stress
exposure was characterized
by a count of total days of
war-zone exposure as well as
standardized instruments.










68% of veterans were classified as
hazardous drinkers at intake.
Drinking status was significantly
associated with PTSD symptoms at
follow-up.
Unchanged hazardous drinkers
experienced more severe avoidance,
numbing, and arousal symptom when
compared to new low-risk drinkers at
9-month follow-up.
Unchanged hazardous drinkers had
more severe arousal symptoms when
compared to unchanged low-risk
drinkers.

A significantly greater number of
deployed troops had a diagnosis of
PTSD than those who were remained
stateside (48% vs. 0% current PTSD;
65% vs. 0% lifetime PTSD).
PTSD diagnoses were frequently
associated with alcohol dependence
(21% current diagnosis; 31% lifetime
diagnosis) and substance dependence
(5% current diagnosis; 4% lifetime
diagnosis)

Analyses: ANOVA, chisquare

Tate, S. R.,
Norman, S. B.,
McQuaid, J. R., &
Brown, S.A. 2007

Health Problems of
Substance-Dependant
Veterans with and
without Trauma History

n=121 treatment-seeking
male veterans (n=55
SUD-only, n=34 SUDTrauma, and n=32 SUDPTSD groups)

Brief Symptom Inventory
(at intake and each
follow-up); Modified
Psychiatric Epidemiology
Research Interview and
structured interview for
more detail; SemiStructured Assessment
for the Genetics of
Alcoholism, Lifetime
Version; Timeline
FollowBack for
Substance Use; Tox
screen for 15% of
participants

Assessments and interviews
completed after admission
and 2 weeks of abstinence,
and quarterly for a year
thereafter. Self-ratings of
current health status, tobacco
use, and number of medical
treatment contacts made for
physical health in prior three
months. Self-report of
number of professionally led
addiction, dual-diagnosis,
mental health and 12-step
groups attended in each
quarter.





Veterans with SUD and PTSD
exhibited the highest rates of chronic
health problems; however, no
significant difference was found
between the SUD-Trauma group and
SUD-PTSD group.
SUD-PTSD and SUD-Trauma
patients rated their health as worse
and had a greater utilization of
medical services.

Analyses: chi-square,
ANOVA, regression analyses
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Vaidya, N. A., &
Garfield, D. A. S.
2003

A Comparison of
Personality
Characteristics of
Patients with
Posttraumatic Stress
Disorders and Substance
Dependence:
Preliminary Findings

n=31 treatment-seeking
male veterans with
substance abuse diagnosis
only and n=30 treatmentseeking male PTSD
veterans

TCI

Retrospective chart review.
PTSD patients were given the
TCI as a part of their clinical
assessment. PTSD was
determined by a researcher
using DSM-IV criteria.



Analyses: t-tests



Scores differed between PTSD
veterans and SUD veterans on the
TCI.
PTSD veterans reported average
novelty seeking, high harm avoidance,
and low reward dependence while
substance abuse patients had high
novelty seeking, average harm
avoidance, and average reward
dependence.
Authors suggest that the findings may
support the hypothesis that PTSD
patients use substances to mitigate
PTSD symptoms.

81

Sleep Disturbances Literature Table n=15
AUTHORS

Aukst-Margetic, B.,
Margetic, B., Tosic,
G., & Bilic-Prcic,
A. 2004

STUDY

Levomepromazine
Helps to Reduce Sleep
Problems in Patients
with PTSD

PARTICIPANTS

n=21 in- and outpatient
veterans with severe
PTSD and persistent
trauma nightmares

INSTRUMENTS

Clinician Administered
PTSD Scale

METHODS
Prospective Study.
Participants had not used
alcohol or other substances
for 6 months. Participants
were medicated for trauma
nightmares. These ongoing
medications were
discontinued and
Levomepromazine was
added. Results were evaluated
in week 4.

RESULTS





Veterans experienced a significant
decrease in CAPS recurrent
distressing dream items, as well as
prolonged sleep and less subjective
sleepiness after waking.
Examined sleep latency, total hours of
sleep, and recurrent distressing
dreams.

Analyses: t-test

David, D., De Faria,
L., & Mellman, T.
2006

Adjunctive Risperidone
Treatment and Sleep
Symptoms in Combat
Veterans with Chronic
PTSD

n=20 male combat
veterans

Mini-International
Neuropsychiatric
Interview; ClinicianAdministered PTSD
Scale; Pittsburgh Sleep
Quality Index; Sleep
Diaries

Open-label, flexible-dose
trial. Risperidone was started
with 1mg and titrated up until
subjects reported
improvement in target
symptoms and/or developed
mild and tolerable side
effects.
Analyses: t-test

Engdahl, B., Eberly,
R., Hurwitz, T.,
Mahowald, M., &
Blake, J. 2000

Sleep in a Community
Sample of Elderly War
Veterans with and
without Posttraumatic
Stress Disorder

n=59 elderly male war
veterans exposed to war
trauma (n= 30 with
PTSD diagnosis)

Structured Clinical
Interview for DSM-III-R
PTSD module; SCID
Non-Patient Edition;
Combat Exposure Scale;
Urine Toxicology Screen,
Polysomnography

Sleep lab study. Three
successive nights of
polysomnography with urine
toxicology screen done prior
to each night. Subjects retired
at normal bedtime and awoke
spontaneously. Subjects rated
their sleep quality and
quantity after each
awakening. A multiple sleep
latency test was performed
during the day following the
second all-night study.











Total CAPS score and specific items
identifying recurrent distressing
dreams and difficulty falling or
staying asleep were improved at 6
weeks.
Sleep logs showed nighttime
awakenings had decreased and there
was a reduction in the proportion of
diaries documenting trauma dreams at
6 weeks.
Examined nightmares, sleep
disruption, PTSD.

Veterans with PTSD had a higher
percentage of REM sleep and
exhibited fewer arousals from NREM
sleep.
Veterans with PTSD reported more
sleep complaints.

Analyses: MANOVA,
ANOVA
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Husain, A., Miller,
P. & Carwile, S.
2001

REM Sleep Behavior
Disorder: Potential
Relationship to Posttraumatic Stress
Disorder

n=53 veterans (34
veterans with REM Sleep
Behavior Disorder (RSB)
and PTSD, 12 veterans
with RSB only, and 7
veterans with PTSD only)

Polysomnography

Sleep lab study and
retrospective chart review.
Charts reviewed for
validation of RBD diagnosis.
PTSD diagnosis based on
DSM-IV criteria and
established through
psychiatric interview. PTSD
patients screened for drug
use.
Analyses: students t-test,
Mann Whitney U test










Inman, D. 1990

Sleep Disturbance in
Post-Traumatic Stress
Disorder: A Comparison
with Non-PTSD

n=35 Vietnam combat
veterans in PTSD
treatment and n=37
treatment-seeking
subjects with insomnia

Structured Clinical
Interview for DSM-III-R
PTSD module; MMPI;
Sleep Disturbance
Inventory

PTSD diagnosis determined
by SCID and MMPI. Subjects
participated in a 1/2 hour
structured interview.



Analyses: t-test





Jukic, V. 1999

Sleep Disturbances and
Nightmares as
Symptoms of
Posttraumatic Stress
Disorder

n=150 Croatian male
former prisoners of war
with PTSD, n=150
Croatian male combat
veterans with PTSD, and
n= Croatian female
refugees with PTSD

Questionnaire created for
the study (included
demographics, trauma
experience, duration of
psychiatric treatment and
sick-leave, appearance,
frequency and intensity
of sleep disturbances and
nightmares)

All PTSD diagnoses were
reexamined using the DSMIV diagnostic criteria.
Questionnaire filled out by an
examiner after a detailed
psychiatric interview.
Analyses: descriptive
statistics, chi-square





RSB/PTSD and PTSD groups
reported frightening content of
dreams.
Dreams/Nightmares were related to
past trauma in all RSB/PTSD and
PTSD patients but only in 42% of
RSB patients.
Sleep efficiency was significantly less
in PTSD group when compared to
PTSD/RSB group.
Periodic movements of sleep were
significantly elevated in PTSD group
when compared to other groups.
REM latency and arousal index were
not significantly different between
groups.
No difference in the severity of
insomnia reported by PTSD patients
and by those with general insomnia
was found.
Insomnia associated with PTSD was
characterized by greater anxiety,
higher levels of psychomotor activity,
and leaving the sleep environment.
Fears concerning falling asleep, fear
of the dark, intrusive thoughts of
Vietnam, and other anxiety thoughts
are present among veterans with
PTSD.
Veterans with PTSD recalled more
dreams than did non-PTSD
insomniacs and reported more
repetitive dreams if the content is
Vietnam-related.
PTSD veterans often had difficulty
returning to sleep after having a
nightmare.
High frequency of nightmares and
other sleep disturbances (87.2%) in
war victims with PTSD with no
statistically significant differences
between groups.
Nightmares were most frequent in
prisoners of war (82%) while their
frequency was significantly lower in
the groups of combat veterans
(64.7%) and female refugees (56%).
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Leskin, G. A.,
Woodward, S. H.,
Young, H. E., &
Sheikh, J. I. 2002

STUDY

Effects of Comorbid
Diagnoses on Sleep
Disturbances in PTSD

PARTICIPANTS

n=591 men (52%) and
women (48%) diagnosed
with PTSD separated into
PTSD/Panic Disorder
(n=25), PTSD/MDD
(n=85), PTSD/GAD
(n=36), PTSD/ETOH
(n=186), PTSD (n=281)

INSTRUMENTS

National Comorbidity
Survey

METHODS
Retrospective chart review.
Reviewed data collected in
the National Comorbidity
Survey, looking at individuals
with PTSD and PTSD with
comorbid disorders.
Examined the proportion of
patients complaining of
nightmares and difficulties
initiating or maintaining sleep
for each of these diagnostic
groups.

RESULTS





High frequencies of nightmares,
insomnia, and exaggerated startle
response were reported in all PTSD
and PTSD/comorbid disorder
participants.
Frequencies ranged from 71-94%
nightmares, 80-100% insomnia, and
61-88% exaggerated startle response.

Analyses: chi-square analyses

Mellman, T. 1997

A Polysomnographic
Comparison of Veterans
with Combat-Related
PTSD, Depressed Men,
and Non-ill Controls

n=25 male Vietnam
combat veterans with
PTSD, n=16 male
patients with Major
Depressive Disorder, and
n=10 male control
subjects (Medical Center
employees)

Structured Clinical
Interview from DSM-IIIR; Mississippi Scale for
Combat-Related PTSD;
Hamilton Depression and
Anxiety Scales; Urine
drug screen;
Polysomnography

Sleep lab study. PTSD and
MD groups were tapered off
medications for at least two
weeks prior to study. Urine
drug screens were given
within two weeks of sleep
recording. All participants
were habituated to
conventional sleep-wake
schedules. Participants spent
2 nights in the laboratory with
measurements done on the
second night of sleep. Patients
were monitored with EEG,
EMG, EOG, EKG, and
oximetry and respiratorystrain gauge monitors.



Veterans with chronic PTSD showed
impairment in maintaining sleep when
compared to clinical and non-clinical
samples. Percentages of REM and
slow-wave sleep do not appear to be
compensatorily increased.



Combat veterans with PTSD reported
significantly fewer hours of sleep than
combat veterans without PTSD.
Insomnia and nonrestorative sleep
were endorsed as significant problems
by 59-73% of PTSD group compared
with 19-38% of non-PTSD group.
Awakening in the middle of the night
was most commonly endorsed by
PTSD veterans with noncombat
nightmares, combat nightmares,
thrashing movements during sleep,
and startle or panic-like awakenings.

Analyses: t-tests, ANOVA,
ANCOVA, Pearson
correlations

Mellman, T.,
Kulick-Bell, R.,
Ashlock, L., &
Nolan, B. 1995

Sleep Events Among
Veterans with Combatrelated Posttraumatic
Stress Disorder (Sleep
Survey)

n=58 male Vietnam
combat veterans (n=37
with PTSD) not in
treatment

Mississippi Scale for
Combat-Related
Posttraumatic Stress
Disorder; Researcherdeveloped survey (sleep
disruption and adaptation
during combat tours,
current sleep habits and
symptoms)

Veterans recruited from two
outpatient settings and one
community setting. Veterans
screened for combat exposure
by review of military
discharge forms and interview
(outpatient veterans only).
Analyses: Chi-square
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Mellman, T.,
Kulick-Bell, R.,
Ashlock, L., &
Nolan, B. 1995

Mellman, T.,
Kulich-Bell, R., Ash
lock, L., & Nolan,
B. 1995

STUDY

Sleep Events Among
Veterans with Combatrelated Posttraumatic
Stress Disorder (Sleep
Diary)

Sleep Events Among
Veterans with Combatrelated Posttraumatic
Stress Disorder (Sleep
Laboratory)

PARTICIPANTS

INSTRUMENTS

n=52 male Vietnam
combat veterans in
inpatient PTSD treatment

Structured Clinical
Interview for DSM-III
PTSD Section;
Mississippi Scale for
Combat-Related
Posttraumatic Stress
Disorder

n=21 male Vietnam
combat veterans with
PTSD and n=8 healthy
male comparison subjects
not exposed to combat

EEG, EGG, EGG leads,
goniometry and
respiratory strain gauge
monitors; electrooculograph

METHODS

Veterans completed sleep
diaries on three consecutive
mornings regarding the
previous night's sleep during
the 3rd or 4th week of a
planned 3-month hospital
stay.

RESULTS




Analyses: Pearson
correlations

Veterans spent 2 consecutive
nights in the sleep laboratory
with data taken the second
night. Veterans filled out a
sleep diary following the
sleep monitoring.





Analyses: MANOVA, t-tests

Neylan, T. C.,
Marmar, C. R.,
Metzler, T. J.,
Weiss, D. S.,
Zatzick, D. F.,
Delucchi, K. L.,
Wu, R. M., &
Schoenfeld, F. B.
1998

Sleep Disturbance in the
Vietnam Generation:
Findings from a
Nationally
Representative Sample
of Male Vietnam
Veterans

n=1200 male Vietnam
theatre veterans, n=412
male Vietnam era
veterans, n=450 male
civilian comparison
subjects

Mississippi Scale for
Combat-Related
Posttraumatic Stress
Disorder (military and
civilian version); DIS;
medical condition
questions taken from the
National Survey of the
Vietnam Generation

Correlational study and
retrospective review of the
data from the National
Vietnam Veterans
Readjustment Study. Sleep
items derived from the
Mississippi Scale for CombatRelated PTSD.
Analyses: Pearson correlation






PTSD symptom severity and average
nightly frequency of types of
awakening were not associated.
Veterans documented an average of
2.5 awakenings per night
characterized by nightmares related to
combat themes, dreams with other
distressing content, startle or fear
awakening with no dream recall, and
panic awakenings.

Among veterans with PTSD, there
was significantly less sleep efficiency,
significantly greater amount of time
awake during sleep, and significantly
more micro-awakenings.
28.6% of PTSD vs. 0% of controls
had body movement and 33.3% of
PTSD vs. 0% of controls had periodic
limb movement.

Frequent nightmares were unique to
veterans diagnosed with PTSD.
Combat exposure was highly
associated with nightmares,
moderately associated with sleep
onset insomnia, and only weakly
associated with sleep maintenance
insomnia.
A strong relationship was noted
between frequency of nightmares and
level of exposure to war zone trauma.
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Raskind, M. A.,
Peskind, E. R.,
Hoff, D. J., & Hart,
K. L. 2007

STUDY

A Parallel Group
Placebo Controlled
Study of Prazosin for
Trauma Nightmares and
Sleep Disturbance in
Combat Veterans with
Post-traumatic Stress
Disorder

PARTICIPANTS

n=40 veterans who have
frequent and severe
nightmares and disturbed
sleep

INSTRUMENTS

CAPS; Nightmare
Frequency Questionnaire
Revised; Hamilton
Depression Rating Scale;
Clinical Global
Impression of Change;
Pittsburgh Sleep Quality
Index

METHODS
Diagnosis of PTSD based on
the results of CAPS score.
Prazosin or placebo capsules
were administered using a
stratified permuted block
randomization procedure and
titrated upward by the
prescriber based on clinical
response. Goal was complete
absence of trauma
nightmares. Systolic and
diastolic blood pressure were
measured at baseline, each
titration visit and at
maintenance dose weeks 4
and 8. Adverse events were
monitored at baseline and at
each subsequent visit.

RESULTS







Prazosin produced significantly
greater improvement than placebo in
addressing frequency and intensity of
trauma-related nightmares, sleep
quality, and global clinical status by
the 8 week follow up.
Prazosin reduced military traumarelated nightmares compared to
nightmares of any kind and shifted
dream characteristics from those
typical of trauma nightmares toward
those of typical normal dreams.
Looked at distressing dreams, sleep
quality, and dream characteristics.

Analyses: Odds ratio,
confidence intervals,
regression analyses.


Roszell, D. K.,
McFall, M. E., &
Malas, K. L. 1991

Stein, M. B., Kline,
N. A., & Matloff, J.
L. 2002

Frequency of Symptoms
and Concurrent
Psychiatric Disorder in
Vietnam Veterans with
Chronic PTSD

Adjunctive Olanzapine
for SSRI-Resistant
Combat-Related PTSD:
A Double-Blind,
Placebo-Controlled
Study

n=116 male Vietnam
veterans referred for
PTSD evaluation

n=19 treatment-seeking
veterans with PTSD

SCID-P

Clinician Administered
PTSD Scale; Center for
Epidemiological Studies
Depression Scale;
Pittsburgh Sleep Quality
Index

n=48 had 4-6 hours of
clinical interviewing to assess
for military history and DSMIII-R Axis I mental disorders
using SCID-P. n=68 only
administered the PTSD
portion of the SCID-P




Analyses: correlations



Psychopharmaceutical study.
Veterans continued taking a
stable dose of SSRIs
throughout the study.
Veterans were assigned to
Olazapine or placebo group
for 12 weeks.



Analyses: t-test



39.2% of veterans avoided sleep
because they anticipated troubling
thoughts or dreams.
Mean number of hours of sleep per
night was 4.4 +_1.3.
Symptoms of reexperiencing were
significantly related to symptoms of
avoidance or numbing and
physiological arousal.
Sleep difficulties were diagnosed in
90.5% of veterans.
Olanzapine was associated with
significantly greater reduction than
placebo in sleep disturbance.
Change in sleep disturbance was
moderately correlated with change in
PTSD symptoms, suggesting that
enhanced sleep accounts for much of
the reported improvement in PTSD
symptoms.
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Woodward, S. H.,
Arsenault, N. J,
Murray, C., &
Bliwise, D. L. 2000

STUDY

Laboratory Sleep
Correlates of Nightmare
Complaint in PTSD
Inpatients

PARTICIPANTS

INSTRUMENTS
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Introduction
Current research has demonstrated that mortality rates due to preventable behavioral causes
are significantly higher among veterans diagnosed with posttraumatic stress disorder (PTSD)
than in the general population. In particular, veterans diagnosed with chronic PTSD die more
frequently from conditions related to substance abuse, such as Hepatitis C, blood diseases,
violence, aggression, and suicide (Drescher, Rosen, Burling, & Foy, 2003; Schafer, 2008). In
addition, rates of behaviorally-related diseases such as obesity, diabetes, and heart disease are
high among veterans diagnosed with chronic PTSD (David, 2004; Kubzansky, Koenen, Spiro,
Vokonas, & Sparrow, 2007). These findings highlight a need to promote healthy behavioral
practices among veterans diagnosed with PTSD. In light of this need, the developers created a
manualized group treatment designed to decrease health risk behaviors and promote positive
health practices among veterans diagnosed with PTSD.
Research has shown that motivational interviewing is effective at reducing alcohol use,
drug use, cigarette smoking, and risky sexual practices among adult populations (Ball et al.,
2006; Bellack, Bennett, Gearon, Brown, & Yang, 2006; Butler et al., 1999; Carroll et al., 2005).
Although the research is limited among veteran populations, studies examining the efficacy of
motivational interviewing in various behavioral domains suggest its efficacy extends to the
veteran population (Davis, Baer, Saxon, & Kivlahan, 2003; Project MATCH Research Group,
1997). In light of the success of motivational interviewing in promoting behavioral change, this
intervention incorporates motivational interviewing strategies to increase veterans’ awareness
of engagement in health risk behaviors and increase their motivation to change. To the
developer’s knowledge, there is currently no standardized, motivational interviewing treatment
protocol that focuses on addressing health risk behaviors in veterans diagnosed with PTSD.
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The Live Long and Prosper group treatment is comprised of a three-piece manual set
that includes a Facilitator’s Guide, Member Workbook, and Assessment Strategy. The
Assessment Strategy is an integral component of the motivational interviewing protocol and is
designed to offer a means to comprehensively and systematically assess veteran engagement in
health risk behaviors as well as assess veteran motivation for change. Motivational interviewing
exercises included in the Live Long and Prosper group protocol foster consideration of personal
values and goals and promote exploration of the dissonance between these values and goals
and the group participant’s current behavior. Assessment instruments strategically placed
within the intervention offer objective data to the group participants which can be used for
further reflection and exploration of their current level of engagement in health risk behaviors,
current motivation to change, and how these correspond with their personal values, interests,
and goals.
The integrated assessments also provide useful information to the group facilitators
about the needs of the group members as well as the efficacy of the intervention. Furthermore,
the assessment strategy provides a comprehensive blueprint for empirical validation of the
group treatment. Pre- and post-intervention measures are included which allow for comparison
of behavioral engagement and motivation for change before and following the intervention. In
addition, pre- and post- session measures of motivation for change are included, which allow for
validation of the efficacy of the intervention for each session. Included within the assessment
strategy is a schedule for test administration to facilitate ease of evaluation and promote
consistency among research studies. Alternative test administration schedules are also included
for those facilities unable to administer all measures or those not involved in empirical
evaluation.
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The assessment strategy includes assessments in five domains: (a) frequency of veteran
engagement in health risk behaviors pre- and post- intervention, (b) veteran readiness to
change pre- and post- intervention, (c) veteran engagement in session specific health risk
behaviors, (d) veteran readiness to change heath risk behaviors pre- and post- session, and (e)
facilitator adherence to the treatment protocol. During the initial group session, all group
participants are administered a comprehensive self-report measure assessing the frequency of
their engagement in all relevant health risk behaviors and a readiness to change measure
assessing their current stage of change for health related behaviors, attitudes, and practices.
These measures will be re-administered at completion of the treatment to monitor changes in
these domains. Each session, veterans will complete pre- and post-session readiness to change
measures specifically related to the session content and session specific measures of behavioral
frequency. Facilitators will complete assessments following each session that are designed to
enhance facilitator adherence to the group treatment.
Development of Assessment Measures
The development of the assessment measures was informed by research and existing
assessment instruments. Initially, assessment measures utilized in existing group treatments
were reviewed. Of particular note were assessments included in Trauma Focus Group Therapy
(Foy, Ruzek, Glynn, Riney, & Gusman, 2002),Trauma and Spirituality Group (Leoni, 2005;
Romesser, 2005; Sornborger, 2005), Group Treatment for Substance Abuse: A Stages-of-Change
Therapy Manual (Velasquez, Maurer, Crouch, & DiClemente, 2001), and Curriculum-Based
Motivation Group: A Five Session Motivational Interviewing Group Intervention (Fields, 2004). In
addition, behavioral frequency and stages of change measures available on the internet for diet,
exercise, and sleep difficulties were reviewed. The content and assessment measures from
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numerous websites, specifically the National Institute of Health, Centers for Disease Control and
Prevention, US Department of Health and Human Services, American College of Sports
Medicine, National Institute on Aging, United States Department of Agriculture, and the Cancer
Prevention Research Center informed the assessment measures created by the developers. In
addition, components of the High-Risk Behavior Questionnaire (Ruzek et al., 2000) were
adapted to inform session specific measures of behavioral frequency and motivation to change.
Research was also undertaken to determine the most common measures of behavioral
frequency used to assess substance use and smoking in research done within the veteran
population. Those measures that appeared with the most frequency in the literature were
identified, their ease of usability was ensured, and they were integrated into the assessment
strategy. In addition, the Facilitator’s Adherence Checklist was adapted from the Trauma and
Spirituality group protocol (Romesser, 2005) to meet the needs of the current intervention.
Live Long and Prosper Assessment Measures
Measures of Behavioral Frequency
Pre-existing measures of the frequency of engagement in health risk behaviors as well
as developer-created measures of behavioral engagement are included in the assessment
strategy. Behavioral frequency measures are administered at the commencement of the group
intervention, at completion of the group intervention, and during each session.
Health Behavior Frequency Measure. The Health Behavior Frequency Measure (HBFM) is
a developer-created self-report instrument that examines the frequency of engagement in
health risk behaviors. This measure is administered to the group participants at the beginning of
the first session of the health promotion group intervention and at the completion of the
intervention. The HBFM assesses each domain of health risk behaviors that are a part of the
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group protocol; specifically, diet, exercise, sleep difficulties, risky sex behavior, aggressive acts,
substance use, and tobacco use. The measure incorporates questions regarding aggressive acts,
gun ownership, smoking, and risky sex behavior from the High-Risk Behavior Questionnaire
(Ruzek et al., 2000), an unpublished measure used in the original Live Long and Prosper group.
In addition, questions regarding substance use were informed by the structure of questions
from the High-Risk Behavior Questionnaire, Alcohol Use Disorders Identification Test (Babor, de
la Fuente, Saunders, & Grant, 1992) and the Drug Use Questionnaire (Skinner, 1982), preexisting measures incorporated into the substance use session. Assessment questions
pertaining to diet, exercise, and sleep difficulties were informed by reviews of research in these
areas.
The HBFM is a 21-question scale, with answers provided in a Yes-No format or on a
Likert scale. The measure allows for the qualitative analysis of veteran’s engagement in a
variety of health risk behaviors that are found with great frequency among veterans diagnosed
with PTSD and lead to increased mortality in this population. This measure is designed to
provide information to the group facilitator about the frequency of veteran engagement in each
behavioral domain at the onset of the group, which allows for the facilitator to address the
needs of individual veterans, as well as illuminate changes in frequency of engagement in risky
behaviors when administered post-intervention. As the measure is administered pre- and postintervention, it allows for empirical validation of the intervention based on changes noted in
veteran engagement in health risk behaviors.
Developer-created session specific measures of behavioral frequency. Session-specific
measures of behavioral frequency are administered during each session. These self-report
instruments provide veterans with objective information about their level of engagement in
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health risk behaviors. These measures promote veteran awareness of their current level of
behavioral engagement and provide information integral to the motivational interviewing
exercises included in the group protocol.
Following an extensive review of measures assessing diet, heart disease, exercise, sleep,
and safe sex behavior, the developers determined that the intervention would be best served by
the creation of new measures specifically designed for the group intervention. The developers
created five behavioral frequency measures designed to assess eating habits, risk for heart
disease, exercise, sleep, and safe sex behavior. Each assessment measure was informed by the
research and follows the recommendations of relevant groups dedicated to prevention of
disease/health risk in these areas; specifically, the National Institute of Health, Centers for
Disease Control and Prevention, United States Department of Agriculture, United States
Department of Health and Human Services, American College of Sports Medicine, and the
National Institute on Aging.
The self-report measures of behavioral frequency are presented in a variety of formats.
Veterans are asked to respond using a Yes-No format, Likert scale, or by checking off individual
boxes. Scoring is included for each measure and is designed to be user friendly. It provides
pertinent information that can be easily disseminated to the veterans orally by the group
facilitators. The information provided in the scoring components is designed to elicit
consideration by the veterans of their current level of engagement in health risk behaviors and
offers suggestions for behavioral change.
Aggressive Behavior Questionnaire and Firearm Safety Questionnaire. The Aggressive
Behavior Questionnaire and the Firearm Safety Questionnaire were created from the High-Risk
Behavior Questionnaire (Ruzek et al., 2000). The developers extracted and combined the
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questions measuring veteran engagement in aggressive behaviors and firearm safety to create
comprehensive measures.
The Aggressive Behavior Questionnaire is an 8-item self-report measure of aggressive
behavior. Specifically, the measure assesses engagement in verbal threats, assault, property
damage, and aggressive driving within the last year. Veterans are also asked to rate their
frequency of engagement in any aggressive behavior in the last year on a Likert scale. The
Firearm Safety Questionnaire is a 7-item self-report measure. It assesses whether firearms are
kept according to National Rifle Association safety guidelines and personal risks factors for
unsafe gun use, such as previous suicide attempt with a firearm or previous discharge of a
weapon outside of military or law enforcement service. Veterans are asked to answer questions
about firearm safety in a Yes-No format. The measures are administered concurrently during
Session 7: Aggressive Behavior/Gun Safety.
Alcohol Use Disorders Identification Test (Babor, de la Fuente, Saunders, & Grant, 1992).
The Alcohol Use Disorder Identification Test (AUDIT) is a 10-question measure of alcohol use
scored on a 5-point Likert scale. It was developed by the World Health Organization as a brief
screening tool for excessive drinking. It is frequently used in the assessment of drinking behavior
in research pertaining to veterans. The AUDIT provides an accurate risk assessment for
hazardous or harmful alcohol use or alcohol dependence across cultures, gender, and age
(Babor, Higgins-Biddle, Saunders, & Monteiro, 2001). Research has shown the AUDIT to have
favorable sensitivity (.90) and lower but still acceptable specificity (.80) for current ICD-9 alcohol
use disorders when using the cut-off score of 8 (Babor et al.), the cutoff score used in this
assessment strategy. Research has also shown the AUDIT to have high internal consistency and
high reliability (r=.86) (Babor et al.).
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The AUDIT was created for primary care workers to identify those who would benefit
from reducing their level of alcohol consumption and to provide a framework for intervention
among this population. These intentions are in line with the rationale for the current manual set
targeting health risk behaviors and promoting motivation to change substance use habits. In the
current group protocol, the AUDIT is administered during the Substance Use session to increase
veteran’s awareness of their current drinking habits.
Drug Use Questionnaire, Short Form (Skinner, 1982). The Drug Use Questionnaire, Short
Form (DAST-10) is a 10-item self-report instrument designed for brief clinical screening and
treatment evaluation research to determine psychoactive drug abuse (Gavin, Ross, & Skinner,
1989). Veterans are asked to note “yes” or “no” to questions regarding their engagement in
drug use over the past 12 months. Research studies have found that the DAST has high levels of
internal consistency reliability (0.92), a largely unidimensional scale, and concurrent validity with
frequency of drug use in the last 12 months (Skinner, 1982). At a cut-off point between 5/6 and
9/10, the DAST shows sensitivity between 96% to 78% and specificity between 79% and 89%
with overall accuracy of 85% (Gavin, Ross, & Skinner). The DAST is also highly correlated with
current (r=0.75) and lifetime (r=0.74) DSM-III drug diagnosis (Gavin, Ross, & Skinner).
The DAST-10 is administered during the Substance Use session of the group intervention
along with the AUDIT. The developers chose to administer the DAST-10, the short form of the
DAST, rather than the DAST to avoid fatiguing the group participants as multiple measures of
behavioral frequency are administered during this session. In the current group protocol, the
DAST-10 is administered during the Substance Use session to increase veteran’s awareness of
their level of drug use.
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Fagerström Test for Nicotine Dependence. (Heatherton, Kozlowski, Frecker, &
Fagerström, 1991). The Fagerström Test for Nicotine Dependence (FTND) is a 6-item self-report
instrument designed to assess for level of nicotine dependence. Specifically, it assesses smoking
frequency and habits. The FTND has been tested for reliability and validity among a psychiatric
population and a population of veterans with PTSD (Buckley et al., 2005). Among these
populations, the FTND was found to be stable based on test-retest reliability (0.82) and was
correlated at statistically significant levels with biological and psychological measures of
dependence (0.40) (Buckley et al.).
The FTND is administered to the group participants during the Tobacco Use session. It is
designed to assist veterans in acknowledging their level of nicotine dependence and to promote
critical thinking about their tobacco use.
Stages of Change Measures
Developer-created stages of change measures are included in the assessment strategy.
Stage of change is measured pre- and post- intervention as well as pre- and post- session. The
developers performed a comprehensive review of existing stages of change measures including
the University of Rhode Island Change Assessment Scale (DiClemente & Hughes, 1990), stages of
change measures utilized in research studies, stages of change measures included in other
group protocols, and stages of change measures for health risk behaviors from the Cancer
Prevention Research Center. As the stages of change measures found did not meet the exact
needs of the current group protocol, the developers created new measures informed by their
research and containing the most salient aspects of measurement of stages of change found
across measures.
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Health Risk Stages of Change Measure. The pre- and post- intervention Health Risk
Stages of Change measure was designed to assess the group participants’ current stage of
change related to any behaviors in which they currently engage that may have a negative impact
on their health. Although the group participants are encouraged to reflect upon those behaviors
included in the group protocol, specific measures of stage of change for individual health risk
behaviors are not included.
The measure assesses the group participants current stage of change by having the
group participants first select one of six statements pertaining to their health related behaviors
and then circling the stage of change that corresponds to the original statement selected. By
separating the statement which best reflects their current health related behavior and the
related stage of change, the developers hope to decrease judgment and promote honest
disclosure of health risk behavior engagement.
The pre- and post- intervention Health Risk Stages of Change Measure is designed to
fulfill several functions. The pre- and post- intervention design offers a format for collecting
empirical data about the efficacy of the group protocol to increase group participants’
motivation to change health risk behaviors over the course of the intervention. It also offers the
group participants objective data on changes in their own motivation for change before and
following the intervention. In addition, the pre-intervention measure is placed within the first
session of the group protocol and is used to educate the group participants about the
transtheoretical model and to familiarize them with the type of measure they will be asked to
complete each week.
Session specific stages of change measures. The group protocol includes seven session
specific stages of change measures which are administered pre- and post- session. The group
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participant is asked to first select one of six statements pertaining to their session specific health
related behaviors and then circle the stage of change the corresponds to the original statement
selected. As with the pre- and post- intervention Health Risk Stages of Change Measure, the
session specific measures separate the statement which best reflects the group participant’s
current health related behavior and the related stage of change to decrease judgment and
promote honest disclosure of health risk behavior engagement.
The session specific stages of change measures are intended to perform multiple
functions. First, they are designed to increase the group participants’ awareness of their current
level of motivation for change, promote critical thinking about their own motivations, and
illuminate any changes in motivation following the group session. In addition, the pre- and postsession design allows for empirical evaluation of the efficacy of the individual group sessions to
motivate change in health risk behaviors.
Facilitator’s Adherence Checklist
Following each session, the facilitators will complete a session-specific Faclitator’s
Adherence Checklist. The Facilitator’s Adherence Checklist was adapted from the Adherence
Checklist (Romesser, 2005) found in the Trauma and Spirituality Group (Romesser, 2005;
Sornborger, 2005; Leoni, 2005). In the Facilitator’s Adherence Checklist, the major components
of each session are identified and the facilitators are asked to check off the completed
components. Additional space is provided so the facilitators may note areas of difficulty,
obstacles to completion, or issues of relevance for each session component. The Facilitator’s
Adherence Checklist allows for assessment of fidelity to the protocol. It also serves as a means
of identifying problem areas, obstacles to successful session protocol completion, and areas for
review when pilot testing the group intervention.
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Administration Schedule
This schedule provides a list of the assessment measures and the session in which they are administered to
the group participants. For appropriate placement of the measures in each session, please refer to the Live
Long and Prosper Facilitator’s Manual.
Session 1: Group Orientation
_______ Health Risk Stages of Change Measure
_______ Health Behavior Frequency Measure
_______ Facilitator’s Adherence Checklist
Session 2: Cardiovascular Disease/Physical Activity
_______ Physical Activity Stages of Change Measure
_______ Heart Disease and Exercise Questionnaire
_______ Facilitator’s Adherence Checklist
Session 3: Obesity/Diabetes/Diet
_______ Healthy Diet Stages of Change Measure
_______ Eating Habits Questionnaire
_______ Facilitator’s Adherence Checklist
Session 4: Sexually Transmitted Diseases
_______ Safe Sex Practices Stages of Change Measure
_______ Safe Sex Behavior Questionnaire
_______ Facilitator’s Adherence Checklist
Session 5: Substance Abuse
_______ Alcohol Abuse Stages of Change Measure
_______ Drug Abuse Stages of Change Measure
_______ Alcohol Use Disorders Identification Test
_______ Drug Use Questionnaire, Short Form
_______ Facilitator’s Adherence Checklist
Session 6: Tobacco Use
_______ Tobacco Use Stages of Change Measure
_______ Fagerström Test for Nicotine Dependence
_______ Facilitator’s Adherence Checklist
Session 7: Aggressive Behavior/Gun Safety
_______ Aggression Stages of Change Measure
_______ Gun Safety Stages of Change Measure
_______Aggressive Behavior Questionnaire
_______ Firearm Safety Questionnaire
_______ Facilitator’s Adherence Checklist
Session 8: Sleep Hygiene
_______ Sleep Hygiene Stages of Change Measure
_______ Sleep Questionnaire
_______ Health Risk Stages of Change Measure
_______ Health Behavior Frequency Measure
_______ Facilitator’s Adherence Checklist
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Abridged Administration Schedule
The abridged assessment schedule offers alternative options for administering assessment measures during
the group intervention. These alternatives are designed for those facilities that do not have the resources to
administer all assessment measures or are not gathering data for empirical investigation.

Option 1:
The group facilitators may administer the assessment measures as indicated, leaving out the second
administration of the session specific Stages of Change measures. This option maintains the integrity of the
intervention, capitalizing on the information gleaned from the session specific Stages of Change measures
administered at the beginning of each session during the MI exercises while saving time and decreasing the
likelihood group participant burnout on assessment measures. All measures of health risk behavior
frequency should be administered as outlined on the Assessment Schedule. In addition, the facilitators
should complete the session specific Facilitators Adherence Checklist to ensure fidelity to the treatment
protocol and identify any obstacles and areas of strength or weakness.

Option 2:
The group facilitators may omit all session specific Stages of Change measures in sessions 2-8; however,
the administration of the Health Risk Stages of Change measure in Session 1 and 8 should be maintained.
The administration of this measure will allow the group facilitators and participants to reflect on any changes
in participant motivation to change health risk behaviors from the beginning to the end of the intervention.
Rather than completing the session-specific stages of change measures, the group participants should be
asked to reflect on their current stage of change related to each session-specific health risk behavior during
the MI exercises. The group facilitators may wish to provide a generic Stages of Change model graph (e.g.
an image of a staircase with the lowest step labeled precontemplation and the highest step labeled
maintenance) on posterboard or on a whiteboard to which group participants can refer throughout the
session. All measures of health risk behavior frequency should be administered as outlined on the
assessment schedule. In addition, the facilitators should complete the session specific Facilitators
Adherence Checklist to ensure fidelity to the treatment protocol and identify any obstacles and areas of
strength or weakness.
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Session 1: Group Orientation

Measures included:
Health Risk Stages of Change Measure
Health Behavior Frequency Measure
Facilitator’s Adherence Checklist
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Health Risk Stages of Change Measure
This group seeks to inform you about behaviors that can negatively impact your long
term health and longevity. It will increase your knowledge in these areas, increase your
awareness of the frequency of your own participation in these behaviors, and perhaps
motivate you to take steps towards changing some of these behaviors.
This measure is designed to help you and your group facilitators assess your current
thoughts about changing health-risk behaviors. You will complete a similar measure
during each session in reference to the specific session topic.
Please take a moment to consider any current behavior in which you engage that may
have a negative impact on your health. In particular, take time to reflect on the
following: your diet, level of engagement in exercise, sleep problems, substance use,
smoking, unsafe sex practices, level of aggression, and gun safety.

Please circle the number that best fits your current health related behavior:
1. I have been engaging in behavior that has positive health impacts regularly for
over 6 months.
2. I have been engaging in behavior that has positive health impacts for less than 6
months.
3. I plan to begin to engage in behavior that has positive health impacts in the next
30 days.
4. I plan to begin to engage in behavior that has positive health impacts in the next
6 months.
5. I have no plans to begin engaging in behaviors that have positive health impacts.
6. I have always engaged in behavior that has positive health impacts.
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Please circle your current stage of change that corresponds to the the number circled
above.
1. I have been engaging in behavior that has positive health impacts regularly for a
long time. I am using strategies to continue this behavior. I am in the
MAINTENANCE stage.
2. I have been engaging in behavior that has positive health impacts. I am taking
steps to avoid pitfalls or obstacles to my engagement in these positive behaviors.
I am in the ACTION stage.
3. I am seriously considering beginning to engage in behavior that has positive
health impacts. I can see the benefits these behaviors and have a plan to start. I
am in the PREPARATION stage.
4. I am considering the possibility of engaging in behaviors that have positive health
impacts, but remain unsure. I may be trying small changes. I am in the
CONTEMPLATION stage.
5. I do not want to change my behavior to engage in those with positive health
impacts. I am in the PRECONTEMPLATION stage.
6. I have always engaged in behavior that has positive health impacts. The stages of
change model is not applicable to me.
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Health Behavior Frequency Measure
This measure is designed to help determine your current engagement in a variety of
different behaviors that can impact on your health. Please circle the response that best
fits your current level of engagement in these behaviors. Please be as honest as
possible.
1) How often do you incorporate these foods into your diet? Please circle the response that
best describes your diet.
Never/Rarely
Sometimes
Daily
Fruits
Vegetables

Never/Rarely

Sometimes

Daily

Low-fat or Fat-free
Dairy Products

Never/Rarely

Sometimes

Daily

Lean Meats
(e.g. chicken or fish
rather than steak)

Never/Rarely

Sometimes

Daily

Whole Grains
(e.g. brown rice, whole
grain bread)

Never/Rarely

Sometimes

Daily

2) How often do you engage in:
a) Light intensity activities (e.g. casual walking, taking out the trash) per week?
Never

1 time

2 times

3 times

4 times

5 or more

4 times

5 or more

b) Moderate intensity activities (e.g. brisk walking) per week?
Never

1 time

2 times

3 times

c) Vigorous intensity activities (e.g. jogging, swimming laps) per week?
Never

1 time

2 times

3 times

4 times

5 or more

4 times

5 or more

d) Strengthening activities (e.g. sit-ups, weight lifting) per week?
Never

1 time

2 times

3 times
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3) Do you have difficulty falling or staying asleep?
Yes

No

4) On average, how many hours of sleep do you get each night? _______________
5) Have you ever been tested for HIV or Hepatitis C?
Yes

No

6) Have you engaged in unprotected sex (i.e. oral, anal, or vaginal sex without a condom)?
Yes

No

7) If so, how frequently do you engage in unprotected sex?
Almost Never

Sometimes

Almost Always

Every time

8) Have you made verbal threats to others?
Yes

No

If so, how often?
Rarely

Sometimes

Very Regularly

9) Have you assaulted others?
Yes

No

If so, how often?
Rarely

Sometimes

Very Regularly

10) Have you intentionally damaged property?
Yes

No

If so, how often?
Rarely

Sometimes

Very Regularly

11) Have you engaged in aggressive driving (e.g. verbal outbursts, angry hand gestures,
tailgating, driving under the influence, intentionally driving your vehicle into another object?)
Yes

No

If so, how often?
Rarely

Sometimes

Very Regularly
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12) Do you own firearms?
Yes

No

13) If you own a firearm, do you keep all of your firearms in a safe manner (e.g. unloaded, in a
locked area with protected locks and the bullets separate from the firearms)?
Yes

No

14) Do you drink alcohol?
Yes

No

15) If you drink alcohol, how often do you have a drink?
Monthly or less

2-4 times a month

2-3 times a week

4 or more times a week

16) On a typical day, how many drinks do you have?
1 or 2

3 or 4

5 or 6

7 to 9

10 or more

17) How often do you have 6 or more drinks on one occasion?
Never

Less than monthly

Monthly

Weekly

Daily or almost daily

18) Have you used drugs other than those required for medical reasons (e.g. abuse of
prescription medication or illegal drugs)?
Yes
No
19) If you use drugs, how often do you use them?
Monthly or less 2-4 times a month
20) Do you smoke cigarettes?
Yes

2-3 times a week

4 or more times a week

No

21) How many cigarettes do you smoke per day?
10 or less

11-20

21-30

31 or more

Thank you for completing this measure. Please return it to your group facilitator.

23

Facilitator’s Adherence Checklist: Group Orientation
Please check off the following items that were covered in the session. Please note any items of
relevance for each session component. In particular, if there were barriers to the completion of
certain items, please note in the space provided the obstacles that presented a problem.

Administration of Health Behavior Frequency Measure
________________________________________________________________________
________________________________________________________________________
Introduction to the group
________________________________________________________________________
________________________________________________________________________
Review group rules
________________________________________________________________________
________________________________________________________________________
Psychoeducation on PTSD and health risk behavior/conditions
________________________________________________________________________
________________________________________________________________________
Introduction of member workbook and overview of session topics
________________________________________________________________________
________________________________________________________________________
Introduction of stages of change model
________________________________________________________________________
________________________________________________________________________
Administration of Health Risk Stages of Change Measure
________________________________________________________________________
________________________________________________________________________
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Personal values exercise
________________________________________________________________________
________________________________________________________________________
Elicit reactions to the session
________________________________________________________________________
________________________________________________________________________
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Session 2:
Cardiovascular Disease/Physical Activity

Measures included:
Physical Activity Stages of Change Measure
Heart Disease and Exercise Questionnaire
Facilitator’s Adherence Checklist

26

Physical Activity Stages of Change Measure
For the purpose of this measure, REGULAR EXERCISE is defined as 30 minutes of
moderate physical activity at least five days per week. Examples of moderate physical
activity include walking briskly, mowing the lawn, dancing, swimming or bicycling.
Please check the box that best fits your current exercise behavior:
1. I have been exercising regularly for over 6 months.
2. I have been exercising regularly for less than 6 months.
3. I plan to begin to exercise regularly in the next 30 days.
4. I plan to begin to exercise regularly in the next 6 months.
5. I have no plans to begin exercising regularly.
6. I have always exercised regularly.
Please circle your current stage of change corresponding to the number circled above.
1. I have been exercising regularly for a long time. I am using strategies to continue
this behavior. I am in the MAINTENANCE stage.
2. I have been exercising regularly. I am taking steps to avoid pitfalls or obstacles to
exercise. I am in the ACTION stage.
3. I am seriously considering beginning to exercise regularly. I can see the benefits
of exercise and have a plan to start. I am in the PREPARATION stage.
4. I am considering the possibility of exercising regularly, but remain unsure. I may
be trying small changes. I am in the CONTEMPLATION stage.
5. I do not want to exercise regularly. I am in the PRECONTEMPLATION stage.
6. I have always exercised regularly. The stages of change model is not applicable to
me.
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Heart Disease and Exercise Questionnaire
1) Please check those items which pertain to your current health status:
High Cholesterol

Diabetes

Obesity

High blood pressure

Smoking

Family History of Heart Disease

2) How often do you engage in light intensity (e.g. casual walking, taking out the trash) physical
activity each week?
Never 1 time
a week

2 times
a week

3 times
a week

4 times
a week

5 or more times
a week

In general, how many minutes do you spend doing these activities on each occasion?______
3) How often do you engage in moderate intensity (e.g. brisk walking, activities that cause you
to break a sweat) physical activity each week?
Never 1 time
a week

2 times
a week

3 times
a week

4 times
a week

5 or more times
a week

In general, how many minutes do you spend doing these activities on each occasion?______
4) How often do you engage in vigorous intensity (e.g. jogging, swimming laps, heavy
gardening) physical activity each week?
Never 1 time
a week

2 times
a week

3 times
a week

4 times
a week

5 or more times
a week

In general, how many minutes do you spend doing these activities on each occasion?______
5) How often do you do muscle strengthening exercises (e.g. lifting weights, doing sit-ups,
shoveling) each week?
Never 1 time
a week

2 times
a week

3 times
a week

4 times
a week

5 or more times
a week

In general, how many repetitions of these exercises do you do? _______________________
In general, what muscle groups are involved in these exercises? (check all that apply)
Legs

Abdomen

Hips

Chest

Shoulders

Arms

Back
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Heart Disease and Exercise Questionnaire Scoring

Heart Disease
Look at Question 1. If any box is checked, you are at risk for developing heart disease.
The more boxes checked, the higher the risk.
Exercise
If you circled any engagement in exercise on Questions 2-5, CONGRATULATIONS! You
are already engaging in physical activity. However, you may need to increase your level
of physical activity to include moderate and vigorous activities, strength exercises, or
increase exercise duration in order to reap the most benefits for your health. Look at
the chart below to see how you measure up.
The amount of physical activity recommended by the NIH, AHA, and the ACSM to
receive health benefits is:
30 minutes of moderate intensity exercise
5 times a week
OR
20 minutes of vigorous exercise
3 times a week
AND
8-12 repetitions of a muscle strengthening exercise
2 times a week
Involving all major muscle groups
Exercise duration can be broken up into 10 minute periods throughout the day.
Look at your questionnaire and determine if you are currently meeting these guidelines.
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Facilitator’s Adherence Checklist: Cardiovascular/Exercise Session
Please check off the following items that were covered in the session. Please note any items of
relevance for each session component. In particular, if there were barriers to the completion of
certain items, please note in the space provided the obstacles that presented a problem.

Administration of Stages of Change measures pre- and post- intervention
________________________________________________________________________
________________________________________________________________________
Review of group rules
________________________________________________________________________
________________________________________________________________________
Discussion of reactions from previous session
________________________________________________________________________
________________________________________________________________________
Introduction of session topic
________________________________________________________________________
________________________________________________________________________
Administration/Discussion of Heart Disease and Exercise Questionnaire
________________________________________________________________________
________________________________________________________________________
Psychoeducation about heart disease and exercise
________________________________________________________________________
________________________________________________________________________
Decisional Balance exercise
________________________________________________________________________
________________________________________________________________________
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Looking Forward exercise
________________________________________________________________________
________________________________________________________________________
Discussion/Ratings of Commitment/Confidence
________________________________________________________________________
________________________________________________________________________
Developing behavioral strategies
________________________________________________________________________
________________________________________________________________________
Elicit reactions to the session
________________________________________________________________________
________________________________________________________________________
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Session 3: Obesity/Diabetes/Diet

Measures Included:
Healthy Diet Stages of Change Measure
Eating Habits Questionnaire
Facilitator’s Adherence Checklist
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Healthy Diet Stages of Change Measure
For the purpose of this measure, A HEALTHY DIET is defined as incorporating fruits,
vegetables, low-fat dairy products, lean meats, and whole grains into your daily diet
and/or abiding by physician recommended dietary restrictions.
Please check the box that best fits your current eating habits:
1. I have been eating a healthy diet for over 6 months.
2. I have been eating a healthy diet for less than 6 months.
3. I plan to begin to eat a healthy diet in the next 30 days.
4. I plan to begin to eat a healthy diet in the next 6 months.
5. I have no plans to begin to eat a healthy diet.
6. I have always eaten a healthy diet.
Please circle your current stage of change corresponding to the number circled above.
1. I have been eating a healthy diet for a long time. I am using strategies to
continue this behavior. I am in the MAINTENANCE stage.
2. I have been eating a healthy diet. I am taking steps to avoid pitfalls or obstacles
to healthy eating. I am in the ACTION stage.
3. I am seriously considering a change to a healthy diet. I can see the benefits of
healthy eating and have a plan to start. I am in the PREPARATION stage.
4. I am considering the possibility of changing to a healthy diet, but remain unsure.
I may be trying small changes. I am in the CONTEMPLATION stage.
5. I do not want to eat a healthy diet. I am in the PRECONTEMPLATION stage.
6. I have always eaten a healthy diet. The stages of change model is not applicable
to me.
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Eating Habits Questionnaire
Please circle the answer which best describes your eating habits.
1) Have you been diagnosed with diabetes?
Yes
No
2) If you have physician recommended dietary restrictions, do you follow these restrictions?
Never/Rarely
Sometimes
Daily
3) How often do you incorporate these foods into your diet? Please circle the response that
best describes your diet.
Never/Rarely
Sometimes
Daily
Fruits
Vegetables

Never/Rarely

Sometimes

Daily

Low-fat or Fat-free
Dairy Products

Never/Rarely

Sometimes

Daily

Lean Meats
(e.g. chicken or fish
rather than steak)

Never/Rarely

Sometimes

Daily

Whole Grains
(e.g. brown rice, whole
grain bread)

Never/Rarely

Sometimes

Daily

4) How often do you eat fried food?
Never/Rarely

Sometimes

Daily

5) How often do you eat at a fast-food restaurant?
Never/Rarely
Sometimes

Daily

6) In which of these behaviors do you regularly engage?
Eating while watching television

Eating quickly

Eating while standing up

Overeating

Emotional eating

Giving into food cravings
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Eating Habits Questionnaire Scoring
Question 1:
If you have been diagnosed with DIABETES, the type of foods that you incorporate into your diet
may differ from those which are recommended in Question 3. Please refer to the dietary
guidelines that have been provided by your physician to distinguish if you are following your
recommended food guidelines.
Question 2:
If you are following your physician recommended dietary restrictions DAILY,
CONGRATULATIONS! You are taking huge steps to benefit your health.
If you are following your physician recommended dietary restrictions SOMETIMES,
CONGRATULATIONS! You are attempting to have an impact on your health. However, you may
need to increase your adherence to these restrictions to achieve the most benefit and avoid
negative health impacts.
If you are following your physician recommended dietary restrictions NEVER/RARELY, you need
to consider the negative impact that your eating habits have on your health and explore the
obstacles that keep you from changing your habits.
Question 3:
Although the recommended daily intake of food groups is different based on your age, gender,
and activity level, the USDA recommends DAILY intake of: fruits, vegetables, fat-free or low-fat
milk group foods (e.g. cheese, yogurt, milk), lean or low-fat meat, poultry, or fish, and whole
grains.
Look at your questionnaire and determine if you are currently meeting these guidelines.
Question 4 & 5:
The USDA recommends that most of your sources of fat come from fish, nuts, and vegetable
oils. Most Americans get enough of the oil they need from the foods they eat, such as nuts, fish,
cooking oil, and salad dressing. As such, your intake of fried and fast food should be limited.
Fried food, particularly those with a batter coating, and fast-food has been shown to be high in
fat content and can add unnecessary fat to your diet. Too much fat in your diet can lead to
numerous negative health consequences such as obesity, high blood pressure, high blood
cholesterol, coronary heart disease, diabetes and some cancers.
Questions 6:
Each of the behaviors listed increases the likelihood that you are eating food that is unhealthy,
that you are eating more food than necessary, and/or that you are eating without thinking, or
really savoring, the food that you are eating. If you have checked one or more of these
behaviors, you may want to consider changing these behaviors in order to promote positive
eating habits and optimal physical health.
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Facilitator’s Adherence Checklist: Obesity/Diabetes/Diet Session
Please check off the following items that were covered in the session. Please note any items of
relevance for each session component. In particular, if there were barriers to the completion of
certain items, please note in the space provided the obstacles that presented a problem.

Administration of Stages of Change measures pre- and post- intervention
________________________________________________________________________
________________________________________________________________________
Review of group rules
________________________________________________________________________
________________________________________________________________________
Discussion of reactions from previous session
________________________________________________________________________
________________________________________________________________________
Introduction of session topic
________________________________________________________________________
________________________________________________________________________
Administration/Discussion of Eating Habits Questionnaire
________________________________________________________________________
________________________________________________________________________
Psychoeducation about obesity, diabetes, and diet
________________________________________________________________________
________________________________________________________________________
Decisional Balance exercise
________________________________________________________________________
________________________________________________________________________
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Looking Forward exercise
________________________________________________________________________
________________________________________________________________________
Discussion/Ratings of Commitment/Confidence
________________________________________________________________________
________________________________________________________________________
Developing behavioral strategies
________________________________________________________________________
________________________________________________________________________
Elicit reactions to the session
________________________________________________________________________
________________________________________________________________________
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Session 4: Sexually Transmitted Diseases

Measures included:
Safe Sex Practices Stages of Change Measure
Safe Sex Behavior Questionnaire
Facilitator’s Adherence Checklist

38

Safe Sex Practices Stages of Change Measure
For the purpose of this measure, SAFE SEX PRACTICES are defined as the use of a
condom each time you engage in sexual activities and having only one sex partner at a
time.
Please check the box that best fits your current sexual behavior:
1. I have been engaging in safe sex practices for over 6 months.
2. I have been engaging in safe sex practices for less than 6 months.
3. I plan to begin engaging in safe sex practices in the next 30 days.
4. I plan to begin to engage in safe sex practices in the next 6 months.
5. I have no plans to begin practicing safe sex.
6. I am not sexually active.
Please circle your current stage of change corresponding to the number circled above.
1. I have not had unsafe sex in a long time. I am using strategies to prevent unsafe
sex. I am in the MAINTENANCE stage.
2. I have stopped having unsafe sex. I am in the ACTION stage.
3. I am seriously considering implementing safe sex behaviors. I can see the
benefits of safe sex. I am in the PREPARATION stage.
4. I am considering the possibility of changing my unsafe sex practices, but remain
unsure. I may be trying small changes. I am in the CONTEMPLATION stage.
5. I do not think my unsafe sex practices are a problem. I am not thinking of
changing my unsafe sex practices. I am in the PRECONTEMPLATION stage.
6. I have never had unsafe sex. The stages of change model is not applicable to me.
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Safe Sex Behavior Questionnaire
For the purposes of this measure, UNPROTECETED SEX is defined as engaging in sexual activities
(oral, anal, vaginal) without the use of a condom.
Please circle that answer that best reflects your sexual practices. Please be as honest as
possible.
1) I have never been tested for HIV or Hepatitis C.
Yes
No
2) Have you engaged in unprotected sex?
Yes
No
3) When you have/had sex, how often do/did you use condoms?
Every time
Sometimes
Never
4) Have you/Are you engaged in sex practices with multiple partners?
Yes
No
5) Have you used intravenous drugs?
Yes
No
6) Do you know the HIV and Hepatitis C status of your sex partner(s)?
Yes
No
7) Have you had unprotected sex with a prostitute?
Yes
No
8) Do you engage in sexual practices while under the influence of alcohol or illegal drugs?
Yes
No
9) Is your sex partner(s) at risk for having HIV or Hepatitis C? For example: Has he/she
engaged in unsafe sex practices, used intravenous drugs, or had sex for drugs or
money?
Yes
No
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Safe Sex Behavior Questionnaire Scoring
Question 1:
If you answered YES to Question 1, CONGRATULATIONS! You have made a big step
toward practicing safe and responsible sex and you have shown concern for the health
of yourself and your sexual partner(s).
If you answered NO to Question 1, you may want to consider the reasons that have kept
you from being tested for HIV and Hepatitis C as well as the negative outcomes that may
come from not finding out your disease status. Both HIV and Hepatitis C are found at
higher rates among veterans with PTSD than among veterans without PTSD or the
general public. By finding out your disease status, you can be treated, if necessary,
which increases positive outcomes for your health and longevity. In addition, by finding
out your disease status, you will be able to practice safe and responsible sex with your
partner(s).
Question 2 & 3:
If you answered NO to Question 2 and EVERYTIME to Question 3, CONGRATULATIONS!
You are practicing safe sex and are protecting yourself and your partner(s) from HIV,
Hepatitis C, and other sexually transmitted diseases.
If you answered SOMETIMES to Question 3, CONGRATULATIONS! You are trying to
practice safe sex; however, without consistent use of condoms you cannot be protected
against HIV and Hepatitis C. You may need to evaluate the situations in which you
practice unsafe sex and consider ways to change your unsafe behavior.
If you answered NEVER to Question 3, you are not engaging in safe sex practices. You
may be compromising your health and that of your partner(s) and are at greater risk of
acquiring HIV and Hepatitis C. You may want to consider the reasons that you choose to
practice unsafe sex and weigh the potential outcomes of these unsafe practices against
your reasons for practicing unsafe sex.
Question 4-9:
If you answered YES to any of these questions, you are at an increased risk of acquiring
and/or having HIV, Hepatitis C, or other sexually transmitted diseases.
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Facilitator’s Adherence Checklist: STDs Session
Please check off the following items that were covered in the session. Please note any items of
relevance for each session component. In particular, if there were barriers to the completion of
certain items, please note in the space provided the obstacles that presented a problem.

Administration of Stages of Change measures pre- and post- intervention
________________________________________________________________________
________________________________________________________________________
Review of group rules
________________________________________________________________________
________________________________________________________________________
Discussion of reactions from previous session
________________________________________________________________________
________________________________________________________________________
Introduction of session topic
________________________________________________________________________
________________________________________________________________________
Administration/Discussion of Safe Sex Behavior Questionnaire
________________________________________________________________________
________________________________________________________________________
Psychoeducation about safe sex
________________________________________________________________________
________________________________________________________________________
Decisional Balance exercise
________________________________________________________________________
________________________________________________________________________
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Looking Forward exercise
________________________________________________________________________
________________________________________________________________________
Discussion/Ratings of Commitment/Confidence
________________________________________________________________________
________________________________________________________________________
Developing behavioral strategies
________________________________________________________________________
________________________________________________________________________
Elicit reactions to the session
________________________________________________________________________
________________________________________________________________________
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Session 5: Substance Abuse

Measures included:
Alcohol Abuse Stages of Change Measure
Drug Abuse Stages of Change Measure
Alcohol Use Disorders Identification Test
Drug Use Questionnaire, Short Form
Facilitator’s Adherence Checklist
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Alcohol Abuse Stages of Change Measure
For the purpose of this measure, ALCOHOL ABUSE is defined as having three drinks in a
row.
Please circle the number of the statement that best fits your current drinking behavior:
1. I have not abused alcohol for over 6 months.
2. I have not abused alcohol within the last 6 months.
3. I plan to stop abusing alcohol in the next 30 days.
4. I plan to stop abusing alcohol in the next 6 months.
5. I have no plans to stop abusing alcohol.
6. I have never abused alcohol.
Please circle your current stage of change corresponding to the number circled above.
1. I have not abused alcohol in a long time. I am using strategies to prevent relapse.
I am in the MAINTENANCE stage.
2. I have quit abusing alcohol. I am taking steps to avoid triggers and seek help
from others. I am in the ACTION stage.
3. I am seriously considering no longer abusing alcohol. I can see the benefits of
quitting and have a plan to quit. I am in the PREPARATION stage.
4. I am considering the possibility of changing my alcohol abuse, but remain
unsure. I may be trying small changes. I am in the CONTEMPLATION stage.
5. I do not think my alcohol abuse is a problem. I am not thinking of quitting
abusing alcohol. I am in the PRECONTEMPLATION stage.
6. I have never abused alcohol. The stages of change model is not applicable to me.
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Drug Abuse Stages of Change Measure
For the purpose of this measure, DRUG ABUSE is defined as any use of illegal drugs (for
example: marijuana, heroin, methamphetamines) or any use of prescription drugs other
than as prescribed.
Please circle the number of the statement that best fits your current drug use:
1. I have not abused drugs for over 6 months.
2. I have stopped abusing drugs within the last 6 months.
3. I am planning to stop abusing drugs in the next 30 days.
4. I am thinking about stopping my drug abuse in the next 6 months.
5. I have no plans to stop abusing drugs.
6. I have never abused drugs.

Please circle your current stage of change corresponding to the number circled above.
1. I have not abused drugs in a long time. I am using strategies to prevent relapse. I
am in the MAINTENANCE stage.
2. I have stopped abusing drugs. I am taking steps to avoid triggers and seek help
from others. I am in the ACTION stage.
3. I am seriously considering no longer abusing drugs I can see the benefits of
quitting and have a plan to quit. I am in the PREPARATION stage.
4. I am considering the possibility of changing my drug abuse, but remain unsure. I
may be trying small changes. I am in the CONTEMPLATION stage.
5. I do not think my drug abuse is a problem. I am not thinking of quitting abusing
drugs. I am in the PRECONTEMPLATION stage.
6. I have never abused drugs. The stages of change model is not applicable to me.
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Alcohol Use Disorders Identification Test (AUDIT)
Place an X in the one box that best describes your answer to each question. (One drink is equal to
one can, glass, or bottle of beer, one shot of liquor or one mixed drink, or one glass of wine.)
Questions
1. How often do you have a drink
containing alcohol?
2. How many drinks containing
alcohol do you have on a typical
day when you are drinking?
3. How often do you have six or
more drinks on one occasion?
4. How often during the last year
have you found that you were
not able to stop drinking once
you had started?
5. How often during the last year
have you failed to do what was
normally expected of you
because of drinking?
6. How often during the last year
have you needed a first drink in
the morning to get yourself going
after a heavy drinking session?
7. How often during the last year
have you had a feeling of guilt or
remorse after drinking?
8. How often during the last year
have you been unable to
remember what happened the
night before because of your
drinking?
9. Have you or someone else
been injured because of your
drinking?
10. Has a relative, friend, doctor,
or other health care worker been
concerned about your drinking or
suggested you cut down?

0
Never

1
Monthly
or less
3 or 4

2
2-4 times a
month
5 or 6

3
2-3 times
a week
7 to 9

4
4 or more
times a week
10 or more

Less than
monthly
Less than
monthly

Monthly

Weekly

Monthly

Weekly

Daily or
almost daily
Daily or
almost daily

Never

Less than
monthly

Monthly

Weekly

Daily or
almost daily

Never

Less than
monthly

Monthly

Weekly

Daily or
almost daily

Never

Less than
monthly

Monthly

Weekly

Daily or
almost daily

Never

Less than
monthly

Monthly

Weekly

Daily or
almost daily

1 or 2

Never
Never

No

No

Yes, but
not in the
last year
Yes, but
not in the
last year

Yes, during
the last year
Yes, during
the last year

TOTAL

Each response is scored using the numbers at the top of each column. After completing the
questionnaire, please write the number that corresponds to the box in which you have placed an X in
the empty column to the right. Then, add the numbers and write the total in TOTAL box.
From “AUDIT: The alcohol use disorders identification test: Guidelines for use in primary care, second edition” by Babor, T. F.,
Higgins-Biddle, J. C., Saunders, J. B., & Monteiro, M. G., 2001, Geneva, Switzerland, The World Health Organization. Copyright 2001
by the World Health Organization. Reproduced with permission.
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AUDIT Scoring
Scores between 1 and 7:
Your drinking has not reached a dangerous level. You may have a few drinks each week, and
drinking may not have begun to cause trouble with other people in your life. If you have a score
toward the high end of this range, you might want to start paying more attention to how much
you are drinking, and how this may be affecting other people in your life.
Scores between 8 and 20:
You may be drinking every day, having blackouts, and feeling guilt or remorse after drinking
Once you start drinking, it may be difficult for you to stop , and you may be having trouble
following through on your responsibilities because of your drinking. You may have even hurt
someone in your life as a result of your drinking.
Scores between 21 and 40:
Your drinking has now reached a very dangerous level. Almost all the questions on the measure
probably sound very familiar to you. There may be days when you cannot even get out of bed
because of your drinking, and you may have trouble thinking about anything else. You may be
experiencing many physical problems as a result of your heavy drinking.

From “AUDIT: The alcohol use disorders identification test: Guidelines for use in primary care, second edition” by Babor, T. F.,
Higgins-Biddle, J. C., Saunders, J. B., & Monteiro, M. G., 2001, Geneva, Switzerland, The World Health Organization. Copyright 2001
by the World Health Organization. Adapted with permission.
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Drug Use Questionnaire
In the statements below, the term DRUG ABUSE refers to the use of drugs not including alcohol
during the past 12 months. Carefully read each question and determine if your answer is YES or
NO, then circle the appropriate response.
1) Have you used drugs other than those required for medical reasons?
Yes
No
1
0
__________
2) Do you abuse more than one drug at a time?
Yes
No
1
0
__________
3) Are you always able to stop using drugs when you want to?
Yes
No
0
1
__________
4) Have you had “blackouts” or “flashbacks” as a result of drug use?
Yes
No
1
0
__________
5) Do you ever feel bad or guilty about your drug use?
Yes
No
1
0
__________
6) Does your spouse (or parents) ever complain about your involvement with drugs?
Yes
No
1
0
___________
7) Have you neglected your family because of your use of drugs?
Yes
No
1
0
___________
8) Have you engage in illegal activities in order to obtain drugs?
Yes
No
1
0
___________
9) Have you ever experienced withdrawal symptoms (felt sick) when you stopped taking
drugs?
Yes
No
1
0
___________
10) Have you had medical problems as a result of your drug use (e.g. memory loss, hepatitis,
convulsions, bleeding, etc.)?
Yes
No
1
0
____________
After completing the questionnaire, for each answer circled, write the corresponding number in
the space provided next to the question. Then, add the number and write your total in the Total
space.
TOTAL____________
©1982 by the Addiction Research Foundation. Author: Harvey A. Skinner Ph.D. Copied with permission from the author.
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Drug Use Questionnaire Scoring
If you scored 0:
You reported no drug related problems.
If you scored 1-2:
You have reported a low incidence of drug related problems; however, this does not necessarily
mean that you are free of drug related problems. Consider the questions on which you endorsed
drug related problems to determine what areas of your life are being affected by your drug use.
If you scored 3-5:
You have reported a moderate number of drug related problems. Your drug use is affecting
several areas of your life. You will likely meet diagnostic criteria for a diagnosis of drug abuse.
You may want to consider seeking treatment for your drug abuse.
If you scored 6-8:
You have reported a substantial number of drug related problems. You may want to consider
seeking intensive treatment in order to change your current level of drug abuse.
If you scored 9-10:
You have reported a severe level of drug related problems that are likely impacting you in every
area of your life. You may want to consider seeking intensive treatment in order to change your
current level of drug abuse.

©1982 by the Addiction Research Foundation. Author: Harvey A. Skinner Ph.D. Copied with permission from the author.
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Facilitator’s Adherence Checklist: Substance Abuse Session
Please check off the following items that were covered in the session. Please note any items of
relevance for each session component. In particular, if there were barriers to the completion of
certain items, please note in the space provided the obstacles that presented a problem.

Administration of Stages of Change measures pre- and post- intervention
________________________________________________________________________
________________________________________________________________________
Review of group rules
________________________________________________________________________
________________________________________________________________________
Discussion of reactions from previous session
________________________________________________________________________
________________________________________________________________________
Introduction of session topic
________________________________________________________________________
________________________________________________________________________
Administration/Discussion of AUDIT and DAST-10
________________________________________________________________________
________________________________________________________________________
Psychoeducation about substance abuse
________________________________________________________________________
________________________________________________________________________
Decisional Balance exercise
________________________________________________________________________
________________________________________________________________________
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Looking Forward exercise
________________________________________________________________________
________________________________________________________________________
Discussion/Ratings of Commitment/Confidence
________________________________________________________________________
________________________________________________________________________
Developing behavioral strategies
________________________________________________________________________
________________________________________________________________________
Elicit reactions to the session
________________________________________________________________________
________________________________________________________________________
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Session 6: Tobacco Use

Measures included:
Tobacco Use Stages of Change Measure
Fagerström Test for Nicotine Dependence
Facilitator’s Adherence Checklist

53

Tobacco Use Stages of Change Measure
For the purpose of this measure, TOBACCO USE is defined as smoking cigars, cigarettes,
and the use of smokeless tobacco.
Please check the box that best fits your current tobacco use:
1. I have not used tobacco for over 6 months.
2. I have not used tobacco for less than 6 months.
3. I am planning to quit using tobacco in the next 30 days.
4. I am thinking about quitting using tobacco in the next 6 months.
5. I am not thinking about quitting using tobacco.
6. I have never used tobacco.
Please circle your current stage of change corresponding to the number circled above.
1. I have not used tobacco in a long time. I am using strategies to prevent relapse. I
am in the MAINTENANCE stage.
2. I have quit using tobacco. I am taking steps to avoid triggers and seek help from
others. I am in the ACTION stage.
3. I am seriously considering quitting using tobacco. I can see the benefits of
quitting and have a plan to quit. I am in the PREPARATION stage.
4. I am considering the possibility of quitting using tobacco, but remain unsure. I
may be trying small changes. I am in the CONTEMPLATION stage.
5. I do not think my tobacco use is a problem. I am not thinking of quitting tobacco
use. I am in the PRECONTEMPLATION stage.
6. I have never used tobacco. The stages of change model is not applicable to me.
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Fagerström Test for Nicotine Dependence
Please circle the answer which best fits your current smoking habits.
1. How soon after you wake up do you smoke your first cigarette?
a) After 60 minutes (0)
b) 31-60 minutes (1)
c) 6-30 minutes (2)
d) Within 5 minutes (3)

______

2. Do you find it difficult to refrain from smoking in places where it is forbidden?
No (0)
Yes (1)
______
3. Which cigarette would you hate most to give up?
a) The first in the morning (1)
b) Any other (0)

______

4. How many cigarettes per day do you smoke?
a) 10 or less (0)
b) 11-20 (1)
c) 21-30 (2)
d) 31 or more (3)

______

5. Do you smoke more frequently during the first hours after awakening than during the
rest of the day?
No (0)
Yes (1)
______
6. Do you smoke even if you are so ill that you are in bed most of the day?
No (0)
Yes (1)

______

After completing the questionnaire, for each answer circled write the corresponding
number in the space provided next to the question. Then add the numbers and write
your total in the Total space below.
TOTAL

______

From “The Fagerström test for nicotine dependence: A revision of the Fagerström Tolerance Questionnaire” by Heatherton, T. F.,
Kozlowski, L. T., Frecker, R. C., & Fagerström, K. O., 1991, British Journal of Addiction,86(9), 1119–1127. Copied with permission from
the author.

55

Fagerström Test for Nicotine Dependence Scoring

Score

Level of Dependence

0-2

Very low dependence

3-4

Low dependence

5

Medium dependence

6-7

High dependence

8-10

Very high dependence

Scores under 5:
Your level of nicotine dependence is still low. If desired, you should act now to change
your smoking habits before your level of dependence increases.
Scores of 5:
Your level of nicotine dependence is moderate. If you don’t quit soon, your level of
dependence on nicotine will increase until you may be seriously addicted.
Scores over 7:
Your level of dependence is high. You aren’t in control of your smoking – it is in control
of you. When you make the decision to quit, you may want to talk with your doctor
about nicotine replacement therapy or other medications to help you break your
addiction.

From “The Fagerström test for nicotine dependence: A revision of the Fagerström Tolerance Questionnaire” by Heatherton, T. F.,
Kozlowski, L. T., Frecker, R. C., & Fagerström, K. O., 1991, British Journal of Addiction,86(9), 1119–1127. Copied with permission from
the author.
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Facilitator’s Adherence Checklist: Tobacco Use Session
Please check off the following items that were covered in the session. Please note any items of
relevance for each session component. In particular, if there were barriers to the completion of
certain items, please note in the space provided the obstacles that presented a problem.

Administration of Stages of Change measures pre- and post- intervention
________________________________________________________________________
________________________________________________________________________
Review of group rules
________________________________________________________________________
________________________________________________________________________
Discussion of reactions from previous session
________________________________________________________________________
________________________________________________________________________
Introduction of session topic
________________________________________________________________________
________________________________________________________________________
Administration/Discussion of Fagerström Test for Nicotine Dependence
________________________________________________________________________
________________________________________________________________________
Psychoeducation about smoking
________________________________________________________________________
________________________________________________________________________
Decisional Balance exercise
________________________________________________________________________
________________________________________________________________________
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Looking Forward exercise
________________________________________________________________________
________________________________________________________________________
Discussion/Ratings of Commitment/Confidence
________________________________________________________________________
________________________________________________________________________
Developing behavioral strategies
________________________________________________________________________
________________________________________________________________________
Elicit reactions to the session
________________________________________________________________________
________________________________________________________________________

From “An Assessment Strategy for a Spirituality Group Intervention” by Romesser, J. M., 2005, Psy.D. dissertation, Pepperdine
University, United States -- California. Retrieved June 16, 2008, from Dissertations & Theses @ Pepperdine University - SCELC
database. (Publication No. AAT 3204843). Copyright 2006 by ProQuest Information and Learning Company. Adapted with permission
from the author.

58

Session 7: Aggressive Behavior/Gun Safety

Measures included:
Aggression Stages of Change Measure
Gun Safety Stages of Change Measure
Aggressive Behavior Questionnaire
Firearm Safety Questionnaire
Facilitator’s Adherence Checklist
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Aggression Stages of Change Measure
For the purpose of this measure, AGGRESSIVE DRIVING is defined as verbal outbursts or
physical gestures while driving; tailgating, cutting off, or chasing other drivers; driving
under the influence; or intentionally driving your vehicle into another object.
Please check the box that best fits your current driving behavior:
1. I have not driven aggressively for over 6 months.
2. I have not driven aggressively for less than 6 months.
3. I plan stop driving aggressively in the next 30 days.
4. I plan to stop driving aggressively in the next 6 months.
5. I don’t think my aggressive driving is a problem.
6. I do not drive.
Please circle your current stage of change corresponding to the number circled above.
1. I have not driven aggressively in a long time. I am in the MAINTENANCE stage.
2. I have stopped driving aggressively. I am in the ACTION stage.
3. I am seriously considering stopping driving aggressively. I can see the benefits
of stopping and have a plan to stop. I am in the PREPARATION stage.
4. I am considering the possibility of changing my aggressive driving, but remain
unsure. I may be trying small changes. I am in the CONTEMPLATION stage.
5. I do not think my aggressive driving is a problem. I am not thinking of stopping. I
am in the PRECONTEMPLATION stage.
6. I have never driven aggressively. The stages of change model is not applicable to
me.
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For the purpose of this measure, AGGRESSIVE BEHAVIOR is defined as making verbal
threats to others, assaulting others, engaging in acts of domestic violence, or
intentionally damaging property.
Please check the box that best fits your current aggressive behavior:
1. I have not been behaving aggressively for over 6 months.
2. I have not been behaving aggressively for less than 6 months.
3. I plan to stop behaving aggressively in the next 30 days.
4. I plan to stop behaving aggressively in the next 6 months.
5. I don’t think my aggressive behavior is a problem.
6. I have never behaved aggressively.
Please circle your current stage of change corresponding to the number circled above.
1. I have not been aggressive in a long time. I am using strategies to prevent
aggression. I am in the MAINTENANCE stage.
2. I have stopped being aggressive. I am taking steps to avoid triggers and seek help
from others. I am in the ACTION stage.
3. I am seriously considering changing my aggressive behavior. I can see the
benefits of stopping and have a plan to stop. I am in the PREPARATION stage.
4. I am considering the possibility of changing my aggressive behavior, but remain
unsure. I may be trying small changes. I am in the CONTEMPLATION stage.
5. I do not think my aggressive behavior is a problem. I am not thinking of changing.
I am in the PRECONTEMPLATION stage.
6. I have never behaved aggressively. The stages of change model is not applicable
to me.

61

Gun Safety Stages of Change Measure
For the purpose of this measure, GUN SAFETY is defined as always keeping your gun in a
gun safe, lock box, or locked cabinet or drawer, always keeping your gun unloaded until
it is ready to use, and always storing the bullets in a separate locked area.
Please check the box that best fits your current gun safety behavior:
1. I have implemented gun safety measures for over 6 months.
2. I have implemented gun safety measures for less than 6 months.
3. I plan to begin to implement gun safety measures in the next 30 days.
4. I plan to begin to implement gun safety measures in the next 6 months.
5. I don’t plan to begin to implement gun safety measures.
6. I do not own a gun.

Please circle your current stage of change corresponding to the number circled above.
1. I have implemented gun safety measures for a long time. I am in the
MAINTENANCE stage.
2. I have implemented gun safety measures. I am in the ACTION stage.
3. I am seriously considering implementing gun safety measures. I can see the
benefits of gun safety and have a plan to store my weapon/s safely. I am in the
PREPARATION stage.
4. I am considering the possibility of changing my gun safety behavior, but remain
unsure. I may be trying small changes. I am in the CONTEMPLATION stage.
5. I do not think my gun safety behavior is a problem. I am not thinking of changing.
I am in the PRECONTEMPLATION stage.
6. I do not own a gun. The stages of change model is not applicable to me.
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Aggressive Behavior Questionnaire
For the purposes of this assessment measure, AGGRESSIVE BEHAVIOR is defined as: 1) making
verbal threats to others, 2) assaulting others, 3) damaging property, and 4) aggressive driving.
1) Have you made verbal threats to others?
a. Yes, in the last year.
b. Yes, but over one year ago.
c. No, I have never done so.
2) Have you assaulted others?
a. Yes, in the last year.
b. Yes, but over one year ago.
c. No, I have never done so.
3) Have you intentionally damaged property?
a. Yes, in the last year.
b. Yes, but over one year ago.
c. No, I have never done so.
4) Have you engaged in verbal outbursts or made angry hand gestures while driving?
a. Yes, in the last year.
b. Yes, but over one year ago.
c. No, I have never done so.
5) Have you tailgated, intentionally cut-off, or chased other drivers?
a. Yes, in the last year.
b. Yes, but over one year ago.
c. No, I have never done so.
6) Have you driven after drinking or taking psychoactive drugs?
a. Yes, in the last year.
b. Yes, but over one year ago.
c. No, I have never done so.
7) Have you intentionally driven your vehicle into another object (e.g. another car, tree,
etc.)?
a. Yes, in the last year.
b. Yes, but over one year ago.
c. No, I have never done so.
8) In the past year, how frequently have you behaved in an aggressive manner (as defined
above)?
Never
Sometimes
Very Regularly
0

1

2

3

4

5

6

From “The High-Risk Behavior Questionnaire” by Ruzek, J., Sherker, J., Dorian, E., Zeller, M., Huss, M., Drescher, K., et al., 2000. An
unpublished instrument. Adapted with permission from the author.
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Aggressive Behavior Questionnaire Scoring
Question 1-3:
Questions 1-3 refer to aggressive behavior including verbal threats, assault, and intentional
damage of property. These questions seek to look at the severity of aggressive acts as reflected
by their recent occurrence.
For those questions to which you chose to answer C, you do not appear to have difficulty with
aggression in these areas.
For those questions to which you answered B, you have had difficulty controlling your
aggression in these areas in the past, but have taken steps to control your aggression and have
not acted aggressively in a long time.
For those questions to which you answered C, you have difficulty with aggression in these areas.
At times your aggression is not under your control. You may need to seek help in order to learn
to control your aggression.
Question 4-7:
Questions 4-7 refer to aggressive driving behavior. These questions increase in the severity of
their level of aggression. Question 4 refers to the least aggressive driving behavior on this
measure. The level of severity increases to Question 7, which reflects the most severe
aggressive driving behavior measured here. Please look at your answers at Questions 4-7 and
note which behaviors you answered with A or B.
For those questions to which you answered C, you have not been engaging in this type of
aggressive driving.
For those questions to which you answered B, you have been engaging in aggressive driving;
however, you have been taking steps to curb your aggressive driving and have not engaged in
aggressive driving for a long time.
For those questions to which you answered C, you have been engaging in aggressive driving. At
times, you aggressive driving is not under control. You may need to seek help to learn to control
your aggression.
Question 8:
Veterans with PTSD are much more likely to engage in aggressive acts than veterans without
PTSD or the general population. Please note how often you have behaved in an aggressive
manner in the last year. The more frequently you have engaged in aggressive acts, the more
severe your difficulty managing your aggression and the more risk you pose to yourself and
others.
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Firearm Safety Questionnaire
For the purposes of this questionnaire, FIREARM SAFETY is defined as: 1) keeping your
firearm(s) unloaded, 2) keeping your firearm(s) in a locked safe, cabinet, or case, 3)
keeping your firearm(s) protected with trigger, action or magazine locks, and 4) keeping
bullets in a locked place, separate from the firearm(s).
1) Do you keep all of your firearms in a safe manner (as defined above) whenever
they are not actively in use? (active use does not include having the gun out “for
protection”)
Yes

No

2) Have you kept all of your firearms in a safe manner when they are not in use for
the past 6 months?
Yes

No

3) Have your friends, family members, or mental health professional ever asked
you to get rid of any or all of your firearms?
Yes

No

4) In the past, have you ever considered suicide with a firearm?
Yes

No

5) In the past, have you ever attempted suicide with a firearm?
Yes

No

6) In the past, have you ever considered using a firearm to harm someone (not
including during a military or law enforcement job)?
Yes

No

7) In the past, have you ever fired a firearm at someone (not including during a
military or law enforcement job)?
Yes

No

From “The High-Risk Behavior Questionnaire” by Ruzek, J., Sherker, J., Dorian, E., Zeller, M., Huss, M., Drescher, K., et al., 2000. An
unpublished instrument. Adapted with permission from the author.
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Firearm Safety Questionnaire Scoring
Question 1 & 2:
If you answered YES to these questions, CONGRATULATIONS! You are keeping your guns
in a safe manner and have been doing so for some time. You are promoting safe
handling of weapons and decreasing the likelihood of a gun-related accident.
If you answered NO to these questions, you may want to reevaluate your gun safety
behaviors. Safe gun safety practices are recommended by the NRA as well as many
other organizations to avoid unwanted injuries, damage, or death. In some states,
improper gun safety may even be considered a crime.
Question 3-7:
Veterans with PTSD have been shown to be more likely to be aggressive and use
substances, both situations in which the likelihood of a gun related accident are
increased.
Veterans with PTSD have also been shown to have high rates of depression. A serious
symptom of depression may be suicidal thoughts. Most completed suicides happen
among men with firearms. When coupled with substance use, the risk of a completed
suicide is even higher.
Questions 3 through 7 refer to situations in which you may be at a higher risk of harming
yourself or someone else with your firearm. If you checked YES to any of these
questions, it may be essential that you maintain good firearm safety practices or that
you consider asking someone else to hold your weapons for you.
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Facilitator’s Adherence Checklist: Aggression and Gun Safety Session
Please check off the following items that were covered in the session. Please note any items of
relevance for each session component. In particular, if there were barriers to the completion of
certain items, please note in the space provided the obstacles that presented a problem.

Administration of Stages of Change measures pre- and post- intervention
________________________________________________________________________
________________________________________________________________________
Review of group rules
________________________________________________________________________
________________________________________________________________________
Discussion of reactions from previous session
________________________________________________________________________
________________________________________________________________________
Introduction of session topic
________________________________________________________________________
________________________________________________________________________
Administration/Discussion of Aggression and Gun Safety Behavior Questionnaires
________________________________________________________________________
________________________________________________________________________
Psychoeducation about aggression, aggressive driving, and gun safety
________________________________________________________________________
________________________________________________________________________
Decisional Balance exercise
________________________________________________________________________
________________________________________________________________________
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Looking Forward exercise
________________________________________________________________________
________________________________________________________________________
Discussion/Ratings of Commitment/Confidence
________________________________________________________________________
________________________________________________________________________
Developing behavioral strategies
________________________________________________________________________
________________________________________________________________________
Elicit reactions to the session
________________________________________________________________________
________________________________________________________________________

From “An Assessment Strategy for a Spirituality Group Intervention” by Romesser, J. M., 2005, Psy.D. dissertation, Pepperdine
University, United States -- California. Retrieved June 16, 2008, from Dissertations & Theses @ Pepperdine University - SCELC
database. (Publication No. AAT 3204843). Copyright 2006 by ProQuest Information and Learning Company. Adapted with permission
from the author.
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Session 8: Sleep Hygiene

Measures included:
Sleep Hygiene Stages of Change Measure
Sleep Questionnaire
Health Risk Stages of Change Measure
Health Behavior Frequency Measure
Facilitator’s Adherence Checklist
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Sleep Hygiene Stages of Change Measure
For the purpose of this measure, SLEEP HYGEINE is defined as 1) establishing a sleep
schedule, 2) avoiding caffeine, alcohol, and cigarettes before bedtime, 3) establishing an
appropriate setting in which to sleep, and 4) using the bed and bedroom only for sleep
and sex.
Please check the box that best fits your current sleep hygiene:
1. I have been practicing good sleep hygiene for over 6 months.
2. I have been practicing good sleep hygiene for less than 6 months.
3. I plan to begin to practice good sleep hygiene in the next 30 days.
4. I plan to begin to practice good sleep hygiene in the next 6 months.
5. I have no plans to practice good sleep hygiene.
6. I do not have sleep difficulties.
Please circle your current stage of change corresponding to the number circled above.
1. I have been practicing good sleep hygiene for a long time. I am using strategies
to continue this behavior. I am in the MAINTENANCE stage.
2. I have been practicing good sleep hygiene. I am taking steps to avoid pitfalls or
obstacles to poor sleep hygiene. I am in the ACTION stage.
3. I am seriously considering changing my sleep behavior. I can see the benefits of
good sleep hygiene and have a plan to start. I am in the PREPARATION stage.
4. I am considering the possibility of changing my sleep behavior, but remain
unsure. I may be trying small changes. I am in the CONTEMPLATION stage.
5. I do not want to change my sleep behavior. I am in the PRECONTEMPLATION
stage.
6. I have do not have sleep difficulties. The stages of change model is not applicable
to me.
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Sleep Questionnaire
1) Do you have difficulty sleeping? Please check all boxes that apply.
Difficulty falling asleep

Frequent nighttime awakenings

Inadequate amount of sleep

Poor sleep quality

2) Do you experience excessive daytime sleepiness?
Yes

No

3) How often do you experience sleep difficulties? (e.g. every night, once a month)__________
4) Do you experience:
Frequent nightmares

Frequent body or limb movement during sleep

Panic-like awakenings

Fears related to sleep (e.g. nightmares, dark)

5) Please check all that apply: Within 4 hours of bedtime, I…
Drink beverages containing alcohol

Eat

Drink beverages containing caffeine

Smoke

Use stimulant drugs

6) Please check all that apply: In general, I…
Get limited exercise

Watch television or work in bed

Find my mind races or worries in bed

Take frequent daytime naps

Have an inconsistent wake and/or sleep schedule
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Sleep Questionnaire Scoring
Question 1-3:
If you experience any of these symptoms on a regular basis, have done so for at least one
month, and if they impact your daily functioning, you may be experiencing sleep disturbances.
Sleep disturbances can be caused by a variety of different things such as a problem with your
sleep-wake cycle, a general medical condition, anxiety or depression, or substance use. If you
are experiencing sleep difficulties, you may want to have a thorough sleep evaluation.
Question 4:
These sleep disturbances are commonly experienced by veterans with PTSD and have been
shown to be related to the PTSD diagnosis. If you checked any of these boxes, your sleep
disturbance may be related to your trauma experience.
Question 5 & 6:
Many sleep difficulties can be remedied by practicing good sleep hygiene. If you checked any of
these boxes, your sleep habits may be contributing to your difficulty sleeping. You may want to
consider changing your sleep related behavior in order to create an environment that supports
healthy sleep. You may want to consider seeing a psychologist who can help you create a
behavioral plan to assist with these changes.
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Health Risk Stages of Change Measure
You have successfully completed the Live Long and Prosper group. You have learned
about health risk behaviors that are particularly relevant to veterans with PTSD,
increased your awareness of your own engagement in health-risk behaviors, and
reflected on your own willingness or need to change you behavior.
Please take a moment to consider any current behavior in which you engage that may
have a negative impact on your health. In particular, take time to reflect on the
following: your diet, level of engagement in exercise, sleep problems, substance use,
smoking, unsafe sex practices, level of aggression, and gun safety.

Please circle the number that best fits your current health related behavior:
1. I have been engaging in behavior that has positive health impacts regularly for over 6
months.
2. I have been engaging in behavior that has positive health impacts for less than 6
months.
3. I plan to begin to engage in behavior that has positive health impacts in the next 30
days.
4. I plan to begin to engage in behavior that has positive health impacts in the next 6
months.
5. I have no plans to begin engaging in behaviors that have positive health impacts.
6. I have always engaged in behavior that has positive health impacts.
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Please circle your current stage of change that corresponds to the the number circled
above.
1. I have been engaging in behavior that has positive health impacts regularly for a long
time. I am using strategies to continue this behavior. I am in the MAINTENANCE stage.
2. I have been engaging in behavior that has positive health impacts. I am taking steps
to avoid pitfalls or obstacles to my engagement in these positive behaviors. I am in the
ACTION stage.
3. I am seriously considering beginning to engage in behavior that has positive health
impacts. I can see the benefits these behaviors and have a plan to start. I am in the
PREPARATION stage.
4. I am considering the possibility of engaging in behaviors that have positive health
impacts, but remain unsure. I may be trying small changes. I am in the
CONTEMPLATION stage.
5. I do not want to change my behavior to engage in those with positive health
impacts. I am in the PRECONTEMPLATION stage.
6. I have always engaged in behavior that has positive health impacts. The stages of
change model is not applicable to me.
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Health Behavior Frequency Measure
This measure is designed to help determine your current engagement in a variety of
different behaviors that can impact on your health. Please circle the response that best
fits your current level of engagement in these behaviors. Please be as honest as
possible.
1) How often do you incorporate these foods into your diet? Please circle the response that
best describes your diet.
Never/Rarely
Sometimes
Daily
Fruits
Vegetables

Never/Rarely

Sometimes

Daily

Low-fat or Fat-free
Dairy Products

Never/Rarely

Sometimes

Daily

Lean Meats
(e.g. chicken or fish
rather than steak)

Never/Rarely

Sometimes

Daily

Whole Grains
(e.g. brown rice, whole
grain bread)

Never/Rarely

Sometimes

Daily

2) How often do you engage in:
a) Light intensity activities (e.g. casual walking, taking out the trash) per week?
Never

1 time

2 times

3 times

4 times

5 or more

4 times

5 or more

4 times

5 or more

4 times

5 or more

b) Moderate intensity activities (e.g. brisk walking) per week?
Never

1 time

2 times

3 times

c) Vigorous intensity activities (e.g. jogging, swimming laps) per week?
Never

1 time

2 times

3 times

d) Strengthening activities (e.g. sit-ups, weight lifting) per week?
Never

1 time

2 times

3 times
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3) Do you have difficulty falling or staying asleep?
Yes

No

4) On average, how many hours of sleep do you get each night? _______________
5) Have you ever been tested for HIV or Hepatitis C?
Yes

No

6) Have you engaged in unprotected sex (i.e. oral, anal, or vaginal sex without a condom)?
Yes

No

7) If so, how frequently do you engage in unprotected sex?
Almost Never

Sometimes

Almost Always

Every time

8) Have you made verbal threats to others?
Yes

No

If so, how often?
Rarely

Sometimes

Very Regularly

9) Have you assaulted others?
Yes

No

If so, how often?
Rarely

Sometimes

Very Regularly

10) Have you intentionally damaged property?
Yes

No

If so, how often?
Rarely

Sometimes

Very Regularly

11) Have you engaged in aggressive driving (e.g. verbal outbursts, angry hand gestures,
tailgating, driving under the influence, intentionally driving your vehicle into another object?)
Yes

No

If so, how often?
Rarely
12) Do you own firearms?

Sometimes

Very Regularly
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Yes

No

13) If you own a firearm, do you keep all of your firearms in a safe manner (e.g. unloaded, in a
locked area with protected locks and the bullets separate from the firearms)?
Yes

No

14) Do you drink alcohol?
Yes

No

15) If you drink alcohol, how often do you have a drink?
Monthly or less

2-4 times a month

2-3 times a week

4 or more times a week

16) On a typical day, how many drinks do you have?
1 or 2

3 or 4

5 or 6

7 to 9

10 or more

17) How often do you have 6 or more drinks on one occasion?
Never

Less than monthly

Monthly

Weekly

Daily or almost daily

18) Have you used drugs other than those required for medical reasons (e.g. abuse of
prescription medication or illegal drugs)?
Yes
No
19) If you use drugs, how often do you use them?
Monthly or less

2-4 times a month

2-3 times a week

4 or more times a week

20) Do you smoke cigarettes?
Yes

No

21) How many cigarettes do you smoke per day?
10 or less

11-20

21-30

31 or more

Thank you for completing this measure. Please return it to your group facilitator.
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Facilitator’s Adherence Checklist: Sleep Session
Please check off the following items that were covered in the session. Please note any items of
relevance for each session component. In particular, if there were barriers to the completion of
certain items, please note in the space provided the obstacles that presented a problem.

Administration of Stages of Change measures pre- and post- intervention
________________________________________________________________________
________________________________________________________________________
Review of group rules
________________________________________________________________________
________________________________________________________________________
Discussion of reactions from previous session
________________________________________________________________________
________________________________________________________________________
Introduction of session topic
________________________________________________________________________
________________________________________________________________________
Administration/Discussion of Sleep Hygiene Questionnaire
________________________________________________________________________
________________________________________________________________________
Psychoeducation about sleep problems and sleep hygiene
________________________________________________________________________
________________________________________________________________________
Decisional Balance exercise
________________________________________________________________________
________________________________________________________________________
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Looking Forward exercise
________________________________________________________________________
________________________________________________________________________
Discussion/Ratings of Commitment/Confidence
________________________________________________________________________
________________________________________________________________________
Developing behavioral strategies
________________________________________________________________________
________________________________________________________________________
Administration of Health Risk Stages of Change and Health Risk Behavior Measures
________________________________________________________________________
________________________________________________________________________
Elicit reactions to the session/intervention
________________________________________________________________________
________________________________________________________________________

From “An Assessment Strategy for a Spirituality Group Intervention” by Romesser, J. M., 2005, Psy.D. dissertation, Pepperdine
University, United States -- California. Retrieved June 16, 2008, from Dissertations & Theses @ Pepperdine University - SCELC
database. (Publication No. AAT 3204843). Copyright 2006 by ProQuest Information and Learning Company. Adapted with permission
from the author.
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